-DOCSTART- -X- N

surgery NN Surgical
operated VBN Surgical
on IN None
local JJ Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

auditory JJ Educational
selective JJ Educational
attention NN Educational
task NN Educational
( ( Educational
SAT NNP Educational
) ) Educational
-DOCSTART- -X- N

everolimus NN Pharmocological
everolimus VB Pharmocological
( ( None
immediate JJ Pharmocological
everolimus NN Pharmocological
n CC None
= VB None
65 CD None
) ) None
or CC None
week NN None
5 CD None
( ( None
delayed VBN None
everolimus NN None
, , None
DE NNP None
everolimus NN None
. . None
-DOCSTART- -X- N

creatine NN Pharmocological
phosphate NN Pharmocological
creatine NN Pharmocological
phosphate NN Pharmocological
plain VB Control
cardioplegic JJ Control
solutions NNS Control
( ( None
creatine VB Pharmocological
phosphate NN Pharmocological
) ) None
( ( None
control NN Control
) ) None
-DOCSTART- -X- N

gemcitabine NN Pharmocological
S-1 NNP Pharmocological
gemcitabine NN None
S-1 NNP None
S-1 NNP Pharmocological
gemcitabine NN Pharmocological
gemcitabine NN Pharmocological
S-1 NNP Pharmocological
-DOCSTART- -X- N

adrenaline NN Pharmocological
racemic JJ Pharmocological
adrenaline NN Pharmocological
( ( Pharmocological
RA NNP Pharmocological
) ) Pharmocological
topical JJ Pharmocological
gauze NN Pharmocological
sponges NNS Pharmocological
soaked VBN Pharmocological
in IN Pharmocological
either DT Pharmocological
1:500 CD Pharmocological
RA NNP Pharmocological
or CC None
0.9 CD Control
% NN Control
sodium NN Pharmocological
chloride NN Pharmocological
( ( Pharmocological
physiological JJ Pharmocological
saline NN Pharmocological
) ) Pharmocological
for IN None
3 CD None
min NN None
after IN None
adenoidectomy NN Surgical
. . None
Adrenaline NNP Pharmocological
adrenaline NN Pharmocological
adrenaline NN Pharmocological
adrenaline NN Pharmocological
-DOCSTART- -X- N

ebrotidine NN Pharmocological
placebo NN Control
The DT None
patients NNS None
were VBD None
assigned VBN None
to TO None
5 CD None
groups NNS None
: : None
placebo NN Pharmocological
, , None
200 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
400 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
600 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
800 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
ebrotidine JJ Pharmocological
once IN None
daily JJ None
. . None
Controls NNS None
were VBD None
performed VBN None
at IN None
baseline NN None
and CC None
every DT None
two CD None
weeks NNS None
at IN None
four CD None
follow-up JJ None
visits NNS None
unless IN None
ulcer NN None
healed VBN None
before RB None
. . None
were VBD None
used VBN None
to TO None
establish VB None
safety NN None
. . None
-DOCSTART- -X- N

walking-associated JJ Educational
cognitive JJ Educational
task NN Educational
simultaneously RB Educational
performed VBN Educational
cognitive JJ Educational
task NN Educational
cognitive JJ Educational
task NN Educational
-DOCSTART- -X- N

aripiprazole NN Pharmocological
aripiprazole NN Pharmocological
dosed VBN Pharmocological
flexibly RB Pharmocological
placebo NN Control
aripiprazole JJ Pharmocological
versus NN None
placebo NN Control
Aripiprazole NNP Pharmocological
-DOCSTART- -X- N

hybrid NN Physical
technique NN Physical
using VBG None
bipolar JJ Surgical
energy NN Surgical
in IN Surgical
transurethral JJ Surgical
resection NN Surgical
and CC None
vaporization NN Surgical
with IN Surgical
bipolar JJ Surgical
PlasmaKinetic NNP Surgical
energy NN Surgical
. . None
PlasmaKinetic NNP Surgical
surgery NN Surgical
or CC None
standard JJ Surgical
transurethral JJ Surgical
prostate NN Surgical
resection NN Surgical
( ( Surgical
TURP NNP Surgical
) ) Surgical
. . None
-DOCSTART- -X- N

prostate-specific JJ Pharmocological
antigen NN Pharmocological
corrected VBN Pharmocological
for IN Pharmocological
total JJ Pharmocological
prostate NN Pharmocological
volume NN Pharmocological
and CC None
transition NN Pharmocological
zone NN Pharmocological
volume NN Pharmocological
screening NN None
study NN None
, , None
of IN None
serum JJ None
prostate-specific JJ None
antigen NN None
levels NNS None
( ( None
PSA NNP None
) ) None
and CC None
PSA NNP None
corrected VBD None
for IN None
both DT None
the DT None
total JJ None
prostate NN None
volume NN None
( ( None
PSA-D NNP None
) ) None
and CC None
the DT None
transition NN None
zone NN None
volume NN None
( ( None
PSA-T NNP None
) ) None
. . None
Planimetric NNP Physical
and CC Physical
prolate VB Physical
ellipsoid JJ Physical
volumes NNS Physical
of IN Physical
the DT Physical
total JJ Physical
prostate NN Physical
as RB Physical
well RB Physical
as IN Physical
of IN Physical
the DT Physical
transition NN Physical
zone NN Physical
were VBD None
measured VBN None
. . None
volumes NNS Physical
of IN Physical
57 CD Physical
radical JJ Physical
prostatectomy NN Physical
specimens NNS Physical
PSA NNP None
and CC None
PSA NNP None
corrected VBD None
for IN None
the DT None
volumes NNS None
measured VBN None
transition NN Physical
zone NN Physical
volume NN Physical
total JJ Physical
prostate NN Physical
volume NN Physical
; : None
-DOCSTART- -X- N

IFN NNP Pharmocological
alpha-N1 JJ Pharmocological
IFN NNP Pharmocological
i.m NN Pharmocological
. . Pharmocological
alpha-2a JJ Pharmocological
IFN NNP Pharmocological
i.m NN Pharmocological
. . Pharmocological
2 CD Pharmocological
alpha-2a JJ Pharmocological
IFN NNP Pharmocological
courses NNS None
-DOCSTART- -X- N

small JJ Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
small JJ Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
needle-knife JJ Physical
group NN Physical
physiotherapy NN Physical
group NN Physical
needle-knife JJ Physical
small JJ Physical
needle-knife JJ Physical
releasing NN Physical
therapy NN Physical
, , Physical
blocking VBG Physical
and CC Physical
functional JJ Physical
training NN Physical
. . Physical
physiotherapy NN Physical
ultra-short JJ Physical
wave NN Physical
, , Physical
modulated VBD Physical
medium NN Physical
frequency NN Physical
current JJ Physical
, , Physical
massage NN Physical
and CC Physical
functional JJ Physical
training NN Physical
. . Physical
needle-knife JJ Physical
needle-knife JJ Physical
needle-knife JJ Physical
physiotherapy NN Physical
Small NNP Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
-DOCSTART- -X- N

group NN Psychological
versus FW Psychological
individual JJ Psychological
cognitive JJ Psychological
behavioural JJ Psychological
therapy NN Psychological
group NN Psychological
and CC Psychological
individual JJ Psychological
cognitive JJ Psychological
behaviour NN Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
group NN Psychological
CBT NNP Psychological
or CC None
individual JJ Psychological
CBT NNP Psychological
. . None
group NN Psychological
vs. FW Psychological
individual JJ Psychological
CBT NNP Psychological
CBT NNP Psychological
group NN Educational
format NN Educational
of IN Educational
CBT NNP Educational
CBT NNP Psychological
. . None
-DOCSTART- -X- N

naltrexone CD Pharmocological
or CC None
to TO None
placebo VB Control
Naltrexone NNP Pharmocological
naltrexone NN Pharmocological
-DOCSTART- -X- N

brovincamine NN Pharmocological
oral JJ Pharmocological
brovincamine NN Pharmocological
cerebral JJ Physical
vasodilator NN Physical
oral JJ Pharmocological
brovincamine NN Pharmocological
untreated JJ Control
control NN Control
group NN Control
. . Control
visual JJ Control
field NN Control
examinations NNS Control
brovincamine NN Pharmocological
brovincamine NN Pharmocological
brovincamine NN Pharmocological
brovincamine NN Pharmocological
brovincamine NN Pharmocological
Oral NNP Pharmocological
brovincamine NN Pharmocological
-DOCSTART- -X- N

acupuncture VB Physical
acupuncture NN Physical
acupuncture NN Physical
acupuncture NN Physical
acupuncture NN Physical
Acupuncture NNP Physical
-DOCSTART- -X- N

web-based JJ Educational
patient NN Educational
activation NN Educational
intervention NN Educational
the DT Educational
intervention NN Educational
condition NN Educational
-- : Educational
Web-based JJ Educational
hypertension NN Educational
feedback NN Educational
, , Educational
based VBN Educational
on IN Educational
the DT Educational
individual JJ Educational
patient NN Educational
's POS Educational
self-report NN Educational
of IN Educational
health NN Educational
variables NNS Educational
and CC Educational
previous JJ Educational
BP NNP Educational
measurements NNS Educational
, , Educational
to TO Educational
prompt VB Educational
them PRP Educational
to TO Educational
ask VB Educational
questions NNS Educational
during IN Educational
their PRP$ Educational
next JJ Educational
physician NN Educational
's POS Educational
visit NN Educational
about IN Educational
hypertension NN Educational
care NN Educational
the DT Educational
control NN Educational
condition NN Educational
-- : Educational
Web-based JJ Educational
preventive JJ Educational
health NN Educational
feedback NN Educational
, , Educational
based VBN Educational
on IN Educational
the DT Educational
individual NN Educational
's POS Educational
self-report NN Educational
of IN Educational
receiving VBG Educational
preventive JJ Educational
care NN Educational
( ( None
e.g. UH None
pap JJ None
testing VBG None
) ) None
, , None
to TO Educational
prompt VB Educational
them PRP Educational
to TO Educational
ask VB Educational
questions NNS Educational
during IN Educational
their PRP$ Educational
next JJ Educational
physician NN Educational
's POS Educational
visit NN Educational
about IN Educational
preventive JJ Educational
care NN Educational
. . None
-DOCSTART- -X- N

enzymatically RB Pharmocological
depolymerized VBN Pharmocological
low JJ Pharmocological
molecular JJ Pharmocological
weight NN Pharmocological
heparin NN Pharmocological
( ( Pharmocological
LMW-heparin NNP Pharmocological
; : Pharmocological
Logiparin NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

home-based JJ Other
intervention NN Other
HBI NNP Other
HBI NNP Other
HBI NNP Other
HBI NNP Other
HBI NNP Other
-DOCSTART- -X- N

customized JJ Educational
letters NNS Educational
customized JJ Educational
letters NNS Educational
control NN Control
form-letter JJ Other
customizing VBG Educational
reminder NN Educational
letters NNS Educational
. . Educational
-DOCSTART- -X- N

Mexiletine NN Pharmocological
mexiletine NN Pharmocological
mexiletine NN Pharmocological
receive VB None
mexiletine NN Pharmocological
( ( Pharmocological
maximum JJ Pharmocological
dose NN Pharmocological
, , Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
for IN None
6 CD None
weeks NNS None
, , None
followed VBN Pharmocological
by IN Pharmocological
the DT Pharmocological
alternative JJ Pharmocological
intervention NN Pharmocological
for IN None
6 CD None
weeks NNS None
after IN None
a DT None
1-week JJ None
washout NN None
period NN None
. . None
in IN None
mexiletine JJ Pharmocological
mexiletine NN Pharmocological
placebo VB Pharmocological
placebo NN Pharmocological
mexiletine VB Pharmocological
placebo NN Pharmocological
. . None
mexiletine NN Pharmocological
placebo NN Pharmocological
. . None
Mexiletine NNP Pharmocological
-DOCSTART- -X- N

real-time JJ Physical
polymerase NN Physical
chain NN Physical
reaction NN Physical
assay NN Physical
-DOCSTART- -X- N

timolol/pilocarpine JJ Pharmocological
timolol NN Pharmocological
pilocarpine NN Pharmocological
timolol JJ Pharmocological
maleate NN Pharmocological
pilocarpine NN Pharmocological
HCl NNP Pharmocological
-DOCSTART- -X- N

lamotrigine NN Pharmocological
and CC None
carbamazepine NN Pharmocological
lamotrigine NN Pharmocological
and CC None
carbamazepine NN Pharmocological
oral JJ Pharmocological
lamotrigine NN Pharmocological
100 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
LTG NNP Pharmocological
100 CD Pharmocological
, , Pharmocological
n RB Pharmocological
= VBZ Pharmocological
115 CD Pharmocological
) ) Pharmocological
or CC None
200 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
LTG NNP Pharmocological
200 CD Pharmocological
, , Pharmocological
n RB Pharmocological
= VBZ Pharmocological
111 CD Pharmocological
) ) Pharmocological
or CC None
carbamazepine $ Pharmocological
600 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
CBZ NNP Pharmocological
lamotrigine NN Pharmocological
lamotrigine NN Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
CBZ NNP Pharmocological
CBZ NNP Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
CBZ NNP Pharmocological
lamotrigine NN Pharmocological
LTG NNP Pharmocological
LTG NNP Pharmocological
lamotrigine NN Pharmocological
carbamazepine NN Pharmocological
. . None
-DOCSTART- -X- N

stretching VBG Physical
durations NNS Physical
Static JJ Physical
stretching NN Physical
stretching VBG Physical
different JJ Physical
stretching VBG Physical
durations NNS Physical
static JJ Physical
stretching NN Physical
. . None
stretching JJ Physical
stretching VBG Physical
20-second JJ Physical
stretching NN Physical
180- JJ Physical
and CC Physical
300-second JJ Physical
stretching NN Physical
20-second JJ Physical
stretching NN Physical
stretching JJ Physical
300-second JJ Physical
stretching NN Physical
20-second JJ Physical
stretching NN Physical
300-second CD Physical
stretching VBG Physical
60-second JJ Physical
stretching NN Physical
stretching JJ Physical
durations NNS Physical
stretching NN Physical
180 CD Physical
seconds NNS Physical
of IN Physical
stretching VBG Physical
stretching VBG Physical
duration NN Physical
. . None
stretching VBG Physical
-DOCSTART- -X- N

posterior JJ Physical
tibial JJ Physical
nerve NN Physical
stimulation NN Physical
posterior JJ None
tibial JJ None
nerve NN None
stimulation NN None
posterior JJ None
tibial JJ None
nerve NN None
stimulation NN None
placebo NN None
Posterior NNP None
tibial JJ None
nerve NN None
stimulation NN None
-DOCSTART- -X- N

exogenous JJ Pharmocological
insulin NN Pharmocological
protocols NNS Pharmocological
exogenous JJ Pharmocological
insulin NN Pharmocological
reduced JJ Pharmocological
glucose JJ Pharmocological
load NN Pharmocological
and CC None
a DT None
physiologic JJ Pharmocological
insulin NN Pharmocological
infusion NN Pharmocological
-DOCSTART- -X- N

low-tilt JJ Physical
biphasic JJ Physical
waveform NN Physical
low-tilt JJ Pharmocological
waveform NN Pharmocological
conventional JJ Pharmocological
waveform NN Pharmocological
low-tilt JJ Physical
waveform NN Physical
conventional JJ Physical
waveform NN Physical
. . None
low-tilt JJ Physical
waveform NN Physical
conventional JJ Pharmocological
waveform NN Pharmocological
low-tilt JJ Pharmocological
biphasic JJ Pharmocological
waveform NN Pharmocological
-DOCSTART- -X- N

Laser NNP Physical
therapy NN Physical
combined VBN Physical
with IN Physical
brachytherapy NN Physical
Laser NNP Physical
therapy NN Physical
laser JJR Physical
therapy NN Physical
endoscopic NN Physical
Nd NN Physical
: : Physical
YAG NNP Physical
laser NN Physical
therapy NN Physical
laser NN Physical
brachytherapy NN Physical
. . None
brachytherapy NN Physical
brachytherapy NN Physical
-DOCSTART- -X- N

Rational-emotive JJ Psychological
therapy NN Psychological
rational-emotive JJ Psychological
therapy NN Psychological
and CC None
rational-emotive JJ Psychological
imagery NN Psychological
. . None
rational-emotive JJ Psychological
therapy NN Psychological
without IN Psychological
imagery NN Psychological
rational-emotive JJ Psychological
imagery NN Psychological
rational-emotive JJ Psychological
therapy NN Psychological
. . None
-DOCSTART- -X- N

amantadine NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
IFN-alpha NNP Pharmocological
plus CC Pharmocological
ribavirin JJ Pharmocological
[ NN Pharmocological
17 CD Pharmocological
] NN Pharmocological
amantadine NN Pharmocological
or CC None
placebo NN Control
amantadine NN Pharmocological
placebo NN Control
amantadine NN Pharmocological
IFN-alpha NNP Pharmocological
plus CC Pharmocological
ribavirin JJ Pharmocological
-DOCSTART- -X- N

succinylcholine NN Pharmocological
rocuronium NN Pharmocological
succinylcholine NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
mg RB Pharmocological
kg-1 NN Pharmocological
) ) Pharmocological
and CC Pharmocological
two CD Pharmocological
doses NNS Pharmocological
of IN Pharmocological
rocuronium NN Pharmocological
( ( Pharmocological
0.6 CD Pharmocological
and CC Pharmocological
0.9 CD Pharmocological
mg JJ Pharmocological
kg-1 NN Pharmocological
) ) Pharmocological
electromyography NN Other
( ( Other
EMG NNP Other
) ) Other
and CC Other
acceleromyography NN Other
electromyographic JJ Other
method NN Other
rocuronium NN Pharmocological
rocuronium $ Pharmocological
rocuronium NN Pharmocological
rocuronium NN Pharmocological
succinylcholine NN Pharmocological
-DOCSTART- -X- N

verbal JJ Psychological
responsiveness NN Psychological
verbal JJ Psychological
responsiveness NN Psychological
Parent NNP Psychological
verbal JJ Psychological
utterances NNS Psychological
videotapes NNS Educational
of IN Educational
naturalistic JJ Educational
parent-child JJ Educational
play NN Educational
sessions NNS Educational
interval JJ None
event-based JJ Educational
coding NN Educational
. . None
Parent NNP Psychological
verbal JJ Psychological
utterances NNS Psychological
-DOCSTART- -X- N

triple JJ Pharmocological
intrathecal JJ Pharmocological
therapy NN Pharmocological
triple JJ Pharmocological
IT NNP Pharmocological
therapy NN Pharmocological
triple NN Pharmocological
IT NNP Pharmocological
therapy NN Pharmocological
group NN Pharmocological
IT NNP Pharmocological
methotrexate NN Pharmocological
triple VB Pharmocological
IT NNP Pharmocological
therapy NN Pharmocological
IT NNP Pharmocological
methotrexate NNP Pharmocological
group NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

First-line JJ Pharmocological
cisplatin NN Pharmocological
with IN Pharmocological
docetaxel NN Pharmocological
or CC None
vinorelbine NN Pharmocological
Docetaxel NNP Pharmocological
( ( Pharmocological
DCT NNP Pharmocological
) ) Pharmocological
and CC None
cisplatin NN Pharmocological
( ( Pharmocological
CDDP NNP Pharmocological
) ) Pharmocological
doublet NN Pharmocological
vinorelbine NN Pharmocological
( ( Pharmocological
VNR NNP Pharmocological
) ) Pharmocological
and CC None
CDDP NNP Pharmocological
VNR/CDDP NNP Physical
CDDP NNP Pharmocological
75 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
plus CC Pharmocological
DCT NNP Pharmocological
75 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
CDDP $ Pharmocological
80 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
on IN Pharmocological
day NN Pharmocological
1 CD Pharmocological
plus CC Pharmocological
VNR NNP Pharmocological
30 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
G-CSF NNP Pharmocological
and/or JJ None
EPO NNP Pharmocological
DCT/CDDP NNP None
VNR/CDDP NNP Pharmocological
DCT/CDDP NNP Pharmocological
VNR/CDDP NNP Pharmocological
DCT/CDDP NNP Pharmocological
VNR/CDDP NNP None
VNR/CDDP NNP Pharmocological
VNR/CDDP NNP Pharmocological
DCT/CDDP NNP Pharmocological
-DOCSTART- -X- N

sham JJ Pharmocological
intravitreal JJ Pharmocological
injections NNS Pharmocological
. . None
sham NN Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
prompt JJ Physical
laser NN Physical
, , None
intravitreal JJ Pharmocological
ranibizumab NN Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
prompt JJ Physical
laser NN Physical
, , None
intravitreal JJ Pharmocological
ranibizumab NN Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
deferred JJ Physical
laser NN Physical
, , None
or CC None
intravitreal VB Pharmocological
triamcinolone JJ Pharmocological
acetonide JJ Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
prompt NN Physical
laser NN Physical
sham VB Physical
plus JJ Physical
prompt JJ Physical
laser NN Physical
real JJ Pharmocological
injection NN Pharmocological
Laser NNP Physical
treatment NN Physical
sham NN Physical
sometimes RB Physical
real JJ Physical
and CC Physical
sometimes RB Physical
sham JJ Physical
. . None
sham NN Physical
plus CC Physical
prompt JJ Physical
laser NN Physical
ranibizumab NN Physical
plus CC Physical
prompt JJ Physical
laser NN Physical
ranibizumab NN Physical
plus CC Physical
deferred JJ Physical
laser NN Physical
triamcinolone NN Pharmocological
plus CC Pharmocological
prompt JJ Pharmocological
laser NN Pharmocological
sham NN Pharmocological
injection NN Pharmocological
real JJ Pharmocological
injection NN Pharmocological
-DOCSTART- -X- N

pentazocine NN Pharmocological
morphine JJ Pharmocological
morphine NN Pharmocological
and CC Pharmocological
pentazocine NN Pharmocological
-DOCSTART- -X- N

heparin NN Pharmocological
( ( Pharmocological
dalteparin NN Pharmocological
) ) Pharmocological
oral JJ Pharmocological
anticoagulant JJ Pharmocological
therapy NN Pharmocological
receiving VBG None
extended VBN Pharmocological
duration NN Pharmocological
therapy NN Pharmocological
heparin NN Pharmocological
( ( None
dalteparin NN Pharmocological
) ) None
-DOCSTART- -X- N

infusion NN Pharmocological
of IN Pharmocological
GHRH NNP Pharmocological
antagonist NN Pharmocological
( ( Pharmocological
( ( Pharmocological
N-Ac-Tyr NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
, , Pharmocological
D-Arg NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
GHRH-29 NNP Pharmocological
( ( Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
) ) Pharmocological
or CC None
saline NN Control
for IN Control
a DT Control
12-h JJ Control
period NN Control
GHRH NNP Pharmocological
-DOCSTART- -X- N

didanosine JJ None
didanosine NN Pharmocological
( ( Pharmocological
ddI NN Pharmocological
) ) None
itraconazole NN Pharmocological
. . None
itraconazole JJ Pharmocological
alone NN Pharmocological
itraconazole JJ Pharmocological
with IN Pharmocological
simultaneous JJ Pharmocological
ddI NNS Pharmocological
single JJ Pharmocological
200-mg JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
itraconazole NN Pharmocological
or CC None
itraconazole NN Pharmocological
with IN Pharmocological
concomitant JJ Pharmocological
oral JJ Pharmocological
ddI NN Pharmocological
300 CD Pharmocological
mg NN Pharmocological
( ( None
two CD None
150-mg JJ None
tablets NNS None
) ) None
itraconazole NN Pharmocological
oral JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
ddI NNS Pharmocological
-DOCSTART- -X- N

induction NN Pharmocological
chemotherapy NN Pharmocological
Induction NNP Pharmocological
chemotherapy NN Pharmocological
radiation NN Physical
therapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
-DOCSTART- -X- N

interactive JJ Pharmocological
multimedia NN Pharmocological
learning NN Pharmocological
system NN Pharmocological
learning NN Physical
system NN Physical
-DOCSTART- -X- N

temporal JJ Educational
outcome NN Educational
temporal JJ Psychological
expectation NN Psychological
task NN Psychological
Videos NNP Psychological
representing VBG Psychological
movements NNS Psychological
-DOCSTART- -X- N

polyunsaturated JJ Pharmocological
Fatty NNP Pharmocological
acids NNS Pharmocological
dietary JJ Pharmocological
supplementation NN Pharmocological
of IN Pharmocological
polyunsaturated JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
PUFA NNP Pharmocological
) ) Pharmocological
PUFA NNP Pharmocological
PUFA NNP Pharmocological
PUFA NNP Pharmocological
placebo NN Control
PUFA NNP Pharmocological
. . Pharmocological
PUFA NNP Pharmocological
placebo NN Control
. . Control
PUFA NNP Pharmocological
placebo NN Control
Polyunsaturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
placebo VB Control
) ) None
Dietary NNP Pharmocological
PUFA NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

laryngeal JJ Surgical
tube-S JJ Surgical
Proseal NNP Surgical
laryngeal JJ Surgical
mask NN Surgical
Laryngeal NNP Physical
Tube NNP Physical
Sonda NNP Physical
( ( Physical
LTS NNP Physical
) ) Physical
ProSeal NNP Physical
Laryngeal NNP Physical
Mask NNP Physical
Airway NNP Physical
( ( Physical
PLMA NNP Physical
) ) Physical
LTS NNP Surgical
PLMA NNP Surgical
-DOCSTART- -X- N

Comprehensive NNP Psychological
cognitive-behavioural JJ Psychological
therapy NN Psychological
atypical JJ Pharmocological
neuroleptic JJ Pharmocological
amisulpride NN Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
single JJ None
dose NN None
of IN None
100 CD None
mg JJ None
ACT-178882 NNP Pharmocological
and CC None
treatment NN None
B NNP None
of IN None
diltiazem NN Pharmocological
300 CD None
mg NN None
once RB None
a DT None
day NN None
for IN None
13 CD None
days NNS None
and CC None
a DT None
single JJ None
dose NN None
of IN None
100 CD None
mg JJ None
ACT-178882 JJ None
on IN None
day NN None
4 CD None
. . None
-DOCSTART- -X- N

probucol NN Pharmocological
probucol NN Pharmocological
control NN Pharmocological
( ( Pharmocological
levamlodipine JJ Pharmocological
besylate NN Pharmocological
plus CC Control
benazepril JJ Control
10 CD Control
or CC Pharmocological
probucol VBN Pharmocological
group NN Pharmocological
( ( Pharmocological
levamlodipine JJ Pharmocological
besylate NN Pharmocological
plus CC Pharmocological
benazepril JJ Pharmocological
plus CC Pharmocological
probucol JJ Pharmocological
-DOCSTART- -X- N

entecavir NN Pharmocological
prophylaxis NN Pharmocological
antiviral JJ Pharmocological
prophylaxis NN Pharmocological
rituximab-based JJ Pharmocological
chemotherapy NN Pharmocological
prophylactic JJ Pharmocological
entecavir NN Pharmocological
( ( Pharmocological
ETV NNP Pharmocological
) ) Physical
before IN Physical
chemotherapy NN Pharmocological
to TO Physical
3 CD Physical
months NNS Physical
after IN Physical
completing VBG Physical
chemotherapy NN Pharmocological
( ( Physical
ETV NNP Physical
prophylactic JJ Physical
group NN Physical
, , Physical
n RB Physical
= VBZ Physical
41 CD Physical
) ) Physical
or CC None
to TO None
receive VB Physical
therapeutic JJ Physical
ETV NNP Physical
at IN Physical
the DT Physical
time NN Physical
of IN Physical
HBV NNP Physical
reactivation NN Physical
and CC Physical
hepatitis NN Physical
B NNP Physical
surface NN Physical
antigen NN Physical
( ( Physical
HBsAg NNP Physical
) ) Physical
reverse NN Physical
seroconversion NN Physical
since IN Physical
chemotherapy NN Physical
( ( Physical
control NN Physical
group NN Physical
, , Physical
n RB Physical
= VBZ Physical
39 CD Physical
) ) Physical
. . None
ETV NNP Physical
Antiviral NNP Pharmocological
prophylaxis NN Pharmocological
-DOCSTART- -X- N

leuprolide JJ Pharmocological
acetate JJ Pharmocological
3-month JJ Pharmocological
3-month JJ Pharmocological
leuprolide NN Pharmocological
depot NN Pharmocological
11.25- JJ Pharmocological
leuprolide JJ Pharmocological
acetate JJ Pharmocological
3-month JJ Pharmocological
Leuprolide NNP Pharmocological
acetate NN Pharmocological
depot NN Pharmocological
leuprolide JJ Pharmocological
acetate JJ Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

isotonic JJ Pharmocological
and CC None
hypertonic JJ Pharmocological
saline NN Pharmocological
solutions NNS Pharmocological
isotonic JJ Pharmocological
or CC None
hypertonic JJ Pharmocological
sodium NN Pharmocological
chloride JJ Pharmocological
solution NN Pharmocological
application NN Pharmocological
of IN Pharmocological
intranasal NN Pharmocological
isotonic NN Pharmocological
or CC None
hypertonic JJ Pharmocological
saline NN Pharmocological
. . None
saline JJ Pharmocological
solutions NNS Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
isotonic JJ Pharmocological
saline NN Pharmocological
isotonic JJ Pharmocological
or CC None
hypertonic JJ Pharmocological
saline NN Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
irrigation NN Pharmocological
-DOCSTART- -X- N

pharmacotherapy NN Pharmocological
olanzapine JJ Pharmocological
plus CC Pharmocological
sertraline JJ Pharmocological
vs. FW Pharmocological
olanzapine JJ Control
plus CC Control
placebo NN Control
. . Control
-DOCSTART- -X- N

receptor-? JJ None
pioglitazone NN None
PPAR-? NNP None
) ) None
pioglitazone NN None
could MD None
of IN None
45 CD None
mg JJ None
daily JJ None
pioglitazone NN None
versus NN None
placebo NN None
, , None
with IN None
a DT None
3-month JJ None
duration/arm NN None
and CC None
a DT None
2-month JJ None
washout NN None
treatment NN None
, , None
pioglitazone NN Pharmocological
significantly RB None
placebo NN None
. . None
Further NNP None
, , None
pioglitazone NN Pharmocological
significantly RB None
Addition NNP None
of IN None
pioglitazone NN Pharmocological
to TO None
RA NNP None
-DOCSTART- -X- N

Internet-based JJ Educational
multimedia NN Educational
program NN Educational
-DOCSTART- -X- N

supplementary JJ Pharmocological
antioxidant JJ Pharmocological
vitamin NNS Pharmocological
anti-oxidant JJ Pharmocological
vitamin NNS Pharmocological
antioxidant NN Pharmocological
vitamin NNS Pharmocological
colestipol/niacin VB Pharmocological
plus JJ None
diet JJ None
placebo JJ Control
plus CC Control
diet JJ Control
. . Control
vitamin NN Pharmocological
E NNP Pharmocological
vitamin NN Pharmocological
C NNP Pharmocological
placebo NN Control
vitamin NN Pharmocological
E NNP Pharmocological
vitamin NNS Pharmocological
E NN Pharmocological
E NNP Pharmocological
vitamin NN Pharmocological
C NNP Pharmocological
placebo NN Control
Supplementary NNP Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
-DOCSTART- -X- N

polymeric JJ Surgical
surgical JJ Surgical
sealant NN Surgical
( ( Surgical
CoSeal NNP Surgical
) ) Surgical
compared VBN None
to TO None
Gelfoam/thrombin NNP Surgical
for IN None
Each DT Surgical
treatment NN Surgical
was VBD Surgical
directly RB Surgical
applied VBN Surgical
to TO Surgical
the DT Surgical
suture NN Surgical
line NN Surgical
after IN Surgical
confirmation NN Surgical
of IN Surgical
anastomotic JJ Surgical
bleeding NN Surgical
. . Surgical
polymeric JJ Surgical
sealant NN Surgical
CoSeal NNP Surgical
polymeric JJ Surgical
sealant NN Surgical
-DOCSTART- -X- N

conventional JJ Physical
arm NN Physical
exercise NN Physical
program NN Physical
robot-assisted JJ Physical
planar NN Physical
reaching NN Physical
( ( Physical
gravity NN Physical
compensated VBN Physical
) ) Physical
, , None
combined VBN Physical
planar NN Physical
with IN Physical
vertical JJ Physical
robot-assisted JJ Physical
reaching NN Physical
intensive JJ Physical
conventional JJ Physical
arm NN Physical
exercise NN Physical
program NN Physical
. . None
-DOCSTART- -X- N

ponezumab NN Pharmocological
placebo-controlled JJ Control
Ponezumab NNP Pharmocological
mg/kg NN None
ponezumab NN None
versus NN None
placebo NN None
Ponezumab NNP None
0.002 CD None
vs NN None
placebo NN None
) ) None
. . None
CONCLUSIONS VB None
mg/kg NNS None
ponezumab NN None
was VBD None
intravenous JJ None
ponezumab NN None
alters NNS None
-DOCSTART- -X- N

demonstration NN Educational
physician JJ Educational
intervention NN Educational
-DOCSTART- -X- N

Acamprosate NNP Pharmocological
placebo-controlled JJ Control
Acamprosate NNP Pharmocological
( ( None
calcium NN Pharmocological
acetylhomotaurinate NN Pharmocological
( ( Pharmocological
CA NNP Pharmocological
) ) Pharmocological
, , None
1.3 CD None
g/day NN None
) ) None
CA NNP Pharmocological
CA NNP Pharmocological
placebo NN Control
. . None
CA NNP Pharmocological
placebo NN Control
CA NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

synthetic JJ Pharmocological
zeaxanthin NN Pharmocological
. . None
Zeaxanthin NNP Pharmocological
zeaxanthin NN Pharmocological
zeaxanthin JJ Pharmocological
zeaxanthin NN Pharmocological
all-E-zeaxanthin JJ Pharmocological
. . None
Zeaxanthin NNP Pharmocological
zeaxanthin NN Pharmocological
zeaxanthin NN Pharmocological
-DOCSTART- -X- N

caudal JJ Physical
block NN Physical
diclofenac NN Pharmocological
suppository NN Pharmocological
caudal JJ Pharmocological
block NN Pharmocological
diclofenac JJ Pharmocological
suppository NN Pharmocological
and CC None
local JJ Pharmocological
anesthetic JJ Pharmocological
infiltration NN Pharmocological
Anesthesia NNP Pharmocological
was VBD None
carried VBN None
out RP None
using VBG None
the DT None
standard JJ None
procedure NN None
. . None
caudal JJ Pharmocological
block NN Pharmocological
with IN Pharmocological
bupivacaine NN Pharmocological
1 CD Pharmocological
mL/kg NN Pharmocological
after IN Pharmocological
anesthetic JJ Pharmocological
induction NN Pharmocological
. . None
diclofenac JJ Pharmocological
suppository JJ Pharmocological
3 CD Pharmocological
mg/kg JJ Pharmocological
postinduction NN Pharmocological
and CC Pharmocological
local JJ Pharmocological
anesthetic JJ Pharmocological
infiltration NN Pharmocological
at IN Pharmocological
the DT Pharmocological
port NN Pharmocological
sites VBZ Pharmocological
diclofenac JJ Pharmocological
suppository NN Pharmocological
anesthetic JJ Pharmocological
infiltration NN Pharmocological
diclofenac JJ Pharmocological
suppository NN Pharmocological
anesthetic JJ None
infiltration NN None
-DOCSTART- -X- N

continuous JJ Physical
glucose JJ Physical
monitoring NN Physical
( ( Physical
CGM NNP Physical
) ) Physical
-DOCSTART- -X- N

ibuprofen JJ Pharmocological
arginate NN Pharmocological
ibuprofen NN Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
standard JJ Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
200 CD Pharmocological
or CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
ibuprofen JJ Pharmocological
200 CD Pharmocological
or CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
or CC None
placebo NN Control
ibuprofen JJ Pharmocological
arginate NN Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
placebo NN Control
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
-DOCSTART- -X- N

brushings NNS Physical
before IN Physical
and CC Physical
after IN Physical
biopsy NN Physical
endoscopic JJ Physical
brushings NNS Physical
brushings NNS Surgical
undergo VB Physical
brushing VBG Physical
either CC Physical
before IN Physical
or CC Physical
after IN Physical
forceps JJ Physical
biopsy NN Physical
. . Physical
brushing NN None
-DOCSTART- -X- N

cytotoxic NN Pharmocological
chemotherapy NN Pharmocological
with IN None
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
and CC Pharmocological
etoposide NN Pharmocological
second JJ Pharmocological
line NN Pharmocological
chemotherapy NN Pharmocological
( ( None
methotrexate NN Pharmocological
and CC Pharmocological
doxorubicin NN Pharmocological
) ) None
or CC None
symptomatic JJ None
treatment NN None
only RB None
. . None
-DOCSTART- -X- N

Double-pulse JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
dpTMS NN Physical
) ) Physical
was VBD Physical
used VBN Physical
to TO Physical
examine VB Physical
inhibition NN Physical
by IN Physical
means NNS Physical
of IN Physical
short-interval JJ Physical
intracortical JJ Physical
inhibition NN Physical
( ( Physical
SICI NNP Physical
) ) Physical
of IN Physical
the DT Physical
contralateral JJ Physical
primary JJ Physical
motor NN Physical
cortex NN Physical
-DOCSTART- -X- N

temafloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
temafloxacin NN Pharmocological
and CC None
ciprofloxacin NN Pharmocological
183mg CD Pharmocological
once-daily JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
caffeine NN Pharmocological
placebo NN Pharmocological
, , None
temafloxacin CC Pharmocological
600mg CD Pharmocological
and CC None
ciprofloxacin VB Pharmocological
750mg CD Pharmocological
caffeine NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
and CC None
theophylline NN Pharmocological
. . None
temafloxacin NN Pharmocological
temafloxacin JJ Pharmocological
-DOCSTART- -X- N

adjuvant JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
adjuvant JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
total JJ Physical
abdominal JJ Physical
hysterectomy NN Physical
and CC None
bilateral JJ Physical
salpingo-oophorectomy JJ Physical
plus CC None
complementary JJ Physical
radium NN Physical
therapy NN Physical
on IN Physical
the DT Physical
vaginal JJ Physical
stump NN Physical
. . None
adjuvant VB Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
or CC Pharmocological
no DT Pharmocological
further JJ Pharmocological
treatment NN Pharmocological
. . None
gestonorone NN Pharmocological
caproate NN Pharmocological
( ( Pharmocological
17 CD Pharmocological
alpha-hydroxy-19-norpregn-4-en JJ Pharmocological
3 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
dione NN Pharmocological
caproate NN Pharmocological
) ) Pharmocological
administered VBD Pharmocological
i.m NN Pharmocological
. . None
at IN Pharmocological
the DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
200 CD Pharmocological
mg/week NN Pharmocological
for IN Pharmocological
1 CD Pharmocological
year NN Pharmocological
. . None
adjuvant JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
no DT Other
further JJ Other
treatment NN Other
) ) None
adjuvant JJ Pharmocological
therapy NN Pharmocological
hormone NN Pharmocological
adjuvant JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

paliperidone NN Pharmocological
paliperidone NN Pharmocological
paliperidone NN Pharmocological
risperidone NN Pharmocological
Paliperidone NNP None
-DOCSTART- -X- N

moderate JJ Pharmocological
dose JJ Pharmocological
multivitamin/mineral JJ Pharmocological
supplement NN Pharmocological
multivitamin/mineral JJ Pharmocological
supplement NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
vitamin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
6 CD Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

vitamin NN Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
D3 NNP Pharmocological
( ( Pharmocological
cholecalciferol NN Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
supplemental JJ Pharmocological
oral JJ Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
( ( None
placebo NN None
short-term JJ None
exposure NN None
to TO None
vitamin VB None
D NNP None
supplementation NN None
-DOCSTART- -X- N

Transcutaneous JJ None
electrical JJ None
nerve NN None
stimulation NN None
Transcutaneous JJ Control
electrical JJ Control
nerve NN Control
stimulation NN Control
( ( Control
TENS NNP Control
) ) Control
placebo-controlled JJ None
-DOCSTART- -X- N

received VBD None
7 CD None
weeks NNS None
wheelchair JJ Physical
training NN Physical
( ( None
3 CD None
week NN None
( ( None
-1 NN None
) ) None
, , None
70 CD None
min NN None
) ) None
at IN None
a DT None
low JJ None
intensity NN None
( ( None
30 CD None
% NN None
of IN None
the DT None
heart NN None
rate NN None
reserve NN None
) ) None
, , None
whereas IN None
the DT None
control NN Educational
group NN None
did VBD Educational
not RB Educational
receive VB Educational
training NN Educational
. . None
During IN None
pre- JJ None
and CC None
post-tests NNS None
, , None
submaximal JJ None
exercise NN None
was VBD None
performed VBN None
on IN None
a DT None
stationary JJ None
wheelchair NN Physical
ergometer NN None
at IN None
fixed JJ None
levels NNS None
of IN None
power NN None
output NN None
. . None
were VBD None
measured VBN None
. . None
-DOCSTART- -X- N

imipenem NN Pharmocological
meropenem NN Pharmocological
constant JJ None
30-min JJ None
infusion NN None
of IN None
either CC None
1 CD None
g NN None
of IN None
imipenem JJ Pharmocological
plus CC Pharmocological
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
cilastatin NN Pharmocological
or CC None
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
meropenem NN Pharmocological
. . None
determined VBN None
by IN None
two-compartment JJ Physical
model NN Physical
and CC None
a DT None
noncompartmental JJ Physical
technique NN Physical
. . None
-DOCSTART- -X- N

liu NN Pharmocological
wei NN Pharmocological
di NN Pharmocological
huang NN Pharmocological
jin NN Pharmocological
gui NN Pharmocological
shen NN Pharmocological
qi JJ Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
Liu NNP Pharmocological
Wei NNP Pharmocological
Di NNP Pharmocological
Huang NNP Pharmocological
Jin NNP Pharmocological
Gui NNP Pharmocological
Shen NNP Pharmocological
Qi NNP Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Chinese JJ Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
-DOCSTART- -X- N

testosterone NN Pharmocological
topical JJ Pharmocological
hormones NNS Pharmocological
local JJ Pharmocological
testosterone NN Pharmocological
received VBD Pharmocological
local JJ Pharmocological
estrogen NN Pharmocological
cream NN Pharmocological
; : None
study CC None
group NN None
2 CD None
received VBD None
local JJ Pharmocological
estrogen NN Pharmocological
and CC Pharmocological
testosterone NN Pharmocological
cream NN Pharmocological
; : Pharmocological
the DT None
control NN None
group NN None
received VBD None
nonhormonal JJ Control
lubricant JJ Control
KY NNP Control
gel NN Control
for IN Control
12 CD Control
weeks NNS Control
. . None
Local NNP Pharmocological
estrogen NN Pharmocological
-DOCSTART- -X- N

behavioral JJ Psychological
treatment NN Psychological
modified JJ Psychological
behavioral JJ Psychological
treatment NN Psychological
single-session NN Psychological
modified VBD Psychological
behavioral JJ Psychological
treatment NN Psychological
( ( Psychological
SSBT NNP Psychological
) ) Psychological
designed VBN None
to TO None
enhance VB None
sense NN None
of IN None
control NN None
over IN None
or CC None
waiting VBG Educational
list NN Educational
control NN Educational
condition NN Educational
( ( Educational
WL NNP Educational
) ) Educational
. . None
SSBT NNP Pharmocological
behavioral JJ Psychological
treatment NN Psychological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

contrast NN Physical
Meglumine NNP Pharmocological
iothalamate NN Pharmocological
( ( Pharmocological
Conray NNP Pharmocological
Meglumin NNP Pharmocological
) ) Pharmocological
, , None
sodium-calcium-meglumine JJ Pharmocological
metrizoate NN Pharmocological
( ( Pharmocological
Isopaque NNP Pharmocological
Cerebral NNP Pharmocological
) ) Pharmocological
and CC None
dimeglumine JJ Pharmocological
iocarmate NN Pharmocological
( ( Pharmocological
Dimerex NNP Pharmocological
) ) Pharmocological
Conray NNP Pharmocological
Meglumin NNP Pharmocological
Isopaque NNP Pharmocological
Cerebral NNP Pharmocological
and CC None
Conray NNP Pharmocological
Meglumin NNP Pharmocological
-DOCSTART- -X- N

soy-based JJ Pharmocological
dietary JJ Pharmocological
supplement NN Pharmocological
soy NN Pharmocological
protein NN Pharmocological
, , None
isoflavones NNS Pharmocological
, , None
and CC None
cotyledon VB Pharmocological
fiber NN Pharmocological
( ( Pharmocological
Abalon NNP Pharmocological
) ) Pharmocological
6 CD Pharmocological
weeks NNS Pharmocological
with IN Pharmocological
Abalon NNP Pharmocological
( ( Pharmocological
soy JJ Pharmocological
protein NN Pharmocological
isoflavones NNS Pharmocological
cotyledon VB Pharmocological
fiber NN Pharmocological
placebo NN Control
Abalon NNP Pharmocological
placebo NN Control
Abalon NNP Pharmocological
Abalon NNP Pharmocological
-DOCSTART- -X- N

histatin-containing JJ Pharmocological
mouthrinse NN Pharmocological
P-113 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
12 CD Pharmocological
amino NN Pharmocological
acid JJ Pharmocological
histatin-based JJ Pharmocological
peptide NN Pharmocological
mouthrinse NN Pharmocological
formulation NN Pharmocological
self-administered JJ Pharmocological
either DT Pharmocological
0.005 CD Pharmocological
% NN Pharmocological
, , Pharmocological
0.01 CD Pharmocological
% NN Pharmocological
, , Pharmocological
0.05 CD Pharmocological
% NN Pharmocological
P-113 NNP Pharmocological
or CC None
placebo NN Control
mouthrinse NN None
formulations NNS None
twice RB None
daily RB None
over IN None
a DT None
four CD None
week NN None
treatment NN None
period NN None
. . None
P-113 JJ Pharmocological
mouthrinse NN Pharmocological
. . None
P-113 NNP Pharmocological
P-113 NNP Pharmocological
mouthrinse NN Pharmocological
-DOCSTART- -X- N

resistance NN Physical
exercise NN Physical
eccentric JJ Educational
( ( Physical
ECC NNP Physical
) ) Physical
or CC Physical
concentric JJ Physical
( ( Physical
CONC NNP Physical
) ) Physical
contractions NNS Physical
exercise NN Physical
ECC NNP Physical
exercise NN Physical
. . None
CONC NNP Physical
exercise NN Physical
acute VB Physical
exercise NN Physical
accumulated JJ Educational
training NN Educational
-DOCSTART- -X- N

Phenobarbital JJ Pharmocological
phenytoin NN Pharmocological
phenobarbital NN Pharmocological
phenytoin NN Pharmocological
phenobarbital NN Pharmocological
phenytoin NN Pharmocological
Phenobarbital NNP Pharmocological
phenytoin NN Pharmocological
-DOCSTART- -X- N

Emergency NNP Educational
Clinical NNP Educational
Pathways NNP Educational
( ( Educational
ECP NNP Educational
) ) Educational
ECP NNP Educational
cluster-RCT NN None
-DOCSTART- -X- N

Amphotericin NNP Pharmocological
B NNP Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
administered VBN Pharmocological
in IN Pharmocological
dextrose JJ Pharmocological
versus NN None
lipid JJ Pharmocological
emulsion NN Pharmocological
. . None
amphotericin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
AmB NNP Pharmocological
) ) Pharmocological
dextrose NN Pharmocological
AmB NNP Pharmocological
infused VBD Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
dextrose NN Pharmocological
AmB NNP Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
AmB NNP Pharmocological
infused VBD None
in IN None
dextrose NN Pharmocological
AmB NNP Pharmocological
infused VBD Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
in IN None
dextrose NN Pharmocological
AmB NNP Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
. . None
AmB NNP Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
in IN None
lipid JJ None
emulsion NN None
dextrose NN Pharmocological
-DOCSTART- -X- N

n-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
group NN Pharmocological
, , Pharmocological
receiving VBG Pharmocological
4 CD Pharmocological
g/day NN Pharmocological
of IN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
concentrate NN Pharmocological
, , Pharmocological
or CC Pharmocological
to TO Pharmocological
a DT Pharmocological
control NN Control
group NN Control
. . Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
n-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

endoscopic NNS Physical
resection NN Physical
techniques NNS Physical
endoscopic JJ Physical
resection NN Physical
techniques NNS Physical
Fifty NNP Physical
endoscopic JJ Physical
resections NNS Physical
suck-and-ligate JJ Physical
device NN Physical
without IN Physical
prior JJ Physical
submucosa NN Physical
injection NN Physical
and CC Physical
the DT Pharmocological
cap NN Pharmocological
technique NN Pharmocological
with IN Pharmocological
prior JJ Pharmocological
submucosa JJ Pharmocological
injection NN Pharmocological
of IN Pharmocological
a DT Pharmocological
dilute JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
of IN Pharmocological
epinephrine NN Pharmocological
. . None
endoscopic NN None
therapy NN None
cap NN Educational
technique NN Educational
ligation NN Educational
technique NN Educational
-DOCSTART- -X- N

random NN Psychological
interval JJ Psychological
repetition NN Psychological
task NN Psychological
. . None
task NN Psychological
task NN Psychological
task NN Educational
task NN Educational
. . None
single-task JJ Psychological
random-interval JJ Psychological
dual-task JJ Psychological
single-task NN Psychological
dual-task JJ Psychological
-DOCSTART- -X- N

mixed JJ Physical
kinesio JJ Physical
taping-compression NN Physical
technique NN Physical
Kinesio NNP Physical
taping NN Physical
) ) None
an DT None
experimental JJ None
group NN None
to TO None
receive VB None
a DT None
mixed JJ None
KT-compression NNP None
treatment NN None
following VBG None
KT NNP None
recommendations NNS None
for IN None
gastrocnemius JJ None
muscle NN None
enhancement NN None
and CC None
functional JJ None
correction NN None
of IN None
the DT None
ankle NN None
, , None
and CC None
adding VBG None
2 CD None
tapes NNS None
to TO None
simulate VB None
traditional JJ None
compression NN None
bandages NNS None
( ( None
no DT None
KT NNP None
guidelines NNS None
) ) None
; : None
or CC None
( ( None
2 CD None
) ) None
a DT None
placebo NN None
control NN None
group NN None
for IN None
sham NN None
KT NNP None
. . None
after IN None
mixed JJ None
KT-compression NNP None
therapy NN None
. . None
placebo NN None
effect NN None
-DOCSTART- -X- N

abciximab NN Pharmocological
primary JJ Surgical
angioplasty NN Surgical
abciximab NN Pharmocological
( ( Pharmocological
ReoPro NNP Pharmocological
) ) Pharmocological
percutaneous JJ Surgical
coronary JJ Surgical
angioplasty NN Surgical
( ( Surgical
pPCI NN Surgical
) ) Surgical
. . None
abciximab NN Pharmocological
-DOCSTART- -X- N

psychotherapeutic JJ Educational
management NN Educational
. . None
psychotherapy NN Psychological
8 CD None
weeks NNS None
to TO None
one CD None
of IN None
three CD None
types NNS None
of IN None
psychotherapy NN Educational
or CC None
to TO None
an DT None
untreated JJ Control
control NN Control
group NN None
, , None
and CC None
were VBD None
followed VBN None
up RP None
six CD None
months NNS None
later RB None
. . None
psychotherapy NN Psychological
psychotherapy NN Psychological
. . None
-DOCSTART- -X- N

walnut NN Pharmocological
consumption NN Pharmocological
walnut NN Pharmocological
consumption NN Pharmocological
ad NN Pharmocological
libitum NN Pharmocological
diet JJ Pharmocological
enriched VBD Pharmocological
with IN Pharmocological
56 CD Pharmocological
g NNS Pharmocological
( ( Pharmocological
366 CD Pharmocological
kcal NN Pharmocological
) ) Pharmocological
walnuts/day NN Pharmocological
and CC None
an DT None
ad NN Control
libitum NN Control
diet NN Control
without IN Control
walnuts NNS Control
for IN Control
8 CD Control
weeks NNS Control
. . None
endothelial JJ Physical
function NN Physical
testing VBG Physical
-DOCSTART- -X- N

interferon NN Pharmocological
gamma NN Pharmocological
Recombinant NNP Physical
human JJ Physical
interferon NN Physical
gamma NN Physical
, , Physical
100 CD Physical
micrograms NNS Physical
, , Physical
was VBD Physical
administered VBN Physical
subcutaneously RB Physical
once RB Physical
daily JJ Physical
for IN Physical
21 CD Physical
days NNS Physical
( ( Physical
or CC Physical
until IN Physical
patient JJ Physical
discharge NN Physical
if IN Physical
prior JJ Physical
to TO Physical
21 CD Physical
days NNS Physical
) ) Physical
as IN Physical
an DT Physical
adjunct NN Physical
to TO Physical
standard VB Physical
antibiotic JJ None
and CC None
supportive JJ Physical
therapy NN Physical
. . None
interferon JJ Pharmocological
gamma-treated JJ Pharmocological
-DOCSTART- -X- N

topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
( ( Pharmocological
pennsaid NN Pharmocological
) ) Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
plus CC None
placebo JJ Control
oral JJ Control
capsules NNS Control
placebo VB Control
topical JJ Control
solution NN Control
plus CC None
oral JJ Pharmocological
diclofenac NN Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
-DOCSTART- -X- N

oestroprogestins NNS None
two CD None
estroprogestins NNS None
( ( None
EPs NNP None
) ) None
, , None
ethinyl-estradiol JJ Pharmocological
( ( None
EE NNP None
) ) None
30 CD None
mcg/drospirenone NN None
( ( None
DRSP NNP None
) ) None
3 CD None
mg NN None
, , None
and CC None
ethinyl-estradiol NN Pharmocological
( ( None
EE NNP None
) ) None
30 CD None
mcg/chlormadinone NN Pharmocological
acetate NN Pharmocological
( ( None
CMA NNP None
) ) None
2 CD None
mg NN None
EE/DRSP NNP None
EE/CMA NNP None
EE/DRSP NNP None
Estroprogestins NNP Pharmocological
EE NNP None
30 CD None
mcg/DRSP NN None
3 CD None
mg NN None
-DOCSTART- -X- N

placebo-controlled JJ Control
streptokinase NN Pharmocological
angioplasty JJ Physical
versus NN Physical
lone NN Physical
angioplasty JJ Physical
therapy NN Physical
thrombolytic JJ Pharmocological
agents NNS Pharmocological
percutaneous JJ Physical
transluminal JJ Physical
coronary NN Physical
angioplasty NN Physical
( ( Physical
PTCA NNP Physical
) ) Physical
therapy NN Physical
intravenous JJ Pharmocological
heparin NNS Pharmocological
oral JJ Pharmocological
aspirin NN Pharmocological
placebo NN Control
or CC None
streptokinase NN Pharmocological
PTCA NNP None
. . None
PTCA NNP None
placebo NN Control
streptokinase NNP Pharmocological
Angioplasty NNP None
placebo NN None
streptokinase NNP Pharmocological
placebo NN None
and CC None
streptokinase NN Pharmocological
placebo NN None
and CC None
streptokinase NN Pharmocological
streptokinase NN Pharmocological
streptokinase NN Pharmocological
therapy NN Pharmocological
PTCA NNP None
therapy NN None
PTCA NNP None
therapy NN None
streptokinase NN Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
sequential JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
. . None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
2 CD Pharmocological
mg NNS Pharmocological
estradiol RB Pharmocological
-DOCSTART- -X- N

analysis NN None
all-polyethylene JJ Pharmocological
versus NN Pharmocological
metal-backed JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
. . Pharmocological
all-polyethylene JJ Pharmocological
and CC Pharmocological
metal-backed JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
. . Pharmocological
all-polyethylene JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
metal-backed JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
. . Pharmocological
all-polyethylene JJ Pharmocological
tibial JJ Pharmocological
component NN Pharmocological
-DOCSTART- -X- N

Cirrhosis NN None
prophylactic JJ Pharmocological
therapy NN Pharmocological
propranolol NN Pharmocological
. . None
endoscopic NN Physical
therapy NN Physical
-DOCSTART- -X- N

venlafaxine NN Pharmocological
placebo NN Control
placebo NN Control
venlafaxine JJ Pharmocological
XR NNP Pharmocological
75 CD Pharmocological
and CC Pharmocological
150 CD Pharmocological
mg NN Pharmocological
venlafaxine JJ Pharmocological
venlafaxine NN Pharmocological
venlafaxine NN Pharmocological
-DOCSTART- -X- N

ball NN Educational
weight NN Educational
of IN Educational
a DT Educational
lighter JJR Educational
ball NN Educational
( ( Educational
Tachikara NNP Educational
Volley NNP Educational
Lite NNP Educational
) ) Educational
on IN Educational
tournament NN Educational
game NN Educational
play NN Educational
and CC Educational
pretest-to-posttest JJ Educational
improvement NN Educational
for IN Educational
a DT Educational
16-day JJ Educational
volleyball NN Educational
practice NN Educational
period NN Educational
. . None
lighter JJR Educational
balls NNS Educational
regulation NN Educational
balls NNS Educational
. . None
regulation NN Educational
balls NNS Educational
lighter JJR Educational
balls NNS Educational
regulation NN Educational
ball NN Educational
. . None
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
chemoendocrine NN Pharmocological
treatment NN Pharmocological
with IN None
that DT None
of IN None
endocrine NN Pharmocological
treatment NN Pharmocological
( ( Pharmocological
ET NNP Pharmocological
) ) Pharmocological
alone RB None
chemotherapy NN Pharmocological
or CC None
endocrine JJ Pharmocological
therapy NN Pharmocological
or CC None
combined VBN Pharmocological
chemoendocrine JJ Pharmocological
treatment NN Pharmocological
. . None
chemotherapy NN Pharmocological
ET NNP Pharmocological
Chemotherapy NNP Pharmocological
-DOCSTART- -X- N

satisfaction NN Educational
questionnaire NN Educational
questionnaire NN Educational
-DOCSTART- -X- N

Thyroid NNP Pharmocological
stimulating VBG Pharmocological
antibodies NNS Pharmocological
: : None
thyroid JJ Pharmocological
stimulating VBG Pharmocological
antibody NN Pharmocological
( ( Pharmocological
TSAb NNP Pharmocological
) ) Pharmocological
post-antithyroid JJ Pharmocological
drug NN Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

selenium NN Pharmocological
chemotherapy NN Pharmocological
radiotherapy NN Physical
. . None
chemotherapy NN Pharmocological
radiotherapy JJ Physical
-DOCSTART- -X- N

Domperidone NN None
, , None
metoclopramide NN None
, , None
and CC None
placebo NN None
. . None
gastric JJ Pharmocological
prokinetic JJ Pharmocological
drugs NNS Pharmocological
metoclopramide RB None
domperidone NN Pharmocological
or CC None
placebo NN None
metoclopramide NN None
domperidone NN None
placebo NN None
placebo NN None
, , None
domperidone NN None
metoclopramide RB Pharmocological
-DOCSTART- -X- N

amlodipine JJ Pharmocological
maleate NN Pharmocological
versus NN Pharmocological
amlodipine NN Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
. . None
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
amlodipine VB Pharmocological
maleate NN Pharmocological
or CC Pharmocological
amlodipine NN Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine VB Pharmocological
besylate NN Pharmocological
: : Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine NN Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
-DOCSTART- -X- N

adaptive JJ Educational
pacing NN Educational
therapy NN Educational
, , None
cognitive JJ Educational
behaviour NN Educational
therapy NN Educational
, , None
graded VBD Educational
exercise NN Educational
therapy NN Educational
specialist VB Other
medical JJ Other
care NN Other
cognitive JJ None
behaviour NN None
therapy NN None
( ( None
CBT NNP None
) ) None
graded VBN None
exercise NN None
therapy NN None
( ( None
GET NNP None
) ) None
pacing NN None
specialist NN None
health NN None
care NN None
. . None
and CC None
randomly RB None
allocated VBN None
by IN None
computer-generated JJ None
sequence NN None
to TO None
receive VB None
specialist NN None
medical JJ None
care NN None
( ( None
SMC NNP None
) ) None
alone RB None
or CC None
with IN None
adaptive JJ Educational
pacing VBG Educational
therapy NN Educational
( ( Educational
APT NNP Educational
) ) Educational
, , None
CBT NNP None
, , None
or CC None
GET NNP None
. . None
longitudinal JJ None
regression NN None
models NNS None
to TO None
compare VB None
SMC NNP None
alone RB None
with IN None
other JJ None
treatments NNS None
, , None
APT NNP Educational
with IN None
CBT NNP Educational
, , None
and CC None
APT NNP None
with IN None
GET NNP None
. . None
SMC-alone NNP Physical
-DOCSTART- -X- N

enflurane NN Pharmocological
and CC None
isoflurane NN Pharmocological
enflurane NN Pharmocological
and CC None
isoflurane NN Pharmocological
enflurane NN Pharmocological
and CC None
isoflurane NN Pharmocological
anesthesia NN None
. . None
enflurane NN Pharmocological
or CC None
isoflurane NN Pharmocological
enflurane NN Pharmocological
enflurane NN Pharmocological
; : None
isoflurane VB Pharmocological
. . None
Enflurane NNP Pharmocological
Isoflurane NNP Pharmocological
enflurane VB Pharmocological
. . None
-DOCSTART- -X- N

camel NN Pharmocological
milk NN Pharmocological
camel NN Pharmocological
milk NN Pharmocological
( ( Pharmocological
CM NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
raw JJ Pharmocological
and CC Pharmocological
boiled VBN Pharmocological
) ) Pharmocological
placebo VB Control
group NN Control
( ( Control
cow JJ Control
milk NN Control
) ) Control
-DOCSTART- -X- N

vitamin NN Pharmocological
A NNP Pharmocological
or CC Pharmocological
beta NN Pharmocological
carotene JJ Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
A DT Pharmocological
beta NN Pharmocological
carotene NN Pharmocological
placebo-controlled JJ Control
7000 CD None
?g NN None
of IN None
retinol NN None
equivalents NNS None
as IN None
retinyl NN None
palmitate NN None
, , None
42 CD None
mg NN None
of IN None
all-trans NNS None
beta JJ None
carotene NN None
, , None
or CC None
placebo NN None
. . None
the DT None
placebo NN None
the DT None
vitamin NN None
A NNP None
and CC None
beta NN None
carotene NN None
the DT None
placebo NN None
, , None
vitamin FW None
A NNP None
, , None
and CC None
beta NN None
carotene NN None
weekly JJ None
vitamin NN None
A DT None
or CC None
beta NN None
-DOCSTART- -X- N

growth NN Pharmocological
hormone-secretagogues NNS Pharmocological
thyrotropin-releasing JJ Pharmocological
hormone NN Pharmocological
. . Pharmocological
TRH NN Pharmocological
( ( Educational
one CD Educational
day NN Educational
) ) Educational
and CC None
placebo NN Control
Peptide NNP None
infusions NNS None
placebo NN Control
TRH NNP Pharmocological
GH-secretagogue NNP Pharmocological
-DOCSTART- -X- N

peer NN Educational
counseling VBG Educational
peer NN Educational
counseling VBG Educational
intervention NN Educational
peer-led JJ Educational
smoking NN Educational
cessation NN Educational
program NN Educational
or CC Educational
to TO Educational
usual JJ Educational
care NN Educational
. . None
usual JJ Educational
care NN Educational
, , Educational
peer NN Educational
counseling NN Educational
peer NN Educational
counseling VBG Educational
intervention NN Educational
programs NNS Educational
-DOCSTART- -X- N

ultrasound NN Physical
-DOCSTART- -X- N

salbutamol NN Pharmocological
4 CD Pharmocological
mg JJ Pharmocological
oral JJ Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
. . None
underwent VBD Pharmocological
the DT Pharmocological
same JJ Pharmocological
procedure NN Pharmocological
at IN Pharmocological
random NN Pharmocological
without IN Pharmocological
salbutamol NN Pharmocological
. . None
salbutamol NN Pharmocological
Salbutamol NNP Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
beta-sympathomimetic JJ Pharmocological
drugs NNS Pharmocological
-DOCSTART- -X- N

trivalent JJ Pharmocological
ferrum NN Pharmocological
preparation NN Pharmocological
trivalent JJ Pharmocological
ferrum NN Pharmocological
preparation NN Pharmocological
sacharose JJ Pharmocological
ferric JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
Venofer NNP Pharmocological
) ) Pharmocological
Venofer NNP Pharmocological
trivalent NN Pharmocological
saccharose VBD Pharmocological
ferric JJ Pharmocological
oxide JJ Pharmocological
-DOCSTART- -X- N

propranolol JJ Pharmocological
80 CD Pharmocological
mg NN Pharmocological
b.i.d. NN Pharmocological
atenolol RB Pharmocological
50 CD Pharmocological
mg NN Pharmocological
b.i.d NN Pharmocological
. . Pharmocological
and CC Control
placebo JJ Control
b.i.d NN Control
. . Control
propranolol NN Pharmocological
atenolol NN Pharmocological
placebo VB Control
Propranolol NNP Pharmocological
-DOCSTART- -X- N

Cyclosporine NNP Pharmocological
randomized VBN None
, , None
controlled VBN None
trial NN None
testing VBG None
the DT None
benefit NN None
of IN None
the DT None
Pgp NNP Pharmocological
modulator NN Pharmocological
, , None
cyclosporin VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
. . None
assigned VBN None
to TO None
treatment NN None
with IN None
cytarabine NN Pharmocological
and CC Pharmocological
infusional JJ Pharmocological
daunorubicin NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
intravenous JJ Pharmocological
CsA NNP Pharmocological
. . None
-DOCSTART- -X- N

Standard NNP Physical
red VBD Physical
cell NN Physical
serological JJ Physical
techniques NNS Physical
-DOCSTART- -X- N

gabapentin NN Pharmocological
placebo-controlled JJ Control
oral JJ Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
placebo NN Control
. . None
gabapentin NN Pharmocological
. . None
-DOCSTART- -X- N

laser-powered JJ Surgical
hydrokinetic JJ Surgical
system NN Surgical
Laser NNP Surgical
systems NNS Surgical
Er NNP Surgical
, , Surgical
Cr NNP Surgical
: : Surgical
YSGG NN Surgical
, , Surgical
laser NN Surgical
system NN Surgical
resin NN Physical
restorations NNS Physical
Er NNP Surgical
, , Surgical
Cr NNP Surgical
: : Surgical
YSGG NNP Surgical
laser NN Surgical
system NN Surgical
Er NNP Surgical
, , Surgical
Cr NNP Surgical
: : Surgical
YSGG NNP Surgical
laser NN Surgical
-DOCSTART- -X- N

Psychological JJ Psychological
adjustment NN Psychological
and CC None
levels NNS None
of IN None
self NN Psychological
esteem NN Psychological
directive JJ Psychological
visual-motor NN Psychological
intervention NN Psychological
( ( Psychological
DVMI NNP Psychological
) ) None
non-directive JJ Psychological
supportive JJ Psychological
intervention NN Psychological
( ( Psychological
NDSI NNP Psychological
) ) Psychological
. . None
NDSI NNP Psychological
DVMI NNP Psychological
. . None
-DOCSTART- -X- N

board NN Educational
game NN Educational
. . None
effectiveness NN Educational
of IN Educational
a DT Educational
board NN Educational
game NN Educational
as IN Educational
a DT Educational
primary JJ Educational
prevention NN Educational
teaching VBG Educational
strategy NN Educational
-DOCSTART- -X- N

parent-mediated JJ Educational
intervention NN Educational
experimental JJ Physical
intervention NN Physical
( ( Physical
Focused JJ Physical
Playtime NNP Physical
Intervention NNP Physical
, , Physical
FPI NNP Physical
) ) Physical
FPI NNP Physical
FPI NNP Physical
FPI NNP Physical
. . None
-DOCSTART- -X- N

tension-free JJ Surgical
hernioplasty NN Surgical
tension-free JJ Surgical
hernioplasty NN Surgical
tension-free JJ Physical
repairs NNS Physical
Cooper NNP Surgical
ligament NN Surgical
or CC Surgical
abdominal JJ Surgical
ring NN Surgical
repair NN Surgical
tension-free JJ Surgical
repair NN Surgical
; : None
abdominal JJ Surgical
ring NN Surgical
repair NN Surgical
Cooper NNP Surgical
ligament NN Surgical
repair NN Surgical
conventionel NN Surgical
herniotomies NNS Surgical
-DOCSTART- -X- N

Mediterranean NNP Other
diet NN Other
and CC None
high JJ Other
dietary JJ Other
acid NN Other
load NN Other
mixed JJ Other
nuts NNS Other
: : None
recommended JJ Control
low-fat JJ Other
diet NN Other
( ( Control
control VB Control
diet JJ Control
group NN Control
) ) Control
, , None
a DT None
Mediterranean NNP Other
diet NN Other
supplemented VBD Other
with IN Other
virgin JJ Other
olive JJ Other
oil NN Other
, , Physical
or CC None
a DT None
Mediterranean NNP None
diet NN None
supplemented VBD None
with IN None
mixed JJ None
nuts NNS None
. . None
Mediterranean NNP Other
diet NN Other
with IN Other
mixed JJ Other
nuts NNS Other
Mediterranean NNP Other
diet NN Other
with IN Other
nuts NNS Other
Mediterranean NNP Educational
dietary JJ Educational
pattern NN Educational
Mediterranean NNP Other
diet NN Other
without IN Other
mixed JJ Other
nuts NNS Other
or CC None
a DT None
control NN Control
diet NN Control
-DOCSTART- -X- N

carbohydrate-protein JJ Pharmocological
supplement NN Pharmocological
protein NN Pharmocological
to TO Pharmocological
a DT Pharmocological
carbohydrate NN Pharmocological
supplement NN Pharmocological
carbohydrate NN Pharmocological
carbohydrate-protein JJ Pharmocological
supplement NN Pharmocological
Supplements NNS None
( ( None
200 CD None
ml NN None
) ) None
were VBD None
provided VBN None
every DT None
20 CD None
min NN None
and CC None
consisted VBN None
of IN None
placebo NN Control
, , None
a DT None
7.75 CD None
% NN None
carbohydrate JJ Pharmocological
solution NN Pharmocological
, , None
and CC None
a DT None
7.75 CD None
% NN None
carbohydrate/1.94 NN Pharmocological
% NN Pharmocological
protein JJ Pharmocological
solution NN Pharmocological
. . None
carbohydrate NN Pharmocological
carbohydrate-protein JJ Pharmocological
supplementation NN Pharmocological
carbohydrate-protein JJ Pharmocological
carbohydrate NN Pharmocological
supplement NN Pharmocological
-DOCSTART- -X- N

laryngeal JJ Physical
tube NN Physical
suction-device NN Physical
( ( Physical
LTS-D NNP Physical
) ) Physical
single-use JJ Physical
laryngeal NN Physical
tube NN Physical
with IN Physical
suction NN Physical
option NN Physical
( ( Physical
LTS-D NNP Physical
) ) Physical
instead RB Surgical
endotracheal JJ Surgical
intubation NN Surgical
( ( Surgical
ET NNP Surgical
) ) Surgical
and CC Surgical
bag-mask-valve JJ Surgical
ventilation NN Surgical
( ( Surgical
BMV NNP Surgical
) ) Surgical
for IN Surgical
emergency NN Surgical
airway NN Surgical
management NN Surgical
could MD Surgical
LTS-D NNP Physical
LTS-D NNP Physical
ET NNP Surgical
BMV NNP Surgical
. . None
LTS-D NNP Physical
ET NNP Surgical
BMV NNP Surgical
LTS-D NNP Physical
ET NNP Surgical
and CC None
BMV NNP Surgical
. . None
LTS-D NNP Physical
ET NNP Surgical
BMV NNP Surgical
ET NNP Surgical
BMV NNP Surgical
. . None
-DOCSTART- -X- N

Clofarabine NNP Pharmocological
? . Pharmocological
fludarabine NN Pharmocological
busulfan NN None
of IN None
i.v NN None
. . None
busulfan NN None
( ( None
Bu NNP None
) ) None
and CC None
fludarabine NN Pharmocological
( ( None
Flu NNP None
) ) None
supplant VB None
Flu NNP None
with IN None
clofarabine NN Pharmocological
( ( None
Clo NNP None
) ) None
, , None
I-Clo NN None
: : None
Flu CD None
IV-single-agent NNP None
Clo NNP None
? . None
Flu NNP None
with IN None
i.v NN None
. . None
Bu NNP None
as IN None
-DOCSTART- -X- N

[ JJ Pharmocological
Afala NNP Pharmocological
placebo-controlled JJ Control
afala NN Pharmocological
afala NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
tablets NNS Pharmocological
4 CD Pharmocological
times NNS Pharmocological
a DT Pharmocological
day NN Pharmocological
placebo VB Control
-DOCSTART- -X- N

carbenicillin NN Pharmocological
ampicillin NN Pharmocological
carbenicillin NN Pharmocological
( ( Pharmocological
CB NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
ampicillin NN Pharmocological
( ( Pharmocological
AMP NNP Pharmocological
) ) Pharmocological
AMP JJ Pharmocological
CB NNP Pharmocological
CB NNP Pharmocological
AMP NNP Pharmocological
CB NNP Pharmocological
-DOCSTART- -X- N

Korean JJ None
version NN None
of IN None
the DT None
PEERS NNP None
( ( None
? . None
) ) None
parent-assisted JJ None
social JJ None
skills NNS None
training VBG None
program NN None
PEERS NNS None
( ( None
? . None
) ) None
( ( None
Program NNP None
for IN None
the DT None
Education NNP None
and CC None
Enrichment NNP None
of IN None
Relational NNP None
Skills NNP None
) ) None
is VBZ None
a DT None
Korean JJ None
version NN None
of IN None
PEERS NNP None
( ( None
? . None
) ) None
for IN None
PEERS NNP None
( ( None
? . None
) ) None
Treatment NN None
delayed VBN None
treatment NN None
control NN None
group NN None
-DOCSTART- -X- N

Divalproex NNP Pharmocological
sodium NN Pharmocological
vs NN None
placebo NN Control
divalproex NN Pharmocological
sodium NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
divalproex JJ Pharmocological
placebo JJ Control
divalproex NN Pharmocological
-DOCSTART- -X- N

imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
curettage VB Surgical
electrodesiccation NN Physical
Curettage NNP Surgical
and CC None
electrodesiccation NN Physical
( ( None
C NNP Physical
& CC Physical
D NNP Physical
) ) None
imiquimod NN Pharmocological
C NNP Surgical
& CC Surgical
D NNP Surgical
C NNP Physical
& CC Physical
D NNP Physical
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
or CC None
vehicle NN Pharmocological
cream NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
. . None
imiquimod JJ Pharmocological
vehicle NN Control
imiquimod NN Pharmocological
Imiquimod NNP Pharmocological
C NNP Surgical
& CC Surgical
D NNP Surgical
C NNP Surgical
& CC Surgical
D NNP Surgical
imiquimod JJ Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

L-5-HTP NNP Physical
placebo NN Control
) ) None
] NN None
L-5-HTP NNP Physical
placebo NN Control
placebo NN Control
- : None
L-5-HTP NNP Pharmocological
L-5-HTP NNP Pharmocological
- : None
placebo NN Control
L-5-HTP NNP Physical
-DOCSTART- -X- N

Tacrolimus/sirolimus NNP Pharmocological
vs NN Pharmocological
tacrolimus/methotrexate NN Pharmocological
tacrolimus NN Pharmocological
and CC Pharmocological
sirolimus NN Pharmocological
( ( Pharmocological
Tac/Sir NNP Pharmocological
) ) Pharmocological
tacrolimus NN Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
Tac/Mtx NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

investigation NN Physical
of IN Physical
the DT Physical
KeraVision NNP Physical
Intacs NNP Physical
. . None
KeraVision NNP Physical
Intacs NNP Physical
-DOCSTART- -X- N

individualized JJ Psychological
breast NN Psychological
cancer NN Psychological
risk NN Psychological
counseling NN Psychological
individualized JJ Psychological
breast NN Psychological
cancer NN Psychological
risk NN Psychological
counseling VBG Psychological
individualized VBN Psychological
breast NN Psychological
cancer NN Psychological
risk NN Psychological
counseling VBG Psychological
general JJ Control
health NN Control
counseling NN Control
( ( Control
control NN Control
) ) Control
risk NN Educational
counseling NN Educational
risk NN Psychological
counseling VBG Psychological
risk-counseling JJ Educational
programs NNS Educational
-DOCSTART- -X- N

sport-tinted JJ Physical
contact NN Physical
lenses NNS Physical
tinted JJ Physical
contact NN Physical
lenses NNS Physical
( ( Physical
CL NNP Physical
) ) Physical
two CD Physical
different JJ Physical
tinted VBN Physical
Nike NNP Physical
Maxsight NNP Physical
( ( Physical
Bausch NNP Physical
& CC Physical
Lomb NNP Physical
, , Physical
Rochester NNP Physical
, , Physical
NY NNP Physical
, , Physical
USA NNP Physical
) ) Physical
CL NNP Physical
in IN Physical
one CD Physical
eye NN Physical
, , None
while IN None
the DT None
contralateral JJ Control
eye NN Control
was VBD Control
fitted VBN Control
with IN Control
a DT Control
clear JJ Control
lens NNS Control
made VBN Control
of IN Control
the DT Control
same JJ Control
material NN Control
( ( None
Optima NNP None
38 CD None
, , None
Bausch NNP None
& CC None
Lomb NNP None
) ) None
. . None
-DOCSTART- -X- N

D-myo-inositol-1,2,6-trisphosphate NNP Pharmocological
D-myo-inositol-1,2,6-trisphosphate NNP Pharmocological
( ( Pharmocological
1,2,6-IP3 CD Pharmocological
) ) Pharmocological
1,2,6-IP3 JJ Pharmocological
isotonic JJ Pharmocological
saline NN Pharmocological
. . None
inositol-1,2,6-trisphosphate JJ Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
whole JJ Pharmocological
abdominal JJ Pharmocological
radiotherapy NN Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
prednisone NN Pharmocological
association NN Pharmocological
. . None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
adriamycin NN Pharmocological
, , None
prednisone NN Pharmocological
. . None
Chemotherapy NNP Pharmocological
-DOCSTART- -X- N

tamsulosin NN Pharmocological
placebo-controlled JJ Control
tamsulosin NN Pharmocological
tamsulosin JJ Pharmocological
placebo NN Control
tamsulosin NN Pharmocological
Tamsulosin NNP Pharmocological
-DOCSTART- -X- N

Bismuth NNP Pharmocological
subsalicylate NN Pharmocological
bismuth NN Pharmocological
subsalicylate NN Pharmocological
, , None
erythromycin JJ Pharmocological
ethylsuccinate NN Pharmocological
, , None
and CC None
placebo RB Control
bismuth NN Pharmocological
active JJ Pharmocological
bismuth NN Pharmocological
erythromycin NNS Pharmocological
placebo NNS Control
. . None
bismuth NN Pharmocological
erythromycin NN Pharmocological
placebo NNS Control
. . None
bismuth RB Pharmocological
placebo NN Control
. . None
bismuth NN Pharmocological
Erythromycin NN Pharmocological
bismuth NN Pharmocological
-DOCSTART- -X- N

low-dose JJ Pharmocological
antacids NNS Pharmocological
. . None
low-dose JJ Pharmocological
antacid NN Pharmocological
( ( Pharmocological
Maalox NNP Pharmocological
70 CD Pharmocological
H2-receptor NNP Pharmocological
antagonist NN Pharmocological
cimetidine NN Pharmocological
( ( Pharmocological
Tagamet NNP Pharmocological
antacid JJ Pharmocological
containing VBG Pharmocological
Mg NNP Pharmocological
and CC Pharmocological
Al NNP Pharmocological
hydroxide NN Pharmocological
( ( Pharmocological
M NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
4 CD Pharmocological
cimetidine NN Pharmocological
-DOCSTART- -X- N

triage NN None
room NN None
or CC None
the DT None
standard JJ None
care NN None
labor NN None
room NN None
. . None
standing VBG Physical
orders NNS Physical
in IN Physical
common JJ Physical
obstetric JJ Physical
problems NNS Physical
-DOCSTART- -X- N

lidocaine NN Pharmocological
lidocaine JJ Pharmocological
solutions NNS None
-DOCSTART- -X- N

oxidized VBN Pharmocological
regenerated VBN Pharmocological
cellulose NN Pharmocological
packed VBN Pharmocological
with IN Pharmocological
ORC NNP Pharmocological
gauze VBP Physical
soaked VBN Physical
in IN Physical
iodine NN Physical
ORC NNP Pharmocological
-DOCSTART- -X- N

growth NN Pharmocological
hormone CD Pharmocological
substitution NN Pharmocological
Growth NNP Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GH NNP Pharmocological
) ) Pharmocological
GH NNP Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
GH NNP Pharmocological
or CC None
placebo NN Control
in IN None
a DT None
dose NN None
of IN None
0.25 CD None
U/kg NNP None
GH NNP Pharmocological
. . None
placebo-controlled JJ Control
GHD NNP None
GHD NNP None
. . None
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

Simvastatin NNP Pharmocological
polyunsaturated JJ Pharmocological
phospholipids NNS Pharmocological
Simvastatin NNP Pharmocological
-DOCSTART- -X- N

life-style JJ None
changes NNS None
. . None
study NN None
, , None
consisting VBG None
of IN None
dietary JJ None
treatment NN None
and/or JJ None
increase NN None
of IN None
physical JJ None
activity NN None
or CC None
training NN None
with IN None
annual JJ None
check-ups NNS None
, , None
-DOCSTART- -X- N

titanoreine NN Pharmocological
titanoreine NN Pharmocological
titanoreine VB Pharmocological
control VB Control
group NN Control
without IN Control
titanoreine NN Control
titanoreine NN Pharmocological
titanoreine NN Pharmocological
Titanoreine NNP Pharmocological
-DOCSTART- -X- N

mexicor NN Pharmocological
mexicor NN Pharmocological
, , Physical
a DT Physical
Russian JJ Physical
cytoprotector NN Physical
mexidor NN Pharmocological
-DOCSTART- -X- N

Maternal NNP Educational
dietary JJ Educational
counseling NN Educational
to TO None
intervention NN None
and CC None
control NN None
and CC None
dietary JJ None
counseling NN None
who WP None
counseled VBD None
that IN None
dietary JJ None
counseling NN None
-DOCSTART- -X- N

multi-component JJ Educational
social JJ Educational
skills NNS Educational
intervention NN Educational
Junior NNP Educational
Detective NNP Educational
Training NNP Educational
Program NNP Educational
multi-component JJ Educational
social JJ Educational
skills NNS Educational
intervention NN Educational
Junior NNP Educational
Detective NNP Educational
Training NNP Educational
Program NNP Educational
-DOCSTART- -X- N

secretin NN Physical
secretin NN None
or CC None
placebo NN Control
secretin NN Physical
placebo JJ Control
-DOCSTART- -X- N

status NN None
of IN None
BRAF NNP None
c.1799T NN None
> VBZ None
A NNP None
( ( None
p.V600E NN None
) ) None
mutation NN None
and CC None
MSI NNP None
[ NNP None
5-fluorouracil CD None
and CC None
leucovorin NN None
( ( None
FU/LV NNP None
) ) None
vs. FW None
irinotecan JJ Pharmocological
( ( Pharmocological
CPT11 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
FU NNP Pharmocological
and CC Pharmocological
LV NNP Pharmocological
( ( Pharmocological
IFL NNP Pharmocological
) ) Pharmocological
; : Pharmocological
chemotherapy NN Pharmocological
IFL NNP Pharmocological
FU/LV NNP Pharmocological
IFL NNP Pharmocological
FU/LV NNP Pharmocological
irinotecan-based JJ Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

pioglitazone NN Pharmocological
( ( None
thiazolidinediones NNS Pharmocological
[ NNP Pharmocological
TZDs NNP Pharmocological
] NNP None
) ) None
pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
or CC None
placebo NN None
in IN None
addition NN None
to TO None
optimal VB None
medical JJ None
therapy NN None
. . None
TZD NNP Pharmocological
TZD NNP Pharmocological
placebo VB None
TZD NNP Pharmocological
TZD NNP Pharmocological
pioglitazone NN Pharmocological
-DOCSTART- -X- N

intra-arterial JJ Physical
PO2 NNP Physical
sensor NN Physical
-DOCSTART- -X- N

Cognitive-behavioral JJ Psychological
therapy NN Psychological
cognitive-behavioral JJ Psychological
therapy NN Psychological
( ( None
CBT NNP Psychological
) ) None
and CC None
standard JJ Pharmocological
medical JJ Pharmocological
care NN Pharmocological
( ( Pharmocological
SMC NNP Pharmocological
) ) Pharmocological
CBT NNP Psychological
SMC NNP Pharmocological
CBT NNP Educational
SMC NNP Pharmocological
) ) None
SMC NNP Pharmocological
CBT NNP Educational
cognitive-behavioral JJ Psychological
therapy NN Psychological
CBT NNP Educational
SMC NNP Pharmocological
SMC NNP Pharmocological
-DOCSTART- -X- N

Lithium NN Pharmocological
lithium NN Pharmocological
( ( None
lithium JJ Control
plus CC Control
early JJ Control
morning NN Control
sleep NN Control
deprivation NN Control
, , None
lithium NN Control
plus CC Control
a DT Control
control NN Control
sleep JJ Control
deprivation NN Control
procedure NN Control
, , None
and CC None
desipramine NN Control
with IN Control
either DT Control
of IN Control
the DT Control
two CD Control
sleep JJ Control
manipulations NNS Control
) ) None
Lithium NNP None
plus CC None
early JJ None
morning NN None
sleep JJ None
deprivation NN None
desipramine/sleep JJ Pharmocological
deprivation NN Pharmocological
sleep/pharmacologic JJ Physical
intervention NN Physical
-DOCSTART- -X- N

Bovine NNP Pharmocological
pericardium NN Pharmocological
vs NN None
dacron NN Pharmocological
Bovine NNP Pharmocological
pericardium NN Pharmocological
( ( Pharmocological
BP NNP Pharmocological
) ) Pharmocological
Dacron NNP Pharmocological
carotid JJ Surgical
endarterectomy NN Surgical
. . None
BP NNP Pharmocological
and CC None
Dacron NNP Surgical
patch NN Surgical
angioplasty NN Surgical
BP NNP Pharmocological
Dacron NNP Surgical
. . None
carotid JJ Surgical
cross-clamp JJ Surgical
removal NN Surgical
BP NNP Pharmocological
Dacron NNP Surgical
BP NNP Pharmocological
Dacron NNP Surgical
BP NNP Pharmocological
Dacron NNP Surgical
BP NNP Pharmocological
Bovine NNP Pharmocological
pericardium NN Pharmocological
Dacron NNP Surgical
. . None
BP NNP Pharmocological
. . None
BP NNP Pharmocological
Dacron NNP Surgical
-DOCSTART- -X- N

audiotapes NNS Educational
audiotapes NNS Educational
audiotaped VBN Educational
. . None
copy NN Educational
of IN Educational
the DT Educational
tape NN Educational
to TO Educational
play VB Educational
at IN Educational
home NN Educational
or CC Educational
not RB Educational
( ( Educational
control VB Educational
group NN Educational
) ) Educational
. . None
audiotape NN Educational
audiotapes NNS Educational
-DOCSTART- -X- N

Primary JJ Physical
stenting NN Physical
Primary NNP Surgical
intracoronary JJ Surgical
stent NN Surgical
placement NN Surgical
conventional JJ Physical
balloon NN Physical
angioplasty NN Physical
. . Physical
stent JJ Surgical
implantation NN Surgical
conventional JJ Physical
stented VBN Surgical
stented VBN Surgical
conventional JJ Pharmocological
stenting VBG Surgical
balloon VB Physical
angioplasty JJ Physical
alone RB Physical
-DOCSTART- -X- N

Faux NNP Educational
pas CC Educational
detection NN Educational
faux JJ Educational
pas NN Educational
task NN Educational
, , Educational
an DT Educational
advanced JJ Educational
test NN Educational
of IN Educational
theory NN Educational
of IN Educational
mind NN Educational
faux JJ Educational
pas NN Educational
-DOCSTART- -X- N

clopidogrel NN Pharmocological
clopidogrel NN Pharmocological
75 CD None
mg/day JJ None
plus CC None
aspirin JJ Pharmocological
81 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
89 CD None
) ) None
or CC None
placebo JJ Control
plus CC None
aspirin JJ Pharmocological
81 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
92 CD None
) ) None
for IN None
9 CD None
weeks NNS None
clopidogrel NN Pharmocological
plus CC None
aspirin JJ Pharmocological
placebo NN Control
plus CC None
aspirin NN Pharmocological
clopidogrel NN Pharmocological
-DOCSTART- -X- N

mitomycin-C JJ Pharmocological
vs. FW Pharmocological
5 CD Pharmocological
FU NNP Pharmocological
infusion NN Pharmocological
with IN Pharmocological
methyl-CCNU NN Pharmocological
5-fluorouracil JJ Pharmocological
96-hour CD Pharmocological
continuous JJ Pharmocological
infusions NNS Pharmocological
bolus JJ Pharmocological
mitomycin-C NN Pharmocological
or CC Pharmocological
oral JJ Pharmocological
methyl-CCNU JJ Pharmocological
. . None
Mitomycin-C JJ Pharmocological
and CC Pharmocological
methyl-CCNU JJ Pharmocological
5 CD Pharmocological
FU-mitomycin JJ Pharmocological
combination NN Pharmocological
combination NN Pharmocological
of IN Pharmocological
infusion NN Pharmocological
5 CD Pharmocological
FU NNP Pharmocological
and CC Pharmocological
methyl-CCNU JJ Pharmocological
5 CD Pharmocological
FU-mitomycin JJ Pharmocological
5 CD Pharmocological
FU-METHYL-CCNU JJ Pharmocological
methyl-CCNU JJ Pharmocological
mitomycin NN Pharmocological
5 CD Pharmocological
FU NNP Pharmocological
infusion NN Pharmocological
-DOCSTART- -X- N

night NN Physical
splint NN Physical
to TO None
eccentric VB Physical
exercises NNS Physical
use NN None
of IN None
a DT None
night NN Physical
splint NN Physical
eccentric JJ Physical
exercises NNS Physical
with IN Physical
a DT Physical
night NN Physical
splint NN Physical
eccentric JJ Physical
exercises NNS Physical
only RB Physical
heavy-load NN Physical
eccentric JJ Physical
training NN Physical
programme NN Physical
. . Physical
night NN Physical
splint NN Physical
in IN None
addition NN None
to TO None
eccentric JJ Physical
exercises NNS Physical
. . None
night NN Physical
splint NN Physical
night NN Physical
splint NN Physical
-DOCSTART- -X- N

oxytocin PRP Pharmocological
oxytocin RP Pharmocological
nasal JJ Pharmocological
spray NN Pharmocological
placebo NN Control
placebo NN Control
, , None
oxytocin JJ Pharmocological
oxytocin JJ Pharmocological
-DOCSTART- -X- N

thiopental NN Pharmocological
Propofol NNP Pharmocological
thiopental JJ Pharmocological
lidocaine NN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
lidocaine JJ Pharmocological
thiopental JJ Pharmocological
manual JJ Physical
venous JJ Physical
occlusion NN Physical
Propofol NNP Pharmocological
lidocaine JJ Pharmocological
thiopental JJ Pharmocological
thiopental JJ Pharmocological
Thiopental JJ Pharmocological
thiopental JJ Pharmocological
thiopental JJ Pharmocological
Thiopental JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
fluconazole JJ Pharmocological
fluconazole NN Pharmocological
or CC None
placebo NN Control
fluconazole NN Pharmocological
placebo VB Control
fluconazole VB Pharmocological
placebo NN Control
fluconazole JJ Pharmocological
fluconazole JJ Pharmocological
treatment NN Pharmocological
fluconazole NN Pharmocological
-DOCSTART- -X- N

Group NNP Educational
cognitive JJ Educational
behavior NN Educational
therapy NN Educational
Cognitive JJ Educational
behavioral JJ Educational
therapies NNS Educational
( ( Educational
CBT NNP Educational
) ) Educational
CBT NNP Educational
CBT NNP Educational
treatment-as-usual JJ Educational
( ( Educational
TAU NNP Educational
) ) Educational
CBT NNP Educational
TAU NNP Educational
CBT NNP Educational
CBT NNP None
TAU NNP None
CBT NNP None
-DOCSTART- -X- N

Extracorporeal NNP Physical
shock NN Physical
wave NN Physical
therapy NN Physical
( ( Physical
ESWT NNP Physical
) ) Physical
extracorporeal NN Physical
shock NN Physical
wave VBP Physical
therapy NN Physical
Heel NNP Physical
cups NNS Physical
ESWT NNP Physical
( ( None
3000 CD None
shock NN None
waves/session NN None
of IN None
0.2 CD None
mJ/mm2 NN None
) ) None
at IN None
weekly JJ None
intervals NNS None
. . None
nonsurgical JJ None
treatment NN None
( ( None
iontophoresis NN Pharmocological
with IN Pharmocological
diclofenac NN Pharmocological
and CC None
an DT None
oral JJ None
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
) ) None
-DOCSTART- -X- N

single- JJ Physical
and CC Physical
dual-coil JJ Physical
active JJ Physical
pectoral JJ Physical
defibrillation NN Physical
lead NN Physical
systems NNS Physical
. . Physical
single JJ Physical
dual JJ Physical
transvenous JJ Physical
coils NNS Physical
. . None
lead JJ Physical
configurations NNS Physical
( ( None
single JJ Physical
coil NN Physical
) ) None
( ( None
dual JJ Physical
coil NN None
) ) None
single-coil JJ Physical
dual-coil JJ Physical
dual-coil NN Physical
dual-coil NN Physical
single-coil NN Physical
-DOCSTART- -X- N

Fine NNP Surgical
needle JJ Surgical
aspiration NN Surgical
coupled VBN Surgical
with IN Surgical
real-time JJ Physical
PCR NNP Physical
: : None
methodology NN Physical
fine JJ Physical
needle JJ Physical
aspiration NN Physical
technique NN Physical
Multiplex NNP Physical
tandem VBD Physical
RT-PCR NNP Physical
painless JJ Physical
methodology NN Physical
-DOCSTART- -X- N

olopatadine JJ Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
ketorolac NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
olopatadine JJ Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
ketorolac NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
Olopatadine NNP Pharmocological
Ketorolac NNP Pharmocological
olopatadine NN Pharmocological
placebo NN Control
ketorolac NN Pharmocological
placebo NN Control
alternate NN Pharmocological
treatment NN Pharmocological
placebo NN Control
Olopatadine NNP Pharmocological
placebo VB Control
Ketorolac NNP Pharmocological
placebo VB Control
. . None
Olopatadine NNP Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
olopatadine NN Pharmocological
ketorolac NN Pharmocological
. . None
-DOCSTART- -X- N

dazmegrel NN Pharmocological
was VBD None
orally RB None
administered VBN None
to TO None
-DOCSTART- -X- N

clomipramine VB Pharmocological
desipramine VB Pharmocological
. . None
clomipramine NN Pharmocological
and CC None
desipramine NN Pharmocological
placebo JJ Control
-DOCSTART- -X- N

clinical JJ Physical
neurosensory JJ Physical
test NN Physical
patients NNS None
were VBD None
provided VBN None
a DT None
sensory JJ None
impairment NN None
score NN None
using VBG None
a DT None
three-level JJ None
drop-out JJ None
clinical JJ None
neurosensory NN None
test NN None
( ( None
NST NNP None
) ) None
, , None
and CC None
blind IN Surgical
comparisons NNS Surgical
were VBD Surgical
made VBN Surgical
with IN Surgical
the DT Surgical
surgical JJ Surgical
findings NNS Surgical
postoperatively RB Surgical
. . None
NST NNP Physical
NST NNP None
-DOCSTART- -X- N

overt JJ Educational
aggression NN Educational
scale NN Educational
for IN None
rating NN None
aggression NN None
-DOCSTART- -X- N

population-based JJ Other
crosssectional JJ Other
survey NN Other
-DOCSTART- -X- N

itraconazole JJ Pharmocological
versus NN None
fluconazole NN Pharmocological
Fluconazole NNP Pharmocological
Itraconazole NNP Pharmocological
itraconazole JJ Pharmocological
oral JJ Pharmocological
solution NN Pharmocological
fluconazole NN Pharmocological
itraconazole NN Pharmocological
( ( Pharmocological
itra JJ Pharmocological
) ) Pharmocological
fluconazole JJ Pharmocological
suspension NN Pharmocological
( ( Pharmocological
flu NN Pharmocological
) ) Pharmocological
Itraconazole NNP Pharmocological
solution NN None
fluconazole JJ Pharmocological
-DOCSTART- -X- N

propofol NN Pharmocological
. . Pharmocological
propofol NN Pharmocological
propofol NN Pharmocological
lignocaine NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
or CC None
normal JJ Control
saline JJ Control
2 CD Pharmocological
ml NN Pharmocological
to TO Pharmocological
the DT Pharmocological
propofol NN Pharmocological
before IN Pharmocological
injection NN Pharmocological
. . None
-DOCSTART- -X- N

U- NNP Surgical
and CC Surgical
H-type NNP Surgical
methods NNS Surgical
of IN Surgical
the DT Surgical
TVT NNP Surgical
SECUR NNP Surgical
procedure NN Surgical
U- JJ Surgical
and CC Surgical
H-type JJ Surgical
methods NNS Surgical
of IN Surgical
the DT Surgical
TVT NNP Surgical
SECUR NNP Surgical
( ( Surgical
TVT-S NNP Surgical
) ) Surgical
procedure NN Surgical
. . Surgical
two CD None
types NNS None
of IN None
TVT-S NNP None
U- JJ Surgical
or CC Surgical
H-type JJ Surgical
method NN Surgical
of IN Surgical
TVT-S. JJ Surgical
methods NNS Surgical
of IN Surgical
TVT-S NNP Surgical
U-type JJ Surgical
method NN Surgical
. . None
-DOCSTART- -X- N

botulinum JJ Pharmocological
toxin-A NN Pharmocological
: : Pharmocological
Botulinum NNP Pharmocological
toxin NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
BTX-A NNP Pharmocological
) ) Pharmocological
BTX-A NNP Pharmocological
placebo NN Control
100 CD Pharmocological
units NNS Pharmocological
BTX-A NNP Pharmocological
, , Pharmocological
diluted VBD Pharmocological
in IN Pharmocological
1 CD Pharmocological
ml NNS Pharmocological
saline NN Pharmocological
, , None
while IN None
the DT None
other JJ Control
half NN Control
received VBD Control
just RB Control
saline NN Control
BTX-A NNP Pharmocological
-DOCSTART- -X- N

one CD Educational
of IN Educational
which WDT Educational
was VBD Educational
given VBN Educational
treatment NN Educational
for IN Educational
8 CD Educational
days NNS Educational
and CC Educational
the DT Educational
other JJ Educational
for IN Educational
15 CD Educational
days NNS Educational
. . None
early RB Educational
discharge VBP Educational
-DOCSTART- -X- N

of IN None
nonintensive JJ None
parent NN None
training VBG None
plus CC None
care-as-usual JJ None
and CC None
care-as-usual JJ None
alone NN None
. . None
The DT None
training NN None
focused VBD None
on IN None
stimulating VBG None
joint JJ None
attention NN None
and CC None
language NN None
skills NNS None
and CC None
was VBD None
based VBN None
on IN None
the DT None
intervention NN None
described VBN None
by IN None
Drew NNP None
et CC None
al NN None
. . None
-DOCSTART- -X- N

bupivacaine NN Pharmocological
infiltration NN Pharmocological
0.25 CD Pharmocological
% NN Pharmocological
plain NN Pharmocological
bupivacaine NN Pharmocological
or CC Pharmocological
0.9 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
-DOCSTART- -X- N

Web-based JJ Educational
and CC Educational
print-delivered JJ Educational
tailored JJ Educational
interventions NNS Educational
Web-based JJ Educational
and CC Educational
a DT Educational
print-delivered JJ Educational
version NN Educational
of IN Educational
the DT Educational
Active NNP Educational
Plus NNP Educational
intervention NN Educational
-DOCSTART- -X- N

barrier NN Physical
cream NN Physical
and CC None
its PRP$ Physical
vehicle NN Physical
barrier NN Pharmocological
creams NNS Pharmocological
barrier NN Pharmocological
cream NN Pharmocological
moisturizing NN Pharmocological
vehicle NN Pharmocological
( ( None
verum NN Physical
or CC Physical
vehicle NN Physical
) ) Physical
over IN Physical
a DT Physical
period NN Physical
of IN Physical
4 CD Physical
weeks NNS Physical
. . None
barrier NN Pharmocological
cream NN Pharmocological
vehicle NN Physical
. . None
vehicle NN Pharmocological
-DOCSTART- -X- N

treatment NN None
-DOCSTART- -X- N

primaquine NN Pharmocological
regimens NNS Pharmocological
Fansidar NNP Pharmocological
( ( None
F. NNP None
Hoffmann-La NNP Other
Roche NNP Other
Ltd. NNP Other
Basel NNP Other
Switzerland NNP Other
) ) Other
( ( None
pyrimethamine NN Pharmocological
and CC None
sulfadoxine NN Pharmocological
) ) None
, , None
primaquine NN Pharmocological
artesunate NN Pharmocological
Fansidar NNP Pharmocological
pyrimethamine NN Pharmocological
and CC None
1,500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
sulfadoxine NN Pharmocological
Fansidar NNP None
( ( None
3 CD None
tablets NNS None
, , None
75 CD None
mg NN None
of IN None
pyrimethamine NN None
and CC None
1,500 CD None
mg NN None
of IN None
sulfadoxine NN None
primaquine NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg NN Pharmocological
a DT Pharmocological
day NN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
received VBN Pharmocological
primaquine NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg NN Pharmocological
a DT Pharmocological
day NN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
received VBN None
artesunate NN Pharmocological
primaquine VB Pharmocological
-DOCSTART- -X- N

Rapeseed NNP Other
and CC Other
soybean NN Other
products NNS Other
rapeseed NN Other
meal NN Other
and CC Other
cake NN Other
and CC Other
soybean NN Other
meal NN Other
and CC Other
cake NN Other
rapeseed NN Other
feeding VBG Other
soybean JJ Other
products NNS Other
. . Pharmocological
soybean JJ Other
meal NN Other
rapeseed VB Other
meal NN Other
soybean JJ Other
cake NN Other
rapeseed VB Other
cake NN Other
. . None
rapeseed NN Other
-DOCSTART- -X- N

eicosapentaenoic NN Pharmocological
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
eicosapentaenoic VBZ Pharmocological
acid NNS Pharmocological
( ( Pharmocological
EPA NNP Pharmocological
) ) Pharmocological
and CC None
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
EPA NNP Pharmocological
DHA NNP Pharmocological
olive JJ Control
oil NN Control
as IN Control
placebo NN Control
placebo NN Control
EPA NNP Pharmocological
DHA NNP Pharmocological
EPA NNP Pharmocological
EPA NNP Pharmocological
. . None
EPA NNP Pharmocological
DHA NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

non-ionic JJ Pharmocological
dimer NN Pharmocological
, , None
iodixanol NN Pharmocological
a DT Pharmocological
non-ionic JJ Pharmocological
monomer NN Pharmocological
, , Pharmocological
iohexol NN Pharmocological
non-ionic JJ Pharmocological
contrast NN Pharmocological
medium NN Pharmocological
iodixanol NN Pharmocological
monomeric NN Pharmocological
, , Pharmocological
non-ionic JJ Pharmocological
iohexol NN Pharmocological
. . None
iodixanol JJ Pharmocological
or CC Pharmocological
iohexol JJ Pharmocological
iodine NN Pharmocological
Iodixanol NN Pharmocological
Iohexol NNP Pharmocological
iohexol JJ Pharmocological
Iodixanol NNP Pharmocological
iohexol NN Pharmocological
. . Pharmocological
Iodixanol NNP Pharmocological
iohexol NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

dihydropyridine JJ Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
nitrendipine NN Pharmocological
placebo VB Control
nitrendipine VB Pharmocological
Nitrendipine NNP Pharmocological
placebo VB Control
nitrendipine JJ Pharmocological
nitrendipine NN Pharmocological
nitrendipine JJ Pharmocological
-DOCSTART- -X- N

heparin/hydrocortisone NN Pharmocological
i.v NN Pharmocological
. . None
catheters NNS Pharmocological
heparin JJ Pharmocological
hydrocortisone NN Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
control NN Control
chemotherapy NN Pharmocological
Vincristine NNP Pharmocological
1 CD None
mg NN None
, , None
cyclophosphamide RB Pharmocological
600 CD None
mg NNS None
and CC None
5-fluorouracil JJ Pharmocological
500 CD None
mg NN None
IV NNP None
Pingyangmycin NNP Pharmocological
Bleomycin NNP Pharmocological
A5 NNP Pharmocological
chemotherapy NN Pharmocological
surgical JJ Surgical
resection NN Surgical
chemotherapy NN Pharmocological
. . None
chemotherapy NN None
chemotherapy NN Pharmocological
-DOCSTART- -X- N

Risperidone NN Pharmocological
risperidone NN Pharmocological
were VBD Pharmocological
followed VBN Pharmocological
for IN Pharmocological
6 CD Pharmocological
months NNS Pharmocological
-DOCSTART- -X- N

fluocinolone NN Pharmocological
acetonide NN Pharmocological
implant NN Pharmocological
: : None
fluocinolone NN Pharmocological
acetonide NN Pharmocological
-DOCSTART- -X- N

vincristine NN Pharmocological
, , Pharmocological
corticosteroids NNS Pharmocological
, , Pharmocological
and CC Pharmocological
anthracyclines NNS Pharmocological
intensified VBN Pharmocological
with IN Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
asparaginase NN Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
. . None
cytarabine JJ Pharmocological
mitoxantrone NN Pharmocological
4-drug JJ Pharmocological
induction NN Pharmocological
( ( Pharmocological
the DT Pharmocological
L-20 NNP Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
. . Pharmocological
consolidation NN Pharmocological
, , Pharmocological
maintenance NN Pharmocological
therapy NN Pharmocological
, , Pharmocological
and CC Pharmocological
central JJ Pharmocological
nervous JJ Pharmocological
system NN Pharmocological
prophylaxis NN Pharmocological
. . None
-DOCSTART- -X- N

anesthesia NN Physical
positioning VBG Physical
30 CD Physical
degrees NNS Physical
Reverse NNP Physical
Trendelenburg NNP Physical
; : None
Supine-Horizontal NN Physical
; : None
30 CD Physical
degrees NNS Physical
Back VBP Physical
Up RP Physical
Fowler NNP Physical
. . None
Mask NNP Physical
ventilation NN Physical
, , Physical
full JJ Physical
neuromuscular JJ Physical
paralysis NN Physical
and CC Physical
direct JJ Physical
laryngoscopy NN Physical
1 CD Pharmocological
% NN Pharmocological
isoflurane NN Pharmocological
in IN Pharmocological
a DT Pharmocological
mixture NN Pharmocological
of IN Pharmocological
50 CD Pharmocological
% NN Pharmocological
oxygen/50 NN Pharmocological
% NN Pharmocological
air NN Pharmocological
Reverse NNP Physical
Trendelenburg NNP Physical
Back VBP Physical
Up NNP Physical
Fowler NNP Physical
Horizontal-Supine NNP Physical
Reverse NNP Physical
Trendelenburg NNP Physical
-DOCSTART- -X- N

postoperative JJ Surgical
CEA NNP Surgical
clearance NN Surgical
tumor NN Surgical
resection NN Surgical
postoperative JJ Surgical
pattern NN Surgical
of IN Surgical
CEA NNP Surgical
clearance NN Surgical
-DOCSTART- -X- N

Continuous JJ Physical
epidural JJ Pharmocological
block NN Pharmocological
was VBD None
instituted VBN None
prior RB None
to TO None
the DT None
induction NN None
of IN None
anesthesia NN None
and CC None
maintained VBD None
throughout IN None
the DT None
surgery NN Physical
in IN None
8 CD None
of IN None
16 CD None
patients NNS None
( ( None
Group NNP None
1 CD None
) ) None
while IN None
it PRP None
was VBD None
instituted VBN None
upon IN None
the DT None
peritoneal JJ None
closure NN None
and CC None
maintained VBD None
thereafter RB None
in IN None
the DT None
remaining VBG None
8 CD None
patients NNS None
( ( None
Group NNP None
2 CD None
) ) None
respiratory NN Physical
inductance NN Physical
plethysmography NN Physical
( ( Physical
Respisomnography NNP Physical
, , Physical
Chest NNP Physical
MI NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

Moderate NNP Pharmocological
sodium NN Pharmocological
restriction NN Pharmocological
, , None
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
, , None
and CC None
thiazide RB Pharmocological
diuretic JJ Pharmocological
in IN None
Dietary NNP Physical
sodium JJ Physical
restriction NN Physical
sodium JJ Physical
Angiotensin NNP Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
The DT None
combination NN None
of IN None
dietary JJ Pharmocological
sodium NN Pharmocological
restriction NN Pharmocological
with IN None
blockade NN None
of IN None
the DT None
renin NN None
system NN None
by IN None
an DT None
ACE NNP Pharmocological
inhibitor NN Pharmocological
thiazide JJ Pharmocological
diuretic NN Pharmocological
-DOCSTART- -X- N

flosequinan NN Pharmocological
flosequinan NN Pharmocological
flosequinan NN Pharmocological
placebo NN Control
Flosequinan NNP Pharmocological
flosequinan JJ Pharmocological
flosequinan NN Pharmocological
-DOCSTART- -X- N

Hypnosis NNP Psychological
treatment NN Psychological
Hypnosis NNP Psychological
biweekly JJ Psychological
hypnosis NN Psychological
sessions NNS Psychological
and CC Psychological
used VBD Psychological
hypnosis NN Psychological
audiotapes NNS Psychological
hypnosis NN Educational
-DOCSTART- -X- N

training NN Educational
laryngeal NN Physical
mask NN Physical
airway NN Physical
: : None
emergency NN Physical
technique NN Physical
of IN Physical
insertion NN Physical
of IN Physical
an DT Physical
LMA NNP Physical
. . None
LMA NNP Physical
LMA NNP Physical
LMA NNP Physical
-DOCSTART- -X- N

Diazoxide NNP Pharmocological
and CC None
labetalol NN Pharmocological
peripheral JJ Pharmocological
vasodilator NN Pharmocological
diazoxide NN Pharmocological
diazoxide JJ Pharmocological
150 CD Pharmocological
mg NN Pharmocological
or CC None
labetalol $ Pharmocological
50 CD Pharmocological
mg NN Pharmocological
diazoxide JJ Pharmocological
diazoxide NN Pharmocological
. . None
labetalol-treated JJ Pharmocological
labetalol $ Pharmocological
labetalol VBD Pharmocological
labetalol NN Pharmocological
. . None
diazoxide NN Pharmocological
-DOCSTART- -X- N

Rifampicin NNP Pharmocological
plus CC Pharmocological
isoniazid NN Pharmocological
isoniazid NN Pharmocological
( ( Pharmocological
6H CD Pharmocological
) ) Pharmocological
isoniazid JJ Pharmocological
plus CC Pharmocological
rifampicin JJ Pharmocological
( ( Pharmocological
3RH CD Pharmocological
) ) Pharmocological
. . None
3RH CD Pharmocological
regimen NNS Pharmocological
-DOCSTART- -X- N

Estradiol NNP Pharmocological
and CC None
the DT None
addition NN None
of IN None
progesterone NN Pharmocological
neuroactive JJ Pharmocological
steroid NN Pharmocological
, , Pharmocological
pregnanolone NN Pharmocological
postmenopausal NN Pharmocological
hormone NN Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
natural JJ Pharmocological
progesterone NN Pharmocological
. . None
pregnanolone NN Pharmocological
HRT NNP Pharmocological
oral JJ Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
vaginal JJ Pharmocological
progesterone NN Pharmocological
or CC None
placebo NN Control
pregnanolone NN None
pregnanolone NN Pharmocological
( ( Pharmocological
3alpha-hydroxy-5beta-pregnan-20-one CD Pharmocological
) ) Pharmocological
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
alone RB Pharmocological
or CC None
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
+progesterone CD Pharmocological
pregnanolone NN Pharmocological
HRT NNP Pharmocological
. . None
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
alone RB None
, , None
or CC None
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
+progesterone NN Pharmocological
, , None
pregnanolone VB Pharmocological
HRT NNP Pharmocological
. . None
-DOCSTART- -X- N

FAM NNP Pharmocological
5-FU JJ Pharmocological
plus JJ Pharmocological
BCNU NNP Pharmocological
. . None
chemotherapy NN Pharmocological
( ( None
FAM NNP Pharmocological
versus IN None
5-FU JJ Pharmocological
plus CC Pharmocological
BCNU NNP Pharmocological
) ) Pharmocological
FAM NNP Pharmocological
FAM NNP Pharmocological
FAM NNP Pharmocological
5-FU JJ Pharmocological
plus CC Pharmocological
BCNU JJ Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
amoxycillin NN Pharmocological
( ( None
placebo NN Control
amoxycillin NN Pharmocological
) ) None
placebo NN None
placebo NN Control
amoxicillin NN Pharmocological
amoxycillin NN Pharmocological
standard JJ Pharmocological
bronchodilator NN Pharmocological
therapy NN Pharmocological
. . None
amoxycillin NN Pharmocological
amoxycillin NN Pharmocological
amoxycillin NN Pharmocological
. . None
-DOCSTART- -X- N

placebo- JJ Control
paliperidone NN Pharmocological
Paliperidone NNP Pharmocological
ER NNP Pharmocological
monotherapy NN Pharmocological
paliperidone NN Pharmocological
ER NNP Pharmocological
olanzapine JJ Pharmocological
paliperidone NN Pharmocological
ER NNP Pharmocological
placebo NN Control
olanzapine JJ Pharmocological
( ( None
paliperidone JJ Pharmocological
ER NNP Pharmocological
) ) None
( ( None
placebo NN Control
) ) None
olanzapine NN Pharmocological
paliperidone NN Pharmocological
ER NNP Pharmocological
olanzapine JJ Pharmocological
placebo NN Control
paliperidone NN Pharmocological
ER NNP Pharmocological
Paliperidone NNP Pharmocological
ER NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

collaborative JJ Educational
care NN Educational
management NN Educational
of IN Educational
Alleviating NNP Educational
Depression NNP Educational
Among IN Educational
( ( Educational
ADAPt-C NNP Educational
) ) Educational
collaborative NN Educational
care NN Educational
management NN Educational
access NN Educational
for IN Educational
up IN Educational
to TO Educational
12 CD Educational
months NNS Educational
to TO Educational
a DT Educational
depression NN Educational
clinical JJ Educational
specialist NN Educational
( ( Educational
supervised VBN Educational
by IN Educational
a DT Educational
psychiatrist NN Educational
) ) Educational
who WP Educational
offered VBD Educational
education NN Educational
, , None
structured VBD Psychological
psychotherapy NN Psychological
, , None
and CC None
maintenance/relapse NN Educational
prevention NN Educational
support NN Educational
. . None
antidepressant JJ Pharmocological
medications NNS Pharmocological
ADAPt-C NNP Educational
collaborative JJ Educational
care NN Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
tetrahydrobiopterin NN Pharmocological
( ( Pharmocological
BH4 NNP Pharmocological
) ) Pharmocological
20 CD None
mg/kg/day JJ None
BH4 NNP None
or CC None
placebo NN None
for IN None
placebo VB None
with IN None
and CC None
placebo NN None
. . None
-DOCSTART- -X- N

RAB-plate JJ Surgical
sliding VBG Surgical
hip NN Surgical
screw NN Surgical
sliding VBG Surgical
hip NN Surgical
screw NN Surgical
120 CD Surgical
degrees NNS Surgical
fixed VBN Surgical
angle JJ Surgical
blade-plate NN Surgical
with IN Surgical
a DT Surgical
buttress NN Surgical
rod NN Surgical
sliding VBG Surgical
hip NN Surgical
screw NN Surgical
RAB-plate NNP Surgical
-DOCSTART- -X- N

Etomidate NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
flumazenil JJ Pharmocological
anesthesia NN Pharmocological
etomidate JJ Pharmocological
administration NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
flumazenil NNS Pharmocological
the DT Pharmocological
flumazenil NN Pharmocological
group NN Pharmocological
the DT Pharmocological
etomidate NN Pharmocological
group NN Pharmocological
etomidate NN Pharmocological
. . None
etomidate NN Pharmocological
flumazenil NNS Pharmocological
placebo NN Control
. . None
flumazenil NN Pharmocological
Etomidate NNP Pharmocological
flumazenil RB Pharmocological
-DOCSTART- -X- N

routine JJ Psychological
bedside NN Psychological
questioning VBG Psychological
and CC Psychological
examination NN Psychological
by IN Psychological
the DT Psychological
visiting NN Psychological
doctor NN Psychological
Thromboprophylaxis NNP Pharmocological
( ( Pharmocological
dextran-70 JJ Pharmocological
, , Pharmocological
low JJ Pharmocological
molecular JJ Pharmocological
weight NN Pharmocological
heparin NN Pharmocological
and CC Pharmocological
graded VBD Physical
elastic JJ Physical
stockings NNS Physical
) ) Pharmocological
Bilateral NNP Physical
venography NN Physical
-DOCSTART- -X- N

ganciclovir NN Pharmocological
valacyclovir NN Pharmocological
ganciclovir NN Pharmocological
and CC None
valacyclovir NN Pharmocological
ganciclovir NN Pharmocological
and CC None
valacyclovir NN Pharmocological
no DT Control
prophylaxis NN Control
. . None
-DOCSTART- -X- N

laquinimod NN Pharmocological
laquinimod JJ Pharmocological
laquinimod NN Pharmocological
placebo VB Control
laquinimod $ Pharmocological
-DOCSTART- -X- N

laparoscopic NN Physical
surgery NN Physical
quyu JJ Pharmocological
jiedu NN Pharmocological
recipe NN Pharmocological
laparoscopic NN Physical
surgery NN Physical
Quyu NNP Pharmocological
Jiedu NNP Pharmocological
Recipe NNP Pharmocological
( ( Pharmocological
QYJDR NNP Pharmocological
) ) Pharmocological
progesterone NN Pharmocological
QYJDR NNP Pharmocological
laparoscopic NN Surgical
surgery NN Surgical
QYJDR NNP Surgical
QYJDR NNP Surgical
-DOCSTART- -X- N

pyridostigmine NN Pharmocological
naloxone NN Pharmocological
TRH NNP None
tests NNS None
were VBD None
performed VBN None
after IN None
an DT None
overnight NN None
( ( None
8 CD None
hours NNS None
) ) None
fast RB None
, , None
placebo JJ Control
administrations NNS None
( ( None
control VB None
test NN None
) ) None
, , None
and CC None
after IN None
prolonged VBN None
( ( None
56 CD None
hours NNS None
) ) None
starvation NN None
. . None
were VBD None
performed VBN None
either RB None
after IN None
placebos NN Control
( ( None
in IN None
all DT None
subjects NNS None
) ) None
or CC None
the DT None
administration NN None
of IN None
pyridostigmine NN Pharmocological
( ( None
180 CD None
mg NNS None
orally RB None
) ) None
( ( None
in IN None
7 CD None
subjects NNS None
, , None
group NN None
1 CD None
) ) None
; : None
naloxone NN Pharmocological
( ( None
0.8 CD None
mg NN None
in IN None
an DT None
i.v NN None
. . None
bolus CC None
injection NN None
) ) None
( ( None
in IN None
7 CD None
subjects NNS None
, , None
group NN None
2 CD None
) ) None
; : None
or CC None
the DT None
combination NN None
of IN None
pyridostigmine NN Pharmocological
and CC Pharmocological
naloxone NN Pharmocological
( ( None
in IN None
7 CD None
subjects NNS None
, , None
group NN None
3 CD None
) ) None
. . None
TRH NNP Pharmocological
plus CC None
placebo NN Control
, , None
TRH NNP Pharmocological
plus CC Pharmocological
naloxone NN Pharmocological
, , Pharmocological
TRH NNP Pharmocological
plus CC Pharmocological
pyridostigmine NN Pharmocological
, , None
and CC None
TRH NNP Pharmocological
plus CC None
naloxone JJ Pharmocological
plus CC None
pyridostigmine NN Pharmocological
pyridostigmine JJ Pharmocological
naloxone JJ Pharmocological
pyridostigmine NN Pharmocological
TRH NNP Pharmocological
-DOCSTART- -X- N

lumiracoxib JJ Pharmocological
celecoxib NN Pharmocological
lumiracoxib NN Pharmocological
lumiracoxib NN Pharmocological
at IN Pharmocological
doses NNS Pharmocological
of IN Pharmocological
100 CD Pharmocological
mg NNS Pharmocological
once RB Pharmocological
daily JJ Pharmocological
( ( Pharmocological
o.d JJ Pharmocological
. . Pharmocological
) ) Pharmocological
and CC Pharmocological
100 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
celecoxib JJ Pharmocological
200 CD Pharmocological
mg NN Pharmocological
o.d NN Pharmocological
. . Pharmocological
lumiracoxib VB Pharmocological
lumiracoxib $ Pharmocological
celecoxib $ Pharmocological
celecoxib NN Pharmocological
lumiracoxib NN Pharmocological
lumiracoxib VBZ Pharmocological
celecoxib JJ Pharmocological
lumiracoxib JJ Pharmocological
celecoxib NN Pharmocological
-DOCSTART- -X- N

Mindfulness-based JJ Psychological
therapy NN Psychological
Mindfulness-based JJ Psychological
therapy NN Psychological
( ( Psychological
MBT NNP Psychological
) ) Psychological
modified JJ Psychological
MBT NNP Psychological
protocol NN Psychological
( ( Psychological
MBT-AS NNP Psychological
) ) Psychological
MBT-AS JJ Educational
training NN Educational
wait-list JJ Control
control NN Control
group NN Physical
. . None
MBT-AS NNP Psychological
. . Psychological
-DOCSTART- -X- N

-DOCSTART- -X- N

total JJ Physical
parenteral JJ Physical
nutrition NN Physical
lipid NN Pharmocological
) ) None
amino JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

strength NN Physical
training NN Physical
strength NN Physical
training NN Physical
( ( Physical
ST NNP Physical
) ) Physical
ST NNP Physical
ST NNP Physical
as IN Control
a DT Control
control NN Control
group NN Control
aerobic JJ Physical
exercise NN Physical
ST NNP Physical
-DOCSTART- -X- N

fluvoxamine NN Pharmocological
placebo-controlled JJ Control
fluvoxamine NN Pharmocological
maleate NN Pharmocological
fluvoxamine-treated JJ Pharmocological
placebo NN Control
Fluvoxamine NNP Pharmocological
placebo VB Control
fluvoxamine NN Pharmocological
Fluvoxamine NNP Pharmocological
placebo NN Control
fluvoxamine NN Pharmocological
-DOCSTART- -X- N

prostaglandin NN Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
intraumbilical JJ Pharmocological
prostaglandin NN Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
( ( None
Hembate NNP Pharmocological
, , None
Upjohn NNP Pharmocological
) ) None
oxytocin JJ Pharmocological
injection NN Pharmocological
Prostaglandin NNP Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
, , None
20 CD None
mg NN None
, , None
diluted VBD Pharmocological
to TO Pharmocological
20 CD Pharmocological
ml NNS Pharmocological
in IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
30 CD Pharmocological
IU NNP Pharmocological
of IN Pharmocological
oxytocin NN Pharmocological
, , None
diluted VBD Pharmocological
to TO Pharmocological
20 CD Pharmocological
ml NNS Pharmocological
in IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
20 CD Pharmocological
ml NNS Pharmocological
of IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
alone RB Pharmocological
prostaglandin NN Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
Oxytocin CC Pharmocological
-DOCSTART- -X- N

CT NNP Physical
and CC None
MRI NNP Physical
CT NNP Physical
MRI NNP Physical
-DOCSTART- -X- N

parsalmide NN Pharmocological
parsalmide NN Pharmocological
-DOCSTART- -X- N

intra-arterial JJ Pharmocological
intravenous JJ Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
randomized VBN None
to TO None
an DT None
intravenous JJ Pharmocological
group NN None
( ( None
n JJ None
= NNP None
250 CD None
) ) None
, , None
receiving VBG None
50 CD None
U/kg NNP None
of IN None
unfractionated JJ None
heparin NN Pharmocological
( ( None
maximal JJ None
dose VBP None
5,000 CD None
U NNP None
) ) None
intravenously RB None
, , None
and CC None
an DT None
intra-arterial JJ Pharmocological
group NN Pharmocological
( ( None
n JJ None
= NNP None
250 CD None
) ) None
receiving VBG None
the DT None
same JJ None
dose JJ None
intra-arterially RB None
. . None
vasodilator NN None
cocktail NN None
intra-arterially RB Pharmocological
and CC None
underwent JJ None
cardiac JJ Physical
catheterization NN Physical
using VBG None
a DT None
5F CD None
introducer NN None
sheath NN None
and CC None
catheters NNS None
. . None
-DOCSTART- -X- N

who WP Educational
received VBD Educational
the DT Educational
same JJ Educational
short-term JJ Educational
intervention NN Educational
types NNS Educational
( ( Educational
6 CD Educational
weeks NNS Educational
with IN Educational
the DT Educational
mother NN Educational
and CC Educational
6 CD Educational
weeks NNS Educational
with IN Educational
the DT Educational
support NN Educational
of IN Educational
an DT Educational
educational JJ Educational
software NN Educational
program NN Educational
) ) Educational
. . None
The DT Educational
intervention NN Educational
process NN Educational
was VBD Educational
conducted VBN Educational
by IN Educational
speech-language JJ Educational
pathologists NNS Educational
who WP Educational
were VBD Educational
part NN Educational
of IN Educational
a DT Educational
graduate NN Educational
program NN Educational
in IN Educational
this DT Educational
area NN Educational
. . None
-DOCSTART- -X- N

primary JJ Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
versus NN None
tissue NN Surgical
plasminogen NN Surgical
activator NN Surgical
therapy NN Surgical
. . None
tissue VB Physical
plasminogen NN Physical
activator NN Physical
( ( Physical
tPA NN Physical
) ) Surgical
or CC None
primary JJ Physical
percutaneous JJ Physical
transluminal JJ Physical
coronary NN Physical
angioplasty NN Physical
( ( Physical
PTCA NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

Etanercept NNP Pharmocological
plus CC Pharmocological
standard JJ Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
etanercept NN Pharmocological
etanercept VB Pharmocological
placebo VB Control
standard JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
glucocorticoids JJ Pharmocological
plus CC Pharmocological
cyclophosphamide JJ Pharmocological
or CC Pharmocological
methotrexate NN Pharmocological
) ) Pharmocological
. . Pharmocological
standard JJ Pharmocological
medications NNS Pharmocological
etanercept NN Pharmocological
etanercept NN Pharmocological
control NN Control
group NN Control
etanercept NN Pharmocological
etanercept NN Pharmocological
etanercept NN Pharmocological
Etanercept NNP Pharmocological
-DOCSTART- -X- N

Counselling NN Educational
6 CD Educational
weekly JJ Educational
, , Educational
counselling VBG Educational
visits NNS Educational
by IN Educational
the DT Educational
Child NNP Educational
Health NNP Educational
Clinic NNP Educational
nurse NN Educational
and CC Educational
the DT Educational
control NN Educational
group NN Educational
received VBD Educational
routine JJ Control
primary NN Control
care NN Control
. . Educational
Counselling VBG Educational
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
operation NN Pharmocological
morphine NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
saline NN Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

cyclosporin VB Pharmocological
A DT Pharmocological
or CC None
methotrexate NN Pharmocological
cyclosporin VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CSA NNP Pharmocological
) ) Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
CSA NNP Pharmocological
and CC None
MTX NNP Pharmocological
in IN None
combination NN None
single-agent JJ None
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
MTX NNP Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Endoscopic NNP Surgical
ligation NN Surgical
sclerotherapy NN Pharmocological
Endoscopic NNP Pharmocological
sclerotherapy NN Pharmocological
Endoscopic NNP Surgical
ligation NN Surgical
variceal JJ Surgical
band NN Surgical
ligation NN Surgical
-DOCSTART- -X- N

granisetron NN Pharmocological
and CC Pharmocological
methylprednisolone NN Pharmocological
granisetron NN Pharmocological
alone RB Pharmocological
and CC None
granisetron JJ Pharmocological
plus CC Pharmocological
methylprednisolone JJ Pharmocological
] NN None
Granisetron NNP Pharmocological
40 CD Pharmocological
micrograms/kg NN Pharmocological
during IN Pharmocological
chemotherapy NN Pharmocological
, , Pharmocological
and CC Pharmocological
methylprednisolone NN Pharmocological
Granisetron NNP Pharmocological
granisetron NN Pharmocological
and CC Pharmocological
methylprednisolone NN Pharmocological
-DOCSTART- -X- N

anterior JJ Physical
rhinomanometry NN Physical
impulse-oscillometric JJ Physical
rhinometry NN Physical
anterior JJ Physical
rhinomanometry NN Physical
( ( Physical
aR NN Physical
) ) Physical
, , Physical
the DT Physical
impulse-oscillometric JJ Physical
rhinometry NN Physical
( ( Physical
IOS NNP Physical
) ) Physical
aR NN Pharmocological
and CC Pharmocological
IOS NNP Pharmocological
. . Pharmocological
IOS NNP None
-DOCSTART- -X- N

carbamazepine VB Pharmocological
sustained-release JJ Pharmocological
morphine NN Pharmocological
carbamazepine NN Pharmocological
( ( Pharmocological
CMZ NNP Pharmocological
) ) Pharmocological
opioids NNS Pharmocological
placebo-controlled JJ Control
CMZ NNP Pharmocological
( ( Pharmocological
600 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
CMZ NNP Pharmocological
sustained-release JJ Pharmocological
morphine NN Pharmocological
( ( Pharmocological
90 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
SCS NNP Pharmocological
. . Pharmocological
CMZ NNP None
placebo NN None
morphine NN Pharmocological
CMZ JJ None
morphine NN None
SCS NNP None
. . None
CMZ NNP Pharmocological
Morphine NNP None
-DOCSTART- -X- N

secretin NN Pharmocological
. . None
secretin NN Pharmocological
placebo NN Control
. . None
synthetic JJ None
human JJ None
secretin NN None
placebo VB Control
( ( Control
saline NN Control
) ) Control
. . None
placebo NN Pharmocological
, , Pharmocological
followed VBD Pharmocological
six CD Pharmocological
weeks NNS Pharmocological
later RB Pharmocological
by IN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
placebo NN Pharmocological
. . None
secretin NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

recombinant JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
vaccine NN Pharmocological
] NN Pharmocological
placebo NN Control
) ) Control
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
IFN NNP Pharmocological
alpha VBP Pharmocological
1b CD Pharmocological
50 CD Pharmocological
micrograms NNS Pharmocological
with IN Pharmocological
3 CD Pharmocological
times NNS Pharmocological
a DT Pharmocological
week NN Pharmocological
for IN Pharmocological
24 CD Pharmocological
weeks NNS Pharmocological
. . None
recombinant JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

depot NN Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
: : None
mail NN Educational
and CC Educational
telephone NN Educational
reminders NNS Educational
only RB None
a DT None
scheduled JJ Other
appointment NN Other
at IN None
the DT None
time NN None
of IN None
the DT None
previous JJ None
injection NN None
. . None
-DOCSTART- -X- N

azithromycin NN Pharmocological
antimicrobials NNS Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
doxycycline NN Pharmocological
azithromycin NN Pharmocological
-DOCSTART- -X- N

intensive JJ Educational
early JJ Educational
intervention NN Educational
intensive VB Control
treatment NN Control
parent NN Educational
training NN Educational
intensive JJ None
treatment NN None
parent NN Educational
training NN Educational
parent NN Educational
training NN Educational
intensive JJ None
treatment NN None
parent NN Educational
training VBG Educational
-DOCSTART- -X- N

Measurements NNS None
of IN None
and CC None
are VBP None
often RB None
followed VBN None
over RP None
time NN None
in IN None
urological JJ Educational
management NN Educational
. . Educational
-DOCSTART- -X- N

[ JJ None
Aortofemoral NNP Surgical
bifurcation NN Surgical
bypass NN Surgical
. . None
( ( None
NLA NNP Physical
, , Physical
thoracic RB Physical
continuous JJ Physical
catheter NN Physical
peridural JJ Physical
anesthesia NN Physical
) ) None
Ringer NNP Pharmocological
lactate JJ Pharmocological
solution NN Pharmocological
-DOCSTART- -X- N

Perioperative JJ None
enteral JJ None
nutrition NN None
perioperative JJ Physical
nutritional JJ Physical
support NN Physical
no DT Physical
preoperative JJ Physical
and CC Physical
standard JJ Physical
postoperative JJ Physical
tube-feeding NN Physical
( ( Physical
group NN Physical
I PRP Physical
) ) Physical
, , Physical
standard JJ Physical
preoperative NN Physical
and CC Physical
postoperative JJ Physical
tube-feeding NN Physical
( ( Physical
group NN Physical
II NNP Physical
) ) Physical
arginine-supplemented JJ Physical
preoperative NN Physical
and CC None
postoperative JJ Physical
tube-feeding NN Physical
preoperatively RB Physical
fed VBN Physical
both DT Physical
pre-fed JJ Physical
groups NNS Physical
. . None
Enteral NNP Physical
nutrition NN Physical
preoperative JJ Physical
enteral JJ Physical
feeding NN Physical
-DOCSTART- -X- N

Standard-dose JJ Pharmocological
lansoprazole NN Pharmocological
high-dose JJ Pharmocological
ranitidine NN Pharmocological
Lansoprazole NNP Pharmocological
standard-dose JJ Pharmocological
lansoprazole NN Pharmocological
high-dose JJ Pharmocological
ranitidine NN Pharmocological
Lansoprazole NNP Pharmocological
ranitidine NN Pharmocological
lansoprazole JJR Pharmocological
ranitidine NN Pharmocological
lansoprazole JJ Pharmocological
. . None
lansoprazole JJ Pharmocological
ranitidine NN Pharmocological
ranitidine NN Pharmocological
lansoprazole NN Pharmocological
. . None
Standard-dose JJ Pharmocological
lansoprazole NN Pharmocological
high-dose JJ Pharmocological
ranitidine NN Pharmocological
-DOCSTART- -X- N

ascorbic JJ Pharmocological
acid NN Pharmocological
. . None
placebo-controlled JJ Control
ascorbic JJ Pharmocological
acid NN Pharmocological
ascorbic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
methylprednisolone NN Pharmocological
methylprednisolone NN Pharmocological
cyclophosphamide NN Pharmocological
IV NNP Pharmocological
MP NNP Pharmocological
bimonthly RB Pharmocological
-DOCSTART- -X- N

hepatitis NN Pharmocological
B NNP Pharmocological
surface NN Pharmocological
antigen NN Pharmocological
( ( Pharmocological
HBsAg NNP Pharmocological
) ) Pharmocological
vaccines NNS Pharmocological
. . Pharmocological
( ( Pharmocological
HBsAg NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

standard JJ Educational
direct-mailed JJ Educational
procedures NNS Educational
( ( Educational
X1 NNP Educational
) ) Educational
, , Educational
X1 NNP Educational
plus CC Educational
culturally RB Educational
tailored JJ Educational
materials NNS Educational
( ( Educational
X2 NNP Educational
) ) Educational
X2 NNP Educational
plus CC Educational
interpersonal JJ Educational
phone NN Educational
contact NN Educational
( ( Educational
X3 NNP Educational
) ) Educational
Interpersonal NNP Educational
communication NN Educational
-DOCSTART- -X- N

surgical JJ Surgical
staging NN Surgical
-DOCSTART- -X- N

risperidone NN Pharmocological
plus CC Pharmocological
topiramate NN Pharmocological
topiramate NN Pharmocological
plus CC Pharmocological
risperidone NN Pharmocological
topiramate+risperidone VB Pharmocological
( ( None
Group NNP None
A NNP None
) ) None
or CC None
placebo+risperidone NN Pharmocological
( ( None
Group NNP None
B NNP None
) ) None
risperidone NN Pharmocological
topiramate NN Pharmocological
topiramate NN Pharmocological
topiramate NN Pharmocological
-DOCSTART- -X- N

Placebo-controlled JJ Control
naltrexone NN Pharmocological
placebo-controlled JJ Control
naltrexone NN Pharmocological
. . None
Naltrexone CD Pharmocological
naltrexone NN Pharmocological
-DOCSTART- -X- N

vincristine/corticosteroid NNS Physical
chemotherapy NN Physical
intensive JJ Physical
chemotherapy NN Physical
protocols NNS Physical
that WDT Physical
contain VBP Physical
vincristine JJ Physical
and CC Physical
corticosteroids NNS Physical
. . None
chemotherapy NN Physical
vincristine NN Pharmocological
bolus NN Pharmocological
vincristine NN Pharmocological
Cronassial NNP Pharmocological
, , Pharmocological
a DT Pharmocological
mixture NN Pharmocological
of IN Pharmocological
four CD Pharmocological
naturally RB Pharmocological
occurring VBG Pharmocological
gangliosides NNS Pharmocological
vincristine-induced JJ Pharmocological
dexamethasone NN Pharmocological
Cronassial NNP Pharmocological
Vincristine NNP Pharmocological
corticosteroids NNS Pharmocological
vincristine/corticosteroid-based JJ Physical
treatment NN Physical
vincristine VB Pharmocological
or CC Pharmocological
corticosteroids NNS Pharmocological
-DOCSTART- -X- N

Iontophoretic JJ Physical
dexamethasone NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
placebo-controlled JJ Control
iontophoretic JJ Pharmocological
dexamethasone NN Pharmocological
placebo-controlled JJ Pharmocological
placebo JJ Pharmocological
Dexamethasone NNP Pharmocological
placebo NN Pharmocological
dexamethasone NN Pharmocological
placebo NN Control
Iontophoresis NNP Physical
-DOCSTART- -X- N

mizolastine JJ Pharmocological
placebo-controlled JJ Control
loratadine NN Pharmocological
Mizolastine NNP Pharmocological
mizolastine NN Pharmocological
with IN Pharmocological
loratadine NN Pharmocological
and CC None
placebo NN Control
placebo NN Control
mizolastine NN Pharmocological
loratadine NN Pharmocological
placebo NN Control
Mizolastine NNP Pharmocological
loratadine VB Pharmocological
mizolastine NN Pharmocological
and CC Pharmocological
loratadine NN Pharmocological
placebo NN Control
( ( None
mizolastine NN Pharmocological
: : None
loratadine NN Pharmocological
: : None
placebo NN Control
: : None
placebo NN Control
( ( None
mizolastine NN Pharmocological
: : None
loratadine NN Pharmocological
: : None
placebo NN Control
: : None
mizolastine NN Pharmocological
loratadine NN Pharmocological
placebo NN Control
placebo VB Control
mizolastine NN Pharmocological
or CC Pharmocological
loratadine NN Pharmocological
. . None
Mizolastine NNP Pharmocological
placebo VB Control
Mizolastine NNP Pharmocological
loratadine NN Pharmocological
-DOCSTART- -X- N

laparoscopically RB Surgical
assisted VBN Surgical
vaginal JJ Surgical
hysterectomy NN Surgical
( ( Surgical
LAVH NNP Surgical
) ) Surgical
and CC None
total JJ Surgical
abdominal JJ Surgical
hysterectomy NN Surgical
( ( Surgical
TAH NNP Surgical
) ) Surgical
LAVH NNP Surgical
and CC None
TAH NNP Physical
. . None
LAVH NNP Surgical
TAH NNP Physical
LAVH NNP Surgical
TAH NNP Physical
; : None
LAVH NNP Surgical
LAVH NNP Physical
TAH NNP Physical
TAH NNP Physical
, , None
LAVH NNP Surgical
LAVH NNP Surgical
TAH NNP Physical
-DOCSTART- -X- N

beta-adrenoceptor NN Pharmocological
pindolol NN Pharmocological
beta-adrenoceptor NN Pharmocological
blocking VBG Pharmocological
agent NN Pharmocological
metoprolol NN Pharmocological
pindolol NN Pharmocological
and CC None
metoprolol NN Pharmocological
metoprolol VB Pharmocological
, , None
pindolol VB Pharmocological
-DOCSTART- -X- N

prone NN Physical
position NN Physical
Initial JJ Physical
sleeping VBG Physical
position NN Physical
was VBD Physical
assigned VBN Physical
randomly RB Physical
. . None
1 CD Physical
minute NN Physical
before IN Physical
and CC Physical
after IN Physical
0.4 CD Physical
mL NN Physical
of IN Physical
water NN Physical
was VBD Physical
instilled VBN Physical
into IN Physical
the DT Physical
oropharynx NN Physical
. . None
-DOCSTART- -X- N

Sulfadoxine/pyrimethamine NNP Pharmocological
alone RB Pharmocological
or CC Pharmocological
with IN Pharmocological
amodiaquine JJ Pharmocological
or CC Pharmocological
artesunate NN Pharmocological
25 CD Pharmocological
mg/kg JJ Pharmocological
sulfadoxine NN Pharmocological
and CC Pharmocological
1.25 CD Pharmocological
mg/kg NN Pharmocological
pyrimethamine NN Pharmocological
plus CC Pharmocological
either DT Pharmocological
placebo NN Pharmocological
, , Pharmocological
25 CD Pharmocological
mg/kg NN Pharmocological
amodiaquine NN Pharmocological
, , Pharmocological
or CC Pharmocological
12 CD Pharmocological
mg/kg JJ Pharmocological
artesunate NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

sensorimotor NN Physical
enrichment NN Physical
group NN Physical
olfactory/tactile JJ Physical
stimulation NN Physical
along IN None
with IN None
exercises NNS Physical
that WDT None
stimulated VBD None
other JJ None
paired JJ None
sensory JJ None
modalities NNS None
, , None
or CC None
to TO None
a DT None
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

inhaled JJ Pharmocological
albuterol NN Pharmocological
powder NN Pharmocological
and CC Pharmocological
aerosol NN Pharmocological
aerosolized JJ Pharmocological
albuterol NN Pharmocological
with IN Pharmocological
the DT Pharmocological
dry JJ Pharmocological
powder NN Pharmocological
formulation NN Pharmocological
placebo NN Pharmocological
albuterol NN Pharmocological
aerosol NN Pharmocological
active JJ Pharmocological
albuterol NN Pharmocological
powder NN Pharmocological
active JJ Pharmocological
albuterol NN Pharmocological
aerosol NN Pharmocological
placebo NN Pharmocological
lactose JJ Pharmocological
powder NN Pharmocological
powder NN Pharmocological
aerosol JJ Pharmocological
albuterol NN Pharmocological
powder NN Pharmocological
albuterol NN Pharmocological
aerosol NN Pharmocological
. . None
-DOCSTART- -X- N

albumin NN Pharmocological
intravenously RB Pharmocological
1 CD Pharmocological
gm/kg NN Pharmocological
of IN Pharmocological
salt-poor JJ Pharmocological
human JJ Pharmocological
serum NN Pharmocological
albumin IN Pharmocological
-DOCSTART- -X- N

single-chamber JJ Surgical
atrial JJ Surgical
pacing NN Surgical
single-chamber JJ Surgical
ventricular JJ Surgical
pacing NN Surgical
single-chamber JJ Surgical
atrial JJ Surgical
pacing NN Surgical
-DOCSTART- -X- N

valaciclovir NN Pharmocological
polymerase NN None
chain NN None
reaction NN None
valaciclovir NN Pharmocological
valaciclovir NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
nefazodone NN Pharmocological
placebo-controlled JJ Control
nefazodone NN Pharmocological
placebo NN Control
Nefazodone NNP Pharmocological
and CC None
placebo VB Control
treatment NN None
placebo NN Control
nefazodone RB Pharmocological
placebo NN Control
) ) None
nefazodone-treated JJ Pharmocological
placebo-treated JJ Control
nefazodone NN Pharmocological
placebo-treated JJ Control
nefazodone-treated JJ Pharmocological
placebo-treated JJ Control
Nefazodone NNP Pharmocological
nefazodone NN Pharmocological
-DOCSTART- -X- N

HPV16 NNP Physical
( ( Physical
and CC Physical
HPV18 NNP Physical
) ) Physical
-DOCSTART- -X- N

trichloroacetic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
TCA NNP Pharmocological
) ) Pharmocological
TCA NNP Pharmocological
TCA NNP Pharmocological
TCA NNP Pharmocological
TCA NNP Pharmocological
-DOCSTART- -X- N

Tubeless NNP Surgical
percutaneous JJ Surgical
nephrolithotomy NN Surgical
: : None
tubeless NN Surgical
percutaneous JJ Surgical
nephrolithotomy NN Surgical
( ( Surgical
PCNL NNP Surgical
) ) Surgical
( ( Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
) ) Pharmocological
Tubeless NNP Surgical
PCNL NNP Surgical
-DOCSTART- -X- N

AnacEtrapib NNP Pharmocological
. . None
Anacetrapib NNP Pharmocological
anacetrapib NN Pharmocological
AnacEtrapib NNP Pharmocological
placebo-controlled JJ Control
anacetrapib NN Pharmocological
anacetrapib NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

chemotherapy NN Physical
doxorubicin NN Pharmocological
and CC None
lomustine NN Pharmocological
cyclophosphamide NN Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
( ( Pharmocological
CF NNP Pharmocological
) ) Pharmocological
. . None
CF NNP Pharmocological
. . None
DC NNP Pharmocological
-DOCSTART- -X- N

carvedilol NN Pharmocological
14C-labeled JJ Pharmocological
drug NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

hypnotherapy NN Psychological
systematic JJ Other
relaxation NN Other
experimental JJ Educational
hypnosis NN Educational
group NN Educational
, , Educational
the DT Physical
comparison NN Other
relaxation NN Other
group NN Other
, , None
and CC None
the DT None
waiting VBG Control
list NN Control
control NN Control
group NN Control
. . None
hypnosis NN Psychological
-DOCSTART- -X- N

Leukotriene NNP Pharmocological
antagonist NN Pharmocological
leukotriene JJ Pharmocological
antagonist JJ Pharmocological
ONO-1078 NNP Pharmocological
( ( Pharmocological
pranlukast NN Pharmocological
) ) Pharmocological
corticosteroid NN Pharmocological
orally RB Pharmocological
ONO-1078 NNP Pharmocological
, , Pharmocological
450 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , None
or CC None
placebo NN Control
. . None
placebo NN Control
placebo NN Control
leukotriene JJ Pharmocological
antagonist JJ Pharmocological
ONO-1078 JJ Pharmocological
-DOCSTART- -X- N

hyperinsulinemic-euglycemic JJ Physical
clamps NNS Physical
-DOCSTART- -X- N

styrene NN Pharmocological
maleic NN Pharmocological
acid NN Pharmocological
oily RB Pharmocological
carcinostatic JJ Pharmocological
agents NNS Pharmocological
4 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
styrene NN Pharmocological
maleic NN Pharmocological
acid NN Pharmocological
neocarzinostatin NN Pharmocological
in IN Pharmocological
4 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
Lipiodol NNP Pharmocological
100 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
epirubicin NN Pharmocological
in IN Pharmocological
4 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
Lipiodol NNP Pharmocological
styrene NN Pharmocological
maleic NN Pharmocological
acid NN Pharmocological
neocarzinostatin NN Pharmocological
epirubicin VB Pharmocological
Lipiodol NNP Pharmocological
-DOCSTART- -X- N

ferumoxytol NN Pharmocological
iron NN Pharmocological
replacement NN Pharmocological
therapies NNS Pharmocological
Ferumoxytol NNP Pharmocological
ferumoxytol NN Pharmocological
placebo-controlled JJ Control
ferumoxytol JJ Pharmocological
versus NN None
saline NN Control
as IN Pharmocological
placebo NN Pharmocological
. . None
IV NNP Pharmocological
injection NN Pharmocological
ferumoxytol NN Pharmocological
or CC None
saline NN Control
placebo NN Pharmocological
ferumoxytol NN Pharmocological
placebo NN Control
. . None
ferumoxytol NN Pharmocological
placebo NN Control
. . None
ferumoxytol NN Pharmocological
or CC None
placebo NN Control
. . None
Ferumoxytol NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

ophthalmic JJ Physical
insert NN Physical
Mydriasert NNP Physical
Mydriasert NNP None
( ( None
ophthalmic JJ None
insert NN None
containing VBG None
tropicamide NN None
and CC None
phenylephrine NN None
) ) None
Mydriasert NNP Pharmocological
Mydriasert NNP Pharmocological
-DOCSTART- -X- N

Secretin NNP Pharmocological
secretin JJ Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
vs. FW Pharmocological
saline NN Control
infusions NNS Control
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
vs. FW None
saline NN Control
infusions NNS Control
secretin NN Pharmocological
, , Pharmocological
porcine NN Pharmocological
or CC Pharmocological
synthetic JJ Pharmocological
-DOCSTART- -X- N

Metronidazole NNP Pharmocological
periodontitis NN Pharmocological
Metronidazole NNP Pharmocological
Metronidazole NNP Pharmocological
metronidazole JJ Pharmocological
metronidazole NNS Pharmocological
metronidazole NN Pharmocological
metronidazole NN Pharmocological
metronidazole NN Pharmocological
. . None
metronidazole NN Pharmocological
. . None
-DOCSTART- -X- N

Argon NNP Physical
laser NN Physical
trabeculoplasty NN Physical
Argon NNP Surgical
laser NN Surgical
trabeculoplasty NN Surgical
( ( Surgical
ALT NNP Surgical
) ) Surgical
ALT NNP Physical
Argon NNP Physical
laser NN Physical
trabeculoplasty NN Physical
-DOCSTART- -X- N

one CD Physical
vs NN Physical
two CD Physical
daily JJ Physical
bouts NNS Physical
of IN Physical
walking VBG Physical
walked VBD Educational
5 CD Physical
d/week NN Physical
for IN Physical
15 CD Physical
weeks NNS Physical
at IN Physical
65 CD Physical
% NN Physical
of IN Physical
their PRP$ Physical
maximal NN Physical
aerobic JJ Physical
power NN Physical
expending VBG Physical
300 CD Physical
kcal JJ Physical
( ( None
1255 CD None
kJ NN None
) ) None
in IN None
exercise NN Educational
in IN None
one CD None
( ( None
Group NNP None
S1 NNP None
) ) None
or CC None
two CD None
daily JJ None
sessions NNS None
( ( None
Group NNP None
S2 NNP None
) ) None
. . None
was VBD None
measured VBN None
in IN None
a DT None
direct JJ Physical
maximal NN Physical
treadmill NN Physical
test NN Physical
. . None
was VBD None
calculated VBN None
and CC None
the DT None
percentage NN None
of IN None
body NN None
fat NN None
( ( None
fat JJ None
% NN None
) ) None
estimated VBN None
using VBG None
skinfold JJ None
measurements NNS None
. . None
walking NN Physical
-DOCSTART- -X- N

oral JJ Pharmocological
chelation NN Pharmocological
succimer NN Pharmocological
succimer NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

FemCap NNP Physical
, , Physical
a DT Physical
new JJ Physical
vaginal JJ Physical
barrier NN Physical
contraceptive NN Physical
Ortho NNP Pharmocological
All-Flex NNP Pharmocological
diaphragm NN Pharmocological
. . None
FemCap NNP Physical
FemCap NNP Pharmocological
or CC Pharmocological
Ortho NNP Pharmocological
All-Flex NNP Pharmocological
contraceptive NN Pharmocological
diaphragm NN Pharmocological
, , Pharmocological
both DT Pharmocological
with IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
nonoxynol-9 JJ Pharmocological
spermicide NN Pharmocological
FemCap NNP Pharmocological
diaphragm NN Physical
FemCap NNP Pharmocological
diaphragm JJ Pharmocological
FemCap NNP Pharmocological
diaphragm JJ Pharmocological
FemCap NNP Pharmocological
FemCap NNP Pharmocological
diaphragm NN Pharmocological
diaphragm JJ Pharmocological
FemCap NNP Pharmocological
FemCap NNP Pharmocological
-DOCSTART- -X- N

[ NN None
Encephalopathy NNP Physical
therapeutic JJ Physical
tongue NN Physical
acupoint NN Physical
apparatus NN Physical
encephalopathy JJ Physical
therapeutic JJ Physical
tongue NN Physical
acupoint NN Physical
apparatus NN Physical
( ( Physical
ETTAA NNP Physical
) ) Physical
tongue JJ Physical
acupuncture NN Physical
conventional JJ Educational
training NN Educational
-DOCSTART- -X- N

reamed VBN Surgical
and CC Surgical
unreamed JJ Surgical
nailing NN Surgical
Stabilization NNP Surgical
of IN Surgical
tibial JJ Surgical
fractures NNS Surgical
either CC Surgical
with IN Surgical
a DT Surgical
slotted VBN Surgical
, , Surgical
stainless JJ Surgical
steel NN Surgical
reamed VBD Surgical
nail JJ Surgical
or CC Surgical
a DT Surgical
solid JJ Surgical
, , Surgical
titanium NN Surgical
unreamed JJ Surgical
nail NN Surgical
. . Surgical
reamed VBN Physical
unreamed JJ Physical
unreamed JJ Physical
nail NN Physical
reamed VBD Physical
reamed VBN None
unreamed JJ None
Unreamed VBD None
nailing VBG None
in IN None
reamed JJ Physical
nailing NN Physical
. . Physical
unreamed JJ None
nails NNS None
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
testosterone NN Pharmocological
undecanoate NN Pharmocological
with IN Pharmocological
injectable JJ Pharmocological
norethisterone JJ Pharmocological
enanthate NN Pharmocological
: : Pharmocological
plus CC Pharmocological
norethisterone JJ Pharmocological
enanthate NN Pharmocological
TU NNP Pharmocological
plus CC Pharmocological
placebo JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

Acute NNP None
reduction NN None
of IN None
arterial JJ None
blood NN None
pressure NN None
acute JJ None
reduction NN None
in IN None
arterial JJ None
blood NN None
pressure NN None
slow JJ None
intravenous JJ None
injection NN None
clonidine NN Pharmocological
saline NN Pharmocological
Clonidine NNP Pharmocological
clonidine JJ Pharmocological
clonidine JJ Pharmocological
-DOCSTART- -X- N

thoracic JJ Pharmocological
peridural JJ Pharmocological
analgesia NN Pharmocological
epidural JJ Pharmocological
analgesia NN Pharmocological
( ( Pharmocological
EA NNP Pharmocological
) ) Pharmocological
. . None
halothane NN Pharmocological
anesthesia NN Pharmocological
neuroleptanalgesia NN Pharmocological
( ( Pharmocological
NLA NNP Pharmocological
) ) Pharmocological
thoracic NNS Pharmocological
EA NNP Pharmocological
with IN Pharmocological
bupivacaine NN Pharmocological
( ( Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
) ) Pharmocological
combination NN None
with IN None
a DT None
light JJ None
general JJ Control
anesthesia NN Control
. . None
-DOCSTART- -X- N

placebo NN Control
human JJ Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
. . None
human JJ Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
( ( Pharmocological
HSS NNP Pharmocological
) ) Pharmocological
placebo NN Control
human JJ Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
( ( Pharmocological
HSS NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
saline JJ Pharmocological
placebo/HSS NN Pharmocological
) ) Pharmocological
( ( None
HSS/saline NNP Pharmocological
placebo NN Pharmocological
) ) None
. . None
placebo NN Control
, , None
secretin FW Pharmocological
treatment NN Pharmocological
HSS NNP Pharmocological
placebo NN Control
. . None
HSS NNP Pharmocological
saline JJ Control
placebo NN Control
. . None
human JJ Pharmocological
secretin NN Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

combined VBN Educational
treatment NN Educational
( ( Educational
COMB NNP Educational
) ) Educational
with IN None
risperidone NN Pharmocological
and CC Pharmocological
parent NN Pharmocological
training NN Pharmocological
( ( Pharmocological
PT NNP Pharmocological
) ) Pharmocological
risperidone JJ Pharmocological
monotherapy NN Pharmocological
aripiprazole VB Pharmocological
risperidone NN Pharmocological
COMB NNP Educational
Final NNP None
CONCLUSIONS NNP None
Medication NNP None
plus CC None
PT NNP None
-DOCSTART- -X- N

postmenopausal JJ Physical
hormonal JJ Physical
replacement NN Physical
therapy NN Physical
Mammograms NNP Physical
-DOCSTART- -X- N

hypnotized VBN Psychological
and CC None
read VB None
a DT None
passage NN None
while IN None
in IN None
hypnosis NN Psychological
. . None
post-hypnotic JJ Psychological
suggestion NN Psychological
hypnosis NN Psychological
-DOCSTART- -X- N

plafibride NN Pharmocological
N-2- NNP Pharmocological
( ( Pharmocological
p-chlorophenoxy JJ Pharmocological
) ) Pharmocological
-isobutyryl-N'-morpholinomethylurea NN Pharmocological
( ( Pharmocological
plafibride NN Pharmocological
, , Pharmocological
ITA NNP Pharmocological
104 CD Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

training NN Educational
live JJ Educational
workshop NN Educational
training NN Educational
video NN Educational
training NN Educational
condition NN Educational
video-trained JJ Educational
Video-trained JJ Educational
-DOCSTART- -X- N

an DT None
ultrasound JJ Physical
Doppler NNP Physical
device NN Physical
in IN Physical
group NN Physical
II NNP Physical
and CC Physical
a DT Physical
real-time JJ Physical
ultrasonograph NN Physical
in IN Physical
group NN Physical
III NNP Physical
. . None
Central NNP Surgical
venous JJ Surgical
catheters NNS Surgical
were VBD Surgical
placed VBN Surgical
into IN Surgical
the DT Surgical
right JJ Surgical
IJV NNP Surgical
by IN Surgical
the DT Surgical
Seldinger NNP Surgical
technique NN Surgical
. . None
-DOCSTART- -X- N

Salbutamol NNP Pharmocological
mist NN Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
saline NN Control
saline NN Control
mist NN Pharmocological
oxygen NN Pharmocological
Salbutamol NNP Pharmocological
-DOCSTART- -X- N

haptic JJ Psychological
decomposition NN Psychological
of IN Psychological
complex JJ Psychological
movements NNS Psychological
robot-assisted JJ Educational
Training VBG Psychological
with IN Psychological
haptic JJ Psychological
guidance NN Psychological
haptic JJ Psychological
feedback NN Psychological
from IN Psychological
a DT Psychological
robotic JJ Psychological
exoskeleton NN Psychological
, , None
but CC None
experienced VBD None
the DT None
simpler NN None
, , None
anatomically-isolated JJ None
motions NNS None
-DOCSTART- -X- N

MF101 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
selective JJ Pharmocological
estrogen NN Pharmocological
receptor NN Pharmocological
estrogen NN Pharmocological
receptor NN Pharmocological
beta NN Pharmocological
selective JJ Pharmocological
Chinese NNP Pharmocological
herbal NN Pharmocological
extract NN Pharmocological
, , None
menopausal JJ Pharmocological
formula NN Pharmocological
101 CD Pharmocological
placebo NN Control
. . None
placebo NN Control
MF101 NNP Pharmocological
-DOCSTART- -X- N

pimecrolimus NN Pharmocological
pimecrolimus NN Pharmocological
pimecrolimus NNS Pharmocological
Pimecrolimus NNP Pharmocological
-DOCSTART- -X- N

crystalloids NNS Pharmocological
colloids NNS Pharmocological
no DT None
prehydration NN None
crystalloid NN Pharmocological
colloid JJ Pharmocological
solution NN Pharmocological
no DT None
prehydration NN None
crystalloid NN Pharmocological
colloid JJ Pharmocological
prehydration NN Pharmocological
crystalloid JJ Pharmocological
solution NN Pharmocological
colloid NN Pharmocological
Haemaccel NNP Pharmocological
no DT Control
prehydration NN Control
colloid NN None
crystalloid NN None
colloid JJ None
prehydration NN None
-DOCSTART- -X- N

cardiac JJ Surgical
transplantation NN Surgical
cardiac JJ Surgical
transplantation NN Surgical
-DOCSTART- -X- N

galantamine NN Pharmocological
and CC None
risperidone NN Pharmocological
galantamine NN Pharmocological
and CC None
risperidone NN Pharmocological
risperidone NN Pharmocological
galantamine NN Pharmocological
galantamine NN Pharmocological
risperidone NN Pharmocological
( ( None
risperidone JJ Pharmocological
plus CC Pharmocological
9-hydroxyrisperidone CD Pharmocological
) ) None
risperidone NN Pharmocological
galantamine JJ Pharmocological
risperidone NN Pharmocological
9-hydroxyrisperidone CD Pharmocological
risperidone NN Pharmocological
) ) None
Galantamine NNP Pharmocological
and CC None
risperidone NN None
risperidone NN Pharmocological
orgalantamine NN Pharmocological
-DOCSTART- -X- N

Somatostatin NNP Pharmocological
and CC Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
vs. FW Pharmocological
ranitidine NN Pharmocological
somatostatin-UCB NN Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
Somatostatin NNP Pharmocological
Somatostatin NNP Pharmocological
-DOCSTART- -X- N

Oral JJ Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
-DOCSTART- -X- N

donepezil JJ Pharmocological
HCl NNP Pharmocological
and CC Pharmocological
digoxin NN Pharmocological
: : Pharmocological
donepezil NN Pharmocological
HCl NNP Pharmocological
and CC Pharmocological
digoxin NN Pharmocological
separately RB Pharmocological
, , Pharmocological
and CC Pharmocological
in IN Pharmocological
combination NN Pharmocological
donepezil NN Pharmocological
administered VBD Pharmocological
alone RB Pharmocological
donepezil NN Pharmocological
administered VBN Pharmocological
in IN None
combination NN None
with IN None
digoxin NN Pharmocological
. . None
digoxin NN Pharmocological
digoxin NN None
donepezil NN None
. . None
donepezil NN None
HCl NNP None
digoxin NN None
-DOCSTART- -X- N

induced VB Pharmocological
hypotension NN Pharmocological
propranolol NN Pharmocological
, , Pharmocological
thiopentone-vecuronium-isoflurane NN Pharmocological
hypotension NN Pharmocological
induced VBN Pharmocological
with IN Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
, , Pharmocological
trimetaphan JJ Pharmocological
camsylate NN Pharmocological
or CC Pharmocological
additional JJ Pharmocological
isoflurane NN Pharmocological
. . None
-DOCSTART- -X- N

Home NN Educational
based VBN Educational
management NN Educational
Home NNP Educational
based VBN Educational
medical JJ Educational
care NN Educational
multidisciplinary JJ Educational
home NN Educational
based VBN Educational
care NN Educational
Comprehensive NNP Educational
planning NN Educational
of IN Educational
home NN Educational
based VBN Educational
intervention NN Educational
-DOCSTART- -X- N

hands NNS Physical
and CC Physical
forearms NNS Physical
were VBD Physical
covered VBN Physical
for IN Physical
15 CD Physical
minutes NNS Physical
with IN Physical
a DT Physical
carbon NN Physical
fibre NN Physical
heating VBG Physical
mitt NN Physical
. . None
active JJ Physical
warming NN Physical
at IN Physical
52 CD Physical
degrees NNS Physical
C NNP Physical
or CC None
passive JJ Control
insulation NN Control
-DOCSTART- -X- N

endocrine NN Pharmocological
radiation NN Physical
therapy NN Physical
orchiectomy NN Surgical
, , None
estrogens VBZ Pharmocological
or CC None
radiotherapy NN Physical
. . None
-DOCSTART- -X- N

Couple-responsible JJ Psychological
therapy NN Psychological
process NN Psychological
: : Psychological
couple-responsible JJ Psychological
and CC Psychological
therapist-responsible JJ Psychological
process NN Psychological
couple NN Psychological
therapy NN Psychological
Couple-responsible JJ Psychological
process NN Psychological
consists VBZ Psychological
of IN Psychological
enactments NNS Psychological
, , Psychological
accommodation NN Psychological
, , Psychological
and CC Psychological
inductive JJ Psychological
process NN Psychological
. . Psychological
Therapist-responsible JJ Psychological
process NN Psychological
consists VBZ Psychological
of IN Psychological
primary JJ Psychological
therapist-couple JJ Psychological
interaction NN Psychological
, , Psychological
therapist JJ Psychological
interpretation NN Psychological
, , Psychological
and CC Psychological
direct JJ Psychological
instruction NN Psychological
. . Psychological
couple-responsible JJ Psychological
and CC Psychological
therapist-responsible JJ Psychological
episodes NNS Psychological
couple-responsible JJ Psychological
episodes NNS Psychological
. . Psychological
therapist NN Physical
process NN Physical
couple-responsible JJ Psychological
episodes NNS Psychological
therapist-responsible JJ Psychological
episodes NNS Psychological
couple-responsible JJ Psychological
episodes NNS Psychological
therapist-responsible JJ Physical
episodes NNS Physical
-DOCSTART- -X- N

pyrimethamine NN Pharmocological
Pyrimethamine NNP Pharmocological
Leucovorin NNP Pharmocological
pyrimethamine NN Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
-DOCSTART- -X- N

epoetin JJ Pharmocological
alfa NN Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
alfa NN Pharmocological
six CD Pharmocological
dosing VBG Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
regimens VBZ Pharmocological
40,000 CD Pharmocological
IU NNP Pharmocological
once RB Pharmocological
weekly RB Pharmocological
15,000 CD Pharmocological
IU NNP Pharmocological
every DT Pharmocological
other JJ Pharmocological
day NN Pharmocological
, , Pharmocological
subcutaneously RB Pharmocological
40,000 CD Pharmocological
IU NNP Pharmocological
day NN Pharmocological
subcutaneously RB Pharmocological
subcutaneous JJ Pharmocological
dosing NN Pharmocological
. . Pharmocological
dosing NN Pharmocological
dosing VBG None
epoetin JJ Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
alfa NN Pharmocological
-DOCSTART- -X- N

aflibercept NN Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
5-fluorouracil JJ Pharmocological
and CC Pharmocological
leucovorin JJ Pharmocological
aflibercept $ Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
5-fluorouracil JJ Pharmocological
and CC Pharmocological
leucovorin JJ Pharmocological
( ( Pharmocological
LV5FU2 NNP Pharmocological
) ) Pharmocological
. . None
placebo VB Control
or CC None
aflibercept VB Pharmocological
irinotecan-LV5FU2 NN Pharmocological
aflibercept JJ Pharmocological
irinotecan-LV5FU2 JJ Pharmocological
placebo NN Control
aflibercept NN Pharmocological
aflibercept JJ Pharmocological
CONCLUSION NNP None
Aflibercept IN None
4 CD None
plus CC None
irinotecan-LV5FU2 JJ None
every DT None
-DOCSTART- -X- N

Adjvant NNP Pharmocological
treatment NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
years NNS Pharmocological
( ( Pharmocological
methotrexate VB Pharmocological
400 CD Pharmocological
mg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
citrovorum NN Pharmocological
factor NN Pharmocological
100 CD Pharmocological
mg NN Pharmocological
+ NNP Pharmocological
bleomycin VBZ Pharmocological
60 CD Pharmocological
mg/week NN Pharmocological
, , Pharmocological
during IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
15 CD Pharmocological
weeks NNS Pharmocological
) ) Pharmocological
, , None
during IN None
2 CD None
years NNS None
, , None
while IN None
the DT None
did VBD Control
not RB Control
receive VB Control
any DT Control
treatment NN Control
. . None
adjuvant JJ Pharmocological
adjuvant JJ Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

antirheumatic JJ Pharmocological
drug NN Pharmocological
therapy NN Pharmocological
combination NN None
of IN None
methotrexate NN Pharmocological
, , None
sulfasalazine NN Pharmocological
, , None
and CC None
hydroxychloroquine NN Pharmocological
with IN Pharmocological
prednisolone NN Pharmocological
( ( Pharmocological
FIN-RACo NNP Pharmocological
) ) Pharmocological
, , None
or CC None
treatment NN None
with IN None
a DT None
single JJ Pharmocological
DMARD NNP Pharmocological
( ( Pharmocological
initially RB Pharmocological
, , Pharmocological
sulfasalazine NN Pharmocological
) ) Pharmocological
with IN None
or CC None
without IN None
prednisolone NN Pharmocological
( ( Pharmocological
SINGLE NNP Pharmocological
) ) Pharmocological
. . None
FIN-RACo NNP Pharmocological
SINGLE NNP Pharmocological
FIN-RACo NNP Pharmocological
SINGLE NNP Pharmocological
combination NN Pharmocological
of IN Pharmocological
DMARDs NNP Pharmocological
DMARD NNP Pharmocological
monotherapy NN Pharmocological
. . None
-DOCSTART- -X- N

ramipril NN Pharmocological
's POS Pharmocological
placebo VB Control
Ramipril NNP Pharmocological
Ramipril JJ Pharmocological
-DOCSTART- -X- N

upper JJ Physical
lip NN Physical
bite JJ Physical
test NN Physical
( ( Physical
a DT Physical
simple JJ Physical
new JJ Physical
technique NN Physical
) ) Physical
with IN Physical
modified VBN Physical
Mallampati NNP Physical
classification NN Physical
oropharyngeal NN Physical
class NN Physical
according VBG Physical
to TO Physical
the DT Physical
modified VBN Physical
Mallampati NNP Physical
criteria NNS Physical
; : Physical
the DT Physical
new JJ Physical
, , Physical
upper JJ Physical
lip NN Physical
bite IN Physical
criteria-class NN Physical
I PRP Physical
= VBP Physical
lower JJR Physical
incisors NNS Physical
can MD Physical
bite VB Physical
the DT Physical
upper JJ Physical
lip NN Physical
above IN Physical
the DT Physical
vermilion NN Physical
line NN Physical
, , Physical
class NN Physical
II NNP Physical
= NNP Physical
lower JJR Physical
incisors NNS Physical
can MD Physical
bite VB Physical
the DT Physical
upper JJ Physical
lip NN Physical
below IN Physical
the DT Physical
vermilion NN Physical
line NN Physical
, , Physical
and CC Physical
class NN Physical
III NNP Physical
= NNP Physical
lower JJR Physical
incisors NNS Physical
can MD Physical
not RB Physical
bite VB Physical
the DT Physical
upper JJ Physical
lip NN Physical
; : Physical
and CC Physical
laryngeal NN Physical
view NN Physical
grading VBG Physical
according VBG Physical
to TO Physical
The DT Physical
modified JJ Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

vaccination NN Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
or CC Pharmocological
an DT Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
pneumococcal JJ Pharmocological
vaccine NN Pharmocological
Influenza NNP Pharmocological
vaccination NN Pharmocological
pneumococcal JJ Pharmocological
vaccine NN Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
influenza NN Pharmocological
and CC Pharmocological
pneumococcal JJ Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

Autism-Spectrum JJ Other
Quotient-Japanese JJ Other
Japanese JJ Other
version NN Other
of IN Other
the DT Other
Autism NNP Other
Spectrum NNP Other
Quotient NNP Other
( ( Other
AQ NNP Other
) ) Other
, , Other
AQ-J NNP Other
AQ-J NNP Other
AQ-J NNP Other
AQ-J NNP Other
. . Other
AQ-J JJ Other
-DOCSTART- -X- N

potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
10 CD None
mmol NN None
of IN None
potassium NN Pharmocological
and CC None
10 CD None
mmol NN None
of IN None
calcium NN Pharmocological
mixed VBN None
in IN None
their PRP$ None
table JJ None
salt JJ None
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
supplement NN Pharmocological
of IN Pharmocological
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
-DOCSTART- -X- N

embolization NN Pharmocological
using VBG Pharmocological
an DT Pharmocological
n-BCA/Tantalum JJ Pharmocological
Powder/Ethiodol NNP Pharmocological
mixture NN Pharmocological
or CC None
Trufill NNP Pharmocological
PVA NNP Pharmocological
. . None
-DOCSTART- -X- N

family NN Educational
intervention NN Educational
program NN Educational
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

Chemotherapy NNP Pharmocological
cisplatin-based JJ Pharmocological
chemotherapy NN Pharmocological
surgery NN Surgical
surgery NN Surgical
cisplatin/vindesine NN Pharmocological
, , Pharmocological
mitomycin/ifosfamide/cisplatin NN Pharmocological
, , Pharmocological
mitomycin/vinblastine/cisplatin NN Pharmocological
or CC Pharmocological
vinorelbine/cisplatin NN Pharmocological
. . Pharmocological
Chemotherapy NNP Pharmocological
surgery NN Surgical
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
no DT None
chemotherapy NN None
chemotherapy NN Pharmocological
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
cisplatin-based JJ Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

alexithymia NN Other
alexithymia NN Other
-DOCSTART- -X- N

Tramadol NNP Pharmocological
suppository NN Pharmocological
placebo NN Control
tramodol NN Pharmocological
placebo NN Control
oftramadol VBP Pharmocological
50 CD Pharmocological
mg NNS Pharmocological
or CC None
two CD Control
tablets NNS Control
ofplacebo RB Control
Tramadol NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

antisecretory JJ Pharmocological
treatment NN Pharmocological
antisecretory NN Pharmocological
treatment NN Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
( ( Pharmocological
PPIs NNP Pharmocological
) ) Pharmocological
or CC None
histamine JJ Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
-receptor NN Pharmocological
antagonists NNS Pharmocological
( ( Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNPS Pharmocological
) ) Pharmocological
PPIs NNP Pharmocological
( ( Pharmocological
omeprazole JJ Pharmocological
; : None
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNP Pharmocological
( ( Pharmocological
ranitidine NN Pharmocological
; : None
PPI-treated JJ Pharmocological
PPI NNP Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNPS Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNP Pharmocological
PPIs NNP Pharmocological
. . None
Antisecretory NNP Pharmocological
reflux JJ Pharmocological
treatment NN Pharmocological
PPIs NNP Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNPS Pharmocological
-DOCSTART- -X- N

Denosumab NNP Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
denosumab NN Pharmocological
with IN None
zoledronic JJ None
acid NN None
receive VB None
either RB None
subcutaneous JJ None
denosumab NN None
120 CD None
mg NN None
and CC None
intravenous JJ None
or CC None
intravenous JJ None
zoledronic JJ None
acid NN None
4 CD None
mg NN None
adjusted VBN None
for IN None
creatinine JJ None
clearance NN None
and CC None
subcutaneous JJ None
daily JJ None
calcium NN None
and CC None
vitamin NN None
D NNP None
RESULTS NNP None
Denosumab NNP None
to TO None
zoledronic JJ None
acid NN None
with IN None
denosumab NN None
. . None
denosumab NN None
; : None
zoledronic JJ None
acid NN None
; : None
CONCLUSION NNP None
Denosumab NNP None
to TO None
zoledronic JJ None
acid NN None
denosumab JJ None
-DOCSTART- -X- N

colloidal JJ Pharmocological
bismuth NN Pharmocological
subcitrate NN Pharmocological
coated VBD Pharmocological
tablets NNS Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
coated VBD Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
coated VBD Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
coated VBD Pharmocological
tablet NN Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
. . None
-DOCSTART- -X- N

general-practitioner-based JJ Educational
interventions NNS Educational
identifying VBG Educational
depression NN Educational
and CC Educational
offering VBG Educational
an DT Educational
evidence-based JJ Educational
intervention NN Educational
multidisciplinary JJ Educational
telephone NN Educational
case NN Educational
conferencing NN Educational
-DOCSTART- -X- N

TXA2 NNP Pharmocological
synthetase NN Pharmocological
inhibitor NN Pharmocological
, , Pharmocological
ozagrel JJ Pharmocological
hydrochloride NN Pharmocological
thromboxane NN Pharmocological
A2 NNP Pharmocological
( ( Pharmocological
TXA2 NNP Pharmocological
) ) Pharmocological
synthetase NN Pharmocological
inhibitor NN Pharmocological
Ozagrel NNP Pharmocological
Hydrochloride NNP Pharmocological
and CC None
placebo NN Control
Ozagrel NNP Pharmocological
Hydrochloride NNP Pharmocological
-DOCSTART- -X- N

mecamylamine NN Pharmocological
oral JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
mecamylamine NN Pharmocological
( ( Pharmocological
2.5 CD Pharmocological
, , Pharmocological
5.0 CD Pharmocological
, , Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC Pharmocological
placebo NN Pharmocological
. . None
placebo NN Pharmocological
Mecamylamine NNP Pharmocological
Mecamylamine NNP Pharmocological
mecamylamine NN Pharmocological
Mecamylamine NNP Pharmocological
-DOCSTART- -X- N

refrain VB Educational
from IN Educational
blinking VBG Educational
refrain VB Educational
from IN Educational
blinking VBG Educational
subjects NNS Educational
who WP Educational
are VBP Educational
discouraged VBN Educational
from IN Educational
blinking VBG Educational
-DOCSTART- -X- N

secretin NN Pharmocological
intravenous JJ Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

estramustine JJ Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
Estracyt NNP Pharmocological
) ) Pharmocological
or CC None
conventional JJ Pharmocological
estrogen NN Pharmocological
. . None
-DOCSTART- -X- N

ablation NN Surgical
surgery NN Surgical
ablation NN Surgical
surgery NN Surgical
( ( Surgical
AS IN Surgical
) ) Surgical
cardiac JJ Surgical
surgery NN Surgical
randomly RB Surgical
assigned VBN Surgical
to TO Surgical
undergo VB Surgical
cardiac JJ Surgical
surgery NN Surgical
with IN Surgical
or CC Surgical
without IN Surgical
AS NNP Surgical
. . None
AS NNP Surgical
probability NN None
of IN None
AS NNP None
being VBG None
concomitant NN None
AS IN None
in IN None
AF NNP None
-DOCSTART- -X- N

closed JJ Physical
suctioning VBG Physical
open JJ Physical
suctioning NN Physical
: : Physical
Closed VBN Physical
( ( Physical
CS NNP Physical
) ) Physical
open JJ Physical
suction NN Physical
( ( Physical
OS NNP Physical
) ) Physical
and CC None
CS NNP Physical
CS NNP Physical
OS NNP Physical
CS NNP Physical
OS NNP Physical
. . None
Closed VBD Physical
suctioning VBG Physical
OS NNP Physical
. . None
CS NNP Physical
-DOCSTART- -X- N

L-ornithine-L-aspartate NNP Pharmocological
L-Ornithine-L-aspartate NNP Pharmocological
( ( Pharmocological
LOLA NNP Pharmocological
) ) Pharmocological
LOLA NNP Pharmocological
oral JJ Pharmocological
glutamine NN Pharmocological
( ( None
20 CD None
g NN None
) ) None
challenges VBZ None
, , None
receiving VBG None
LOLA NNP Pharmocological
( ( None
5 CD None
g RB None
intravenously RB None
) ) None
placebo NN Control
LOLA NNP Pharmocological
LOLA NNP Pharmocological
placebo NN Control
LOLA NNP Pharmocological
-DOCSTART- -X- N

salvinorin NN Pharmocological
A NNP Pharmocological
Salvinorin VB Pharmocological
A DT Pharmocological
placebo NN Control
salvinorin NN Pharmocological
A NNP Pharmocological
salvinorin NN Pharmocological
A NNP Pharmocological
and CC None
4 CD None
intermixed JJ Control
placebo NN Control
Salvinorin CC None
A DT None
conditions NNS None
, , None
salvinorin VBP None
A DT None
-DOCSTART- -X- N

Abacavir NNP Pharmocological
lamivudine NN Pharmocological
and CC Pharmocological
efavirenz NN Pharmocological
Ziagen NNP Pharmocological
abacavir NN Pharmocological
( ( Pharmocological
ABC NNP Pharmocological
) ) Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
lamivudine NN Pharmocological
( ( Pharmocological
3TC CD Pharmocological
) ) Pharmocological
efavirenz NN Pharmocological
( ( Pharmocological
EFV NNP Pharmocological
) ) Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
3TC CD Pharmocological
EFV NNP Pharmocological
ABC NNP Pharmocological
3TC CD Pharmocological
EFV NNP Pharmocological
-DOCSTART- -X- N

sphygmomanometrically RB Physical
determined VBN Physical
and CC None
mean JJ None
calcium NN Pharmocological
channel NN Pharmocological
blocking VBG Pharmocological
agent NN Pharmocological
, , None
digoxin NN Pharmocological
diuretic JJ Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
digoxin NN Pharmocological
noninvasive JJ Physical
blood NN Physical
pressure NN Physical
measurement NN Physical
-DOCSTART- -X- N

tobacco JJ Pharmocological
abstinent JJ Pharmocological
approximately RB None
1-2mg JJ Pharmocological
of IN Pharmocological
nasal JJ Pharmocological
nicotine JJ Pharmocological
spray NN Pharmocological
and CC None
after IN Control
an DT Control
equivalent JJ Control
volume NN Control
of IN Control
an DT Control
active JJ Control
placebo NN Control
spray NN Control
of IN Control
oleoresin NN Control
of IN Control
pepper NN Control
Nicotine NNP Pharmocological
nicotine NN Pharmocological
nicotine NN Pharmocological
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
iatrogenic JJ Physical
hookworm NN Physical
infection NN Physical
hookworm NN Physical
infection NN Physical
-DOCSTART- -X- N

Oral JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
placebo-controlled JJ Control
S-adenosylmethionine JJ Pharmocological
oral JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
S-adenosylmethionine JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
S-adenosylmethionine NNP Pharmocological
S-adenosylmethionine NNP Pharmocological
oral JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

clomipramine VB Pharmocological
haloperidol VB Pharmocological
clomipramine NN Pharmocological
placebo NN Control
haloperidol NN Pharmocological
placebo NN Control
clomipramine NN Pharmocological
-DOCSTART- -X- N

azithromycin NN Pharmocological
Azithromycin NNP Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
plus CC None
warm JJ Pharmocological
compresses NNS Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
Azithromycin NNP Pharmocological
-DOCSTART- -X- N

propofol NN Pharmocological
propofol NN Pharmocological
placebo-controlled JJ Control
normal JJ Pharmocological
saline NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
3.3 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
3.3 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
1.0 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
3.3 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
50 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
Rapid NNP Physical
injection NN Physical
lidocaine JJ Pharmocological
slow VB Physical
injection NN Physical
pretreatment NN Pharmocological
with IN Pharmocological
lidocaine JJ Pharmocological
Rapid JJ Physical
injection NN Physical
slow JJ Physical
injection NN Physical
with IN None
lidocaine JJ Pharmocological
slow VB Physical
injection NN Physical
after IN Pharmocological
pretreatment NN Pharmocological
with IN Pharmocological
lidocaine JJ Pharmocological
rapid JJ Physical
administration NN Physical
of IN None
propofol JJ Pharmocological
slow JJ Physical
administration NN Physical
of IN None
propofol NN Pharmocological
. . None
-DOCSTART- -X- N

L-arginine NNP Pharmocological
L-arginine NNP Pharmocological
two CD None
groups NNS None
according VBG None
to TO None
different JJ None
ovarian JJ None
stimulation NN None
protocols NNS None
: : None
( ( None
i NN None
) ) None
flare-up JJ Pharmocological
gonadotrophin-releasing JJ Pharmocological
hormone NN Pharmocological
analogue NN Pharmocological
( ( Pharmocological
GnRHa NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
elevated JJ Pharmocological
pure NN Pharmocological
follicle NN Pharmocological
stimulating VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
pFSH NN Pharmocological
) ) Pharmocological
( ( None
n JJ None
= NNP None
17 CD None
) ) None
; : None
and CC None
( ( None
ii NN None
) ) None
flare-up NN Pharmocological
GnRHa NNP Pharmocological
plus CC Pharmocological
elevated VBN Pharmocological
pFSH JJ Pharmocological
plus CC Pharmocological
oral JJ Pharmocological
L-arginine NNP Pharmocological
( ( None
n JJ None
= NNP None
17 CD None
) ) None
. . None
the DT None
patients NNS None
were VBD None
submitted VBN None
to TO None
hormonal VB None
( ( None
oestradiol NN None
and CC None
growth NN None
hormone NN None
) ) None
, , None
ultrasonographic JJ Physical
( ( None
follicular JJ None
number NN None
and CC None
diameter NN None
, , None
endometrial JJ None
thickness NN None
) ) None
and CC None
Doppler NNP None
( ( None
uterine JJ None
and CC None
perifollicular JJ None
arteries NNS None
) ) None
evaluations NNS None
. . None
L-arginine NNP Pharmocological
L-arginine NNP Pharmocological
L-arginine JJ Pharmocological
-DOCSTART- -X- N

radiofrequency NN Physical
ablation NN Physical
conventional JJ Surgical
high JJ Surgical
ligation NN Surgical
radiofrequency NN Physical
ablation NN Physical
( ( Physical
RFA NNP Physical
) ) Physical
RFA NNP Physical
RFA NNP Physical
RFA NNP Physical
RFA NNP Physical
RFA NNP Physical
. . None
-DOCSTART- -X- N

combination NN None
of IN None
ketamine NN Pharmocological
and CC None
propofol NN Pharmocological
, , None
propofol VB Pharmocological
alone RB None
, , None
or CC None
a DT None
combination NN None
of IN None
ketamine NN Pharmocological
and CC None
diazepam NN Pharmocological
before IN None
and CC None
after IN None
induction NN Pharmocological
of IN Pharmocological
propofol NN Pharmocological
ketamine JJ Pharmocological
hydrochloride NN Pharmocological
and CC Pharmocological
propofol NN Pharmocological
ketamine VB Pharmocological
hydrochloride NN Pharmocological
diazepam NN Pharmocological
anesthesia NN Pharmocological
anesthetized VBN Pharmocological
with IN Pharmocological
isoflurane NN Pharmocological
. . None
acepromazine NN Pharmocological
oxymorphone NN Pharmocological
propofol NN Pharmocological
, , Pharmocological
K-P NNP Pharmocological
, , Pharmocological
or CC Pharmocological
K-D. NNP Pharmocological
K-P NNP Pharmocological
K-D NNP Pharmocological
K-P NNP Pharmocological
K-P NNP Pharmocological
K-D NNP Pharmocological
-DOCSTART- -X- N

treprostinil NN Pharmocological
prostanoid NN Pharmocological
therapy NN Pharmocological
prostacyclin NN Pharmocological
treprostinil NN Pharmocological
treprostinil NN Pharmocological
inhaled JJ None
treprostinil NN None
on IN None
inhaled VBN None
treprostinil NN None
4 CD None
receiving VBG None
background NN None
PAH NNP None
therapy NN None
; : None
12 CD None
Inhaled VBD None
treprostinil NN None
was VBD None
treprostinil NN None
appears VBZ None
-DOCSTART- -X- N

radiotherapy NN Physical
enucleation NN Physical
-DOCSTART- -X- N

FRF NNP Physical
model NN Physical
functional JJ Physical
( ( Physical
f JJ Physical
) ) Physical
MRI-adaptation NN Physical
protocol NN Physical
-DOCSTART- -X- N

Selenium NNP Pharmocological
supplementation NN Pharmocological
prevention NN Educational
selenium NN Pharmocological
as IN Pharmocological
selenized VBN Pharmocological
yeast NN Pharmocological
selenium JJ Pharmocological
supplementation NN Pharmocological
selenium JJ Pharmocological
supplementation NN Pharmocological
selenium NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Metoprolol NNP Pharmocological
CR/XL NNP Pharmocological
metoprolol NN Pharmocological
controlled VBN Pharmocological
release/extended VBD Pharmocological
release NN Pharmocological
( ( Pharmocological
CR/XL NNP Pharmocological
) ) Pharmocological
Metoprolol NNP Pharmocological
CR/XL NNP Pharmocological
metoprolol NN Pharmocological
CR/XL NNP Pharmocological
placebo NN Control
Metoprolol NNP Pharmocological
CR/XL NNP Pharmocological
-DOCSTART- -X- N

Chronic NNP None
kidney NN None
disease NN None
( ( None
CKD NNP None
) ) None
CKD NNP None
multivariable JJ Physical
logistic JJ Physical
regression NN Physical
model NN Physical
patients NNS None
with IN None
and CC None
without IN None
CKD NNP None
. . None
Matched NNP Educational
Cox NNP Educational
regression NN Educational
analyses NNS Educational
CKD NNP None
with IN None
and CC None
without IN None
CKD NNP None
CKD NNP None
-DOCSTART- -X- N

local JJ Pharmocological
anesthesia NN Pharmocological
and CC Surgical
endometrial JJ Surgical
biopsy NN Surgical
with IN None
paracervical JJ Pharmocological
block NN Pharmocological
by IN Pharmocological
10 CD Pharmocological
mL NNS Pharmocological
of IN Pharmocological
1 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
hydrochloride JJ Pharmocological
solution NN Pharmocological
no DT Control
local JJ Control
anesthesia NN Control
Paracervical JJ Physical
anesthesia NN Physical
-DOCSTART- -X- N

Information NNP Educational
source NN Educational
videotape NN Educational
-DOCSTART- -X- N

home-based JJ Educational
intervention NN Educational
programme NN Educational
early JJ Educational
childhood NN Educational
intervention NN Educational
Intervention NNP Educational
received VBD Educational
an DT Educational
additional JJ Educational
home-based JJ Educational
programme NN Educational
consisting NN Educational
of IN Educational
40 CD Educational
weekly JJ Educational
visits NNS Educational
. . None
-DOCSTART- -X- N

strategies NNS None
: : None
ETT NNP None
or CC None
exercise NN None
MPI NNP None
. . None
ETT NNP None
or CC None
exercise NN None
MPI NNP None
. . None
-DOCSTART- -X- N

Statin NNP Pharmocological
treatment NN Pharmocological
withdrawal NN None
statin NN Pharmocological
pretreatment NN Pharmocological
and CC None
its PRP$ None
withdrawal NN None
statin VB Pharmocological
withdrawal NN None
for IN None
the DT None
first JJ None
3 CD None
days NNS None
after IN None
admission NN None
( ( None
n JJ None
= NNP None
46 CD None
) ) None
or CC None
to TO None
immediately RB None
receive VB None
atorvastatin NN Pharmocological
20 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
43 CD None
) ) None
non-statin-withdrawal JJ None
Statin NNP Physical
-DOCSTART- -X- N

chemotherapy NN Pharmocological
before IN None
chemotherapeutic JJ None
treatment NN None
as RB None
well RB None
chemotherapy NN None
and CC None
chemotherapy NN None
for IN None
before IN None
chemotherapy NN None
and CC None
chemotherapy NN None
( ( None
p JJ None
< NNP None
0.005 CD None
DISCUSSION NNP None
Chemotherapy NNP None
significantly RB None
-DOCSTART- -X- N

imipramine NN Pharmocological
, , None
mexiletine NN Pharmocological
, , None
pirmenol NN Pharmocological
, , None
procainamide NN Pharmocological
, , None
propafenone NN Pharmocological
, , None
quinidine NN Pharmocological
, , None
and CC None
sotalol NN Pharmocological
electrophysiologic NN Physical
study NN Physical
or CC Physical
Holter NNP Physical
monitoring VBG Physical
together RB Physical
with IN Physical
exercise NN Physical
testing NN Physical
. . None
-DOCSTART- -X- N

BCG NNP Pharmocological
( ( Pharmocological
RIVM NNP Pharmocological
) ) Pharmocological
mitomycin JJ Pharmocological
intravesical JJ Pharmocological
therapy NN Pharmocological
bacillus JJ None
Calmette-Gu?rin NNP None
( ( None
BCG NNP None
) ) None
RIVM NNP None
, , None
a DT None
Dutch JJ None
BCG NNP None
with IN None
mitomycin JJ None
C NNP None
BCG NNP None
RIVM NNP None
and CC None
mitomycin VB None
C NNP None
for IN None
BCG-treated JJ None
for IN None
MMC-treated JJ None
-DOCSTART- -X- N

ciclesonide NN Pharmocological
Ciclesonide NNP Pharmocological
ciclesonide JJ Pharmocological
placebo NN Control
ciclesonide NN Pharmocological
placebo NN Control
ciclesonide NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

anaferon NN Pharmocological
complex JJ Pharmocological
therapy NN Pharmocological
anaferon NN Pharmocological
anaferon NN Pharmocological
complex JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

dietary JJ Pharmocological
glutamine NN Pharmocological
supplementation NN Pharmocological
. . Pharmocological
Dietary JJ Pharmocological
supplementation NN Pharmocological
of IN Pharmocological
glutamine NN Pharmocological
free JJ Pharmocological
access NN Pharmocological
to TO Pharmocological
diets NNS Pharmocological
supplemented VBN Pharmocological
with IN Pharmocological
1 CD Pharmocological
% NN Pharmocological
L-glutamine NNP Pharmocological
( ( Pharmocological
wt NN Pharmocological
: : Pharmocological
wt NN Pharmocological
) ) Pharmocological
or CC Pharmocological
isonitrogenous JJ Pharmocological
L-alanine JJ Pharmocological
( ( Pharmocological
control NN Pharmocological
) ) Pharmocological
. . Pharmocological
Dietary NNP Pharmocological
glutamine JJ Pharmocological
supplementation NN Pharmocological
the DT Pharmocological
glutamine NN Pharmocological
treatment NN Pharmocological
glutamine NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

novel JJ Pharmocological
antibiotic JJ Pharmocological
regimens NNS Pharmocological
including VBG Educational
concomitant NN Educational
, , Educational
sequential JJ Educational
hybrid JJ Physical
therapies NNS Physical
. . None
concomitant NN Physical
therapy NN Physical
: : Physical
omeprazole JJ Physical
amoxicillin RB Pharmocological
clarithromycin VBD Pharmocological
tinidazole JJ Pharmocological
sequential JJ Physical
therapy NN Physical
: : Physical
omeprazole JJ Physical
amoxicillin $ Pharmocological
omeprazole JJ Pharmocological
clarithromycin VBD Pharmocological
tinidazole JJ Pharmocological
hybrid JJ Physical
therapy NN Physical
: : Physical
omeprazole JJ Physical
amoxicillin VBZ Pharmocological
omeprazole JJ Pharmocological
amoxicillin RB Pharmocological
clarithromycin VBD Pharmocological
tinidazole JJ Pharmocological
( ( Physical
13 CD Physical
) ) Physical
C-urea NNP Physical
breath NN Physical
test NN Physical
. . None
second-line JJ Physical
therapy NN Physical
omeprazole JJ Pharmocological
levofloxacin VBD Pharmocological
amoxicillin RB Pharmocological
concomitant JJ Pharmocological
regimen NNS Pharmocological
sequential JJ Physical
therapy NN Physical
hybrid JJ Pharmocological
regimen NNS Pharmocological
. . None
second-line JJ Pharmocological
regimen NNS Pharmocological
. . None
concomitant NN Pharmocological
sequential JJ None
therapy NN None
hybrid JJ None
therapy NN None
levofloxacin-based JJ None
triple NN None
therapy NN None
-DOCSTART- -X- N

diclofenac NN Pharmocological
diclofenac NN Pharmocological
and CC None
ketorolac NN Pharmocological
postoperative VB Pharmocological
diclofenac NN Pharmocological
in IN None
one CD None
eye NN None
and CC None
ketorolac NN Pharmocological
in IN Pharmocological
the DT Pharmocological
other JJ Pharmocological
. . None
-DOCSTART- -X- N

surgical JJ Surgical
adjuvant NN Surgical
chemotherapy NN Surgical
using VBG None
5-fluorouracil JJ Pharmocological
and CC Pharmocological
dl-leucovorin JJ Pharmocological
with IN Pharmocological
CDDP NNP Pharmocological
5-FU JJ Pharmocological
and CC Pharmocological
dl-leucovorin JJ Pharmocological
surgical JJ Surgical
adjuvant NN Surgical
chemotherapy NN Surgical
dl-leucovorin JJ Pharmocological
( ( Pharmocological
dl-LV JJ Pharmocological
) ) Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
( ( Pharmocological
FL-therapy NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
CDDP NNP Pharmocological
, , Pharmocological
5-FU JJ Pharmocological
, , Pharmocological
and CC Pharmocological
dl-LV JJ Pharmocological
( ( Pharmocological
PFL-therapy NNP Pharmocological
) ) Pharmocological
CDDP NNP Pharmocological
5-FU JJ Pharmocological
dl-LV NN Pharmocological
5-FU JJ Pharmocological
dl-LV NN Pharmocological
dl-LV JJ Pharmocological
5-FU JJ Pharmocological
PFL-therapy NNP None
FL-therapy NNP None
surgical JJ Surgical
adjuvant NN Surgical
therapies NNS Surgical
-DOCSTART- -X- N

Alkalinized NNP Pharmocological
lidocaine NN Pharmocological
and CC Pharmocological
heparin NN Pharmocological
alkalinized JJ Pharmocological
lidocaine NN Pharmocological
and CC Pharmocological
heparin NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

interferon VB Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

randomized VBN None
to TO None
endoscopic VB None
injection NN None
treatment NN None
with IN None
one CD None
of IN None
the DT None
following JJ None
agents NNS None
: : None
cyanoacrylate NN Pharmocological
; : None
a DT Pharmocological
1:1:1 CD Pharmocological
mixture NN Pharmocological
of IN Pharmocological
sodium NN Pharmocological
tetradecyl NN Pharmocological
sulfate VBP Pharmocological
3 CD Pharmocological
% NN Pharmocological
, , Pharmocological
ethanol RB Pharmocological
98 CD Pharmocological
% NN Pharmocological
, , Pharmocological
and CC Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
; : None
ethanolamine VB Pharmocological
oleate VBP Pharmocological
5 CD Pharmocological
% NN Pharmocological
; : None
sodium NN Pharmocological
morrhuate VBP Pharmocological
5 CD Pharmocological
% NN Pharmocological
; : Pharmocological
sodium NN Pharmocological
tetradecyl NN Pharmocological
sulfate VBP Pharmocological
1.5 CD Pharmocological
% NN Pharmocological
; : Pharmocological
polidocanol CC Pharmocological
1 CD Pharmocological
% NN Pharmocological
; : None
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
with IN Pharmocological
epinephrine JJ Pharmocological
1:10,000 CD Pharmocological
; : None
or CC None
normal JJ Control
saline JJ Control
solution NN Control
( ( Control
control NN Control
) ) Control
. . Control
-DOCSTART- -X- N

knee NN Physical
position NN Physical
knee JJ Physical
position NN Physical
leg NN None
elevated VBD None
30? CD None
at IN None
the DT None
hip NN None
over IN None
an DT None
inactive JJ None
CPM NNP None
for IN None
72 CD None
h NN None
postoperatively RB None
. . None
the DT None
knee NN None
flexed VBD None
to TO None
30? CD None
during IN None
this DT None
period NN None
. . None
the DT None
knee NN None
extended VBD None
that IN None
flexion NN None
of IN None
the DT None
knee NN None
to TO None
-DOCSTART- -X- N

high-intensity NN Physical
aerobic JJ Physical
exercise NN Physical
exhaustive JJ Physical
cycling NN Physical
exercise NN Physical
-DOCSTART- -X- N

low-dose JJ Physical
hormone NN Physical
therapy NN Physical
Chinese JJ Pharmocological
formulated VBN Pharmocological
herbs NN Pharmocological
products NNS Pharmocological
] NNP None
low-dose JJ Physical
hormone NN Physical
therapy NN Physical
( ( Physical
HT NNP Physical
) ) Physical
Chinese JJ Pharmocological
formulated VBN Pharmocological
herbs NN Pharmocological
products NNS Pharmocological
. . None
estradiol NN Pharmocological
valerate NN Pharmocological
( ( Pharmocological
E2 NNP Pharmocological
V NNP Pharmocological
) ) Pharmocological
1 CD Pharmocological
mg/d NN Pharmocological
+ NNP None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
2 CD Pharmocological
mg/d NN Pharmocological
; : None
group NN None
B NNP None
: : None
conjugated JJ Pharmocological
equine NN Pharmocological
estrogen NN Pharmocological
0.45 CD Pharmocological
mg/d NN Pharmocological
+ NNP None
MPA NNP Pharmocological
2 CD Pharmocological
group NN None
C NNP None
: : None
tibolone NN Pharmocological
group NN None
D NNP None
: : None
a DT Pharmocological
Chinese JJ Pharmocological
formulated VBN Pharmocological
herbs JJ Pharmocological
product NN Pharmocological
( ( Pharmocological
Kuntai NNP Pharmocological
) ) Pharmocological
calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
low-dose JJ Pharmocological
HT NNP Pharmocological
-DOCSTART- -X- N

medical JJ Pharmocological
ozone NN Pharmocological
therapy NN Pharmocological
medical JJ Pharmocological
ozone NN Pharmocological
basic JJ Physical
therapy NN Physical
basic JJ Pharmocological
therapy NN Pharmocological
plus CC Pharmocological
ozone NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

sodium NN Pharmocological
oxybate NN Pharmocological
placebo-controlled JJ Control
sodium NN Pharmocological
oxybate NN Pharmocological
( ( Pharmocological
SXB NNP Pharmocological
) ) Pharmocological
withdrawn VBN Pharmocological
from IN Pharmocological
antidepressants NNS Pharmocological
and CC Pharmocological
sedative/hypnotics NNS Pharmocological
placebo VB Control
placebo NN Control
-DOCSTART- -X- N

Dexamethasone NNP Pharmocological
versus NN None
prednisone NN Pharmocological
intravenous JJ Pharmocological
mercaptopurine NN Pharmocological
Conventional NNP Pharmocological
therapy NN Pharmocological
prednisone NN Pharmocological
and CC None
oral JJ None
6-mercaptopurine JJ Pharmocological
. . None
dexamethasone NN Pharmocological
over IN None
prednisone NN Pharmocological
and CC None
for IN None
intravenous JJ Pharmocological
( ( Pharmocological
IV NNP Pharmocological
) ) Pharmocological
over IN None
oral JJ Pharmocological
6-mercaptopurine CD Pharmocological
dexamethasone NN Pharmocological
and CC None
IV NNP Pharmocological
6-mercaptopurine JJ Pharmocological
. . None
dexamethasone NN None
plus CC Other
taper NN Other
prednisone NN Pharmocological
IV NNP Pharmocological
6-mercaptopurine NN Pharmocological
oral JJ Pharmocological
6-mercaptopurine JJ Pharmocological
. . None
dexamethasone JJ Pharmocological
with IN Other
taper NN Other
. . None
Intrathecal NNP Pharmocological
( ( Pharmocological
IT NNP Pharmocological
) ) Pharmocological
methotrexate NN Pharmocological
dexamethasone NN Pharmocological
prednisone NN Pharmocological
dexamethasone NN Pharmocological
. . None
dexamethasone NN Pharmocological
prednisone NN Pharmocological
oral JJ Pharmocological
or CC Pharmocological
IV JJ Pharmocological
6-mercaptopurine JJ Pharmocological
; : None
IV NNP Pharmocological
6-mercaptopurine JJ Pharmocological
-DOCSTART- -X- N

hyperfractionated VBN Physical
chest JJS Physical
wall NN Physical
irradiation NN Physical
versus IN None
once-daily RB Physical
chest JJS Physical
wall NN Physical
irradiation NN Physical
after IN Physical
chemotherapy NN Pharmocological
hyperfractionated JJ Physical
radiotherapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
hyperfractionated VBN Physical
( ( Physical
twice-daily JJ Physical
, , Physical
b.i.d NN Physical
. . Physical
) ) Physical
chest JJS Physical
wall NN Physical
RT NNP Physical
q.d NN Physical
. . Physical
arm NN None
b.i.d NN Physical
. . Physical
arm NN None
b.i.d NN Physical
. . Physical
arm NN None
q.d NN Physical
. . Physical
arm NN None
postmastectomy NN Physical
RT NNP Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
placebo-controlled JJ Control
Pentoxifylline NNP Pharmocological
placebo NN Control
. . None
pentoxifylline NN Pharmocological
placebo NN Control
pentoxifylline NN Pharmocological
placebo NN Control
. . None
pentoxifylline NN Pharmocological
placebo NN Control
. . None
pentoxifylline NN Pharmocological
-DOCSTART- -X- N

nitazoxanide NN Pharmocological
nitazoxanide-a JJ Physical
new JJ None
broad-spectrum JJ None
antiparasitic JJ None
drug-on JJ None
-DOCSTART- -X- N

Stepping VBG Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
: : Educational
parenting VBG Educational
program NN Educational
Triple NNP Educational
P NNP Educational
Positive NNP Educational
Parenting NNP Educational
Program NNP Educational
Stepping VBG Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
Stepping NNP Educational
Stones NNP Educational
Stepping VBG Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
-DOCSTART- -X- N

Sun NNP Educational
protection NN Educational
behaviors NNS Educational
sun NN Educational
protection NN Educational
behaviors NNS Educational
avoid VBZ Educational
the DT Educational
sun NN Educational
during IN Educational
midday NN Educational
sunscreen JJ Other
) ) None
-DOCSTART- -X- N

Competitive JJ Psychological
memory NN Psychological
training NN Psychological
( ( Psychological
COMET NNP Psychological
) ) Psychological
COMET NNP Psychological
COMET NNP Psychological
in IN Physical
addition NN Physical
to TO Physical
their PRP$ Physical
regular JJ Psychological
therapy NN Psychological
( ( Physical
COMET NNP Psychological
+ NNP Physical
therapy NN Psychological
as IN Psychological
usual JJ Psychological
[ NNP Psychological
TAU NNP Psychological
] NN Psychological
: : None
of IN None
ongoing VBG Control
regular JJ Control
therapy NN Control
( ( Control
TAU NNP Control
only RB Control
: : None
COMET NNP Psychological
TAU NNP Psychological
COMET NNP Psychological
TAU NNP Physical
COMET NNP Psychological
+ NNP None
TAU NNP Psychological
COMET NNP Psychological
+ NNP None
TAU NNP Psychological
COMET NNP Psychological
-DOCSTART- -X- N

oral JJ Pharmocological
contraceptives NNS Pharmocological
( ( Pharmocological
OCs NNP Pharmocological
) ) Pharmocological
progestogens NNS Pharmocological
, , None
desogestrel NN Pharmocological
and CC None
gestodene NN Pharmocological
20 CD None
micrograms NNS None
ethinyl VBP Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
E2 NNP Pharmocological
) ) Pharmocological
150 CD None
micrograms NNS None
desogestrel VBD Pharmocological
ethinyl VBP Pharmocological
E2 NNP Pharmocological
plus CC Pharmocological
75 CD Pharmocological
micrograms NNS Pharmocological
gestodene VBP Pharmocological
-DOCSTART- -X- N

Margarines NNS None
fortified VBN None
with IN None
?-linolenic JJ None
acid NN None
, , None
eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
, , None
or CC None
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
of IN None
?-linolenic JJ None
acid NN None
( ( None
ALA NNP None
) ) None
, , None
EPA NNP None
, , None
or CC None
DHA NNP None
incorporated VBN None
which WDT None
margarines NNS None
fortified VBD None
with IN None
either DT None
10 CD None
weight NN None
percent NN None
ALA NNP None
, , None
EPA NNP None
, , None
or CC None
DHA NNP None
ethyl VBP None
esters NNS None
replaced VBD None
-DOCSTART- -X- N

bladder NN Physical
flap NN Physical
bladder NN Physical
flap NN Physical
abdominal JJ Surgical
surgeries NNS Surgical
cesarean JJ Surgical
deliveries NNS Surgical
omission NN Physical
of IN Physical
the DT Physical
bladder NN Physical
flap NN Physical
-DOCSTART- -X- N

confession NN Educational
decisions NNS Educational
. . Educational
-DOCSTART- -X- N

transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Shenmen NNP Physical
point NN Physical
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Shenmen NNP Physical
point NN Physical
group NN Physical
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Eye NNP Physical
point NN Physical
group NN Physical
control NN Control
group NN Control
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
pressurization NN None
and CC None
connected VBN None
line NN None
were VBD None
the DT None
same JJ None
with IN None
group NN None
A NNP None
, , None
but CC None
without IN None
electrical JJ Control
stimulation NN Control
. . None
-DOCSTART- -X- N

acarbose NN Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
acarbose NN Pharmocological
placebo-controlled JJ Control
acarbose JJ Pharmocological
placebo NN Control
placebo NN Control
placebo NN Control
acarbose NN Pharmocological
sulphonylurea/insulin VB Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
Acarbose NNP Pharmocological
-DOCSTART- -X- N

Etanercept NNP Pharmocological
etanercept FW Pharmocological
etanercept NN Pharmocological
etanercept JJ Pharmocological
-DOCSTART- -X- N

on IN None
the DT None
QLQ-C30 NNP Educational
SSQ NNP Educational
SSQ NNP Educational
SSQ NNP Educational
SSQ NNP Educational
SSQ NNP Educational
QLQ-C30 NNP Educational
QLQ-C30 NNP Educational
. . None
-DOCSTART- -X- N

norfloxacin NN Pharmocological
norfloxacin NN Pharmocological
and CC None
trimethoprim/sulfamethoxazole NN Pharmocological
Norfloxacin NNP Pharmocological
, , None
trimethoprim/sulfamethoxazole NN Pharmocological
, , None
cytokines NNS Pharmocological
, , None
nitric JJ Pharmocological
oxide NN Pharmocological
Trimethoprim/sulfamethoxazole NNP Pharmocological
Norfloxacin NNP Pharmocological
trimethoprim/sulfamethoxazole JJ Pharmocological
-DOCSTART- -X- N

PostureJac NNP Physical
PostureJac NNP Physical
PostureJac NNP None
-DOCSTART- -X- N

community NN Educational
pharmacists NNS Educational
intensive JJ Educational
skill NN Educational
development NN Educational
program NN Educational
community NN Educational
pharmacists VBZ Educational
-DOCSTART- -X- N

botulinum NN Pharmocological
toxin NN Pharmocological
type NN Pharmocological
A NNP Pharmocological
. . Pharmocological
botulinum NN Pharmocological
toxin NN Pharmocological
type NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
BoNT-A NNP Pharmocological
) ) Pharmocological
injected VBN Pharmocological
with IN Pharmocological
BoNT-A NNP Pharmocological
or CC None
placebo NN Control
placebo NN Control
BoNT-A NNP Pharmocological
-DOCSTART- -X- N

John NNP Pharmocological
's POS Pharmocological
wort NN Pharmocological
( ( Pharmocological
SJW NNP Pharmocological
) ) Pharmocological
SJW NNP Pharmocological
SJW NNP Pharmocological
SJW NNP Pharmocological
300 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
600 CD Pharmocological
mg NN Pharmocological
, , None
or CC None
a DT None
matching JJ None
placebo NN Control
tablet NN None
3 CD None
times NNS None
a DT None
day NN None
combined VBN Educational
with IN Educational
a DT Educational
behavioral JJ Psychological
intervention NN Psychological
for IN Educational
12 CD Educational
weeks NNS Educational
. . Educational
SJW NNP Pharmocological
SJW NNP Pharmocological
. . Pharmocological
SJW NNP Pharmocological
-DOCSTART- -X- N

diuretics NNS Pharmocological
diuretics NNS Pharmocological
placebo NN Control
oral JJ Pharmocological
diuretics NNS Pharmocological
( ( Pharmocological
chlorothiazide NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg/kg/dose NN Pharmocological
and CC Pharmocological
spironolactone NN Pharmocological
, , Pharmocological
1.5 CD Pharmocological
mg/kg/dose NN Pharmocological
) ) Pharmocological
given VBN None
twice RB None
daily RB None
, , None
or CC None
placebo NN Control
. . None
placebo NN Control
. . None
placebo NN Control
. . None
diuretics NNS Pharmocological
-DOCSTART- -X- N

radiation NN Surgical
therapy NN Surgical
split VB Surgical
course NN Surgical
radiation NN Surgical
therapy NN Surgical
combined VBN None
with IN None
mitomycin JJ Pharmocological
C NNP Pharmocological
and CC None
5 CD Pharmocological
fluorouracil NN Pharmocological
radiotherapy NN Surgical
, , None
50 CD None
Gy NNP None
in IN None
20 CD None
fractions NNS None
in IN None
28 CD None
days NNS None
split JJ Surgical
course NN Surgical
radiotherapy NN Surgical
and CC None
concurrent NN Pharmocological
chemotherapy NN Pharmocological
, , None
25 CD None
Gy NNP None
in IN None
10 CD None
fractions NNS None
in IN None
14 CD None
days NNS None
followed VBN None
by IN None
a DT None
4 CD None
week NN None
rest NN None
and CC None
a DT None
further JJ None
25 CD None
Gy NNP None
in IN None
10 CD None
fractions NNS None
in IN None
14 CD None
days NNS None
starting VBG None
on IN None
day NN None
43 CD None
; : None
Mitomycin NNP Pharmocological
C NNP Pharmocological
was VBD None
given VBN None
on IN None
day NN None
1 CD None
and CC None
day NN None
43 CD None
and CC None
5FU CD Pharmocological
continuous JJ None
infusions NNS None
on IN None
days NNS None
1 CD None
-- : None
4 CD None
and CC None
days NNS None
43 CD None
-- : None
46 CD None
. . None
radiotherapy NN Surgical
concurrent JJ Pharmocological
chemotherapy NN Pharmocological
with IN None
Mitomycin NNP Pharmocological
C NNP Pharmocological
and CC None
5 CD Pharmocological
Fluorouracil NNP Pharmocological
-DOCSTART- -X- N

two-month JJ Educational
vocal JJ Educational
exercising NN Educational
spectral JJ Educational
biofeedback NN Educational
voice NN Educational
training VBG Educational
traditional JJ Other
way NN Other
-DOCSTART- -X- N

After IN None
pre-screening NN None
and CC None
a DT None
washout JJ None
period NN None
of IN None
at IN None
least JJS None
14 CD None
days NNS None
, , None
eligible JJ None
volunteers NNS None
received VBD None
ASA NNP Pharmocological
81 CD Pharmocological
mg NN Pharmocological
with IN None
or CC None
without IN None
esomeprazole JJ Pharmocological
20 CD Pharmocological
mg NN Pharmocological
once RB None
daily JJ None
for IN None
5 CD None
days NNS None
in IN None
randomized JJ None
order NN None
, , None
with IN None
a DT None
14-day JJ None
washout NN None
between IN None
treatments NNS None
. . None
-DOCSTART- -X- N

total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
radical JJ Surgical
prostatectomy NN Surgical
( ( Surgical
RP NNP Surgical
) ) Surgical
neoadjuvant JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
NHT NNP Pharmocological
) ) Pharmocological
. . None
total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
NHT NNP Pharmocological
) ) None
total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
neoadjuvant JJ Pharmocological
therapy NN Pharmocological
immediate JJ Pharmocological
surgery NN Pharmocological
alone RB Pharmocological
total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
before IN None
RP NNP Surgical
NHT NNP Pharmocological
-DOCSTART- -X- N

diclofenac JJ Pharmocological
diethylamine JJ Pharmocological
Topical JJ Pharmocological
diclofenac NN Pharmocological
diethylamine NN Pharmocological
( ( Pharmocological
DDEA NNP Pharmocological
) ) Pharmocological
1.16 CD Pharmocological
% NN Pharmocological
gel NN Pharmocological
placebo NN Pharmocological
gel NN Pharmocological
lower JJR None
with IN None
DDEA NNP None
gel NN None
with IN None
DDEA NNP None
gel NN None
-DOCSTART- -X- N

incentives VB Educational
use NN Educational
of IN Educational
lottery JJ Educational
tickets NNS Educational
as IN Educational
incentives NNS Educational
three CD None
incentive JJ None
groups NNS None
: : None
( ( None
a DT None
) ) None
no DT Control
incentive NN Control
; : None
( ( None
b NN None
) ) None
a DT None
promised JJ Educational
incentive NN Educational
of IN Educational
one CD Educational
lottery NN Educational
ticket NN Educational
to TO Educational
be VB Educational
received VBN Educational
upon IN Educational
reply NN Educational
; : None
( ( None
c NN None
) ) None
a DT None
promised JJ Educational
incentive NN Educational
of IN Educational
one CD Educational
lottery NN Educational
ticket NN Educational
to TO Educational
be VB Educational
received VBN Educational
upon IN Educational
reply NN Educational
and CC Educational
an DT Educational
additional JJ Educational
lottery NN Educational
ticket NN Educational
upon IN Educational
reply NN Educational
within IN Educational
1 CD Educational
week NN Educational
. . None
no DT Control
incentive NN Control
group NN Control
one CD Educational
plus CC Educational
one CD Educational
lottery NN Educational
ticket NN Educational
group NN Educational
incentive NN Educational
group NN Educational
. . None
lottery JJ Educational
tickets NNS Educational
Incentives NNS Educational
-DOCSTART- -X- N

Clarithromycin NNP Pharmocological
placebo-controlled JJ Control
semisynthetic JJ Pharmocological
macrolide NN Pharmocological
antibiotic JJ Pharmocological
, , None
clarithromycin NN Pharmocological
methacholine VB Pharmocological
clarithromycin VBZ Pharmocological
placebo NN Pharmocological
dextrose JJ Pharmocological
clarithromycin NNS Pharmocological
clarithromycin NN Pharmocological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
and CC None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
] NNP None
. . None
tamoxifen NN Pharmocological
( ( Pharmocological
TAM NNP Pharmocological
) ) None
TAM NNP Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
-DOCSTART- -X- N

leukotriene NN Pharmocological
D4 NNP Pharmocological
methacholine VB Pharmocological
cysteinyl JJ Pharmocological
leukotriene NN Pharmocological
LTE4 NNP Pharmocological
LTD4 NNP Pharmocological
LTD4 NNP Pharmocological
methacholine NN Pharmocological
( ( Pharmocological
PBS/ethanol NNP Pharmocological
-DOCSTART- -X- N

Weighted VBN Other
blankets NNS Other
weighted-blanket JJ Other
intervention NN Other
commercially RB Other
available JJ Other
weighted JJ Other
blanket NN Other
or CC Other
otherwise RB Other
identical JJ Other
usual JJ Other
weight NN Other
blanket NN Other
weighted JJ Other
blanket NN Other
control NN Control
blanket NN Control
weighted JJ Other
blanket NN Other
. . None
weighted JJ Other
blanket NN Other
weighted JJ Other
blanket NN Other
-DOCSTART- -X- N

pegylated VBN Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
HCl NNP Pharmocological
( ( Pharmocological
CAELYX/Doxil NNP Pharmocological
) ) Pharmocological
conventional JJ Pharmocological
doxorubicin NN Pharmocological
CAELYX NNP Pharmocological
[ NNP Pharmocological
pegylated VBD Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
HCl NNP Pharmocological
( ( Pharmocological
PLD NNP Pharmocological
) ) Pharmocological
] NN None
doxorubicin VB Pharmocological
PLD NNP Pharmocological
doxorubicin $ Pharmocological
60 CD Pharmocological
mg/m2 NN Pharmocological
anthracycline NN Pharmocological
PLD NNP Pharmocological
doxorubicin NNS Pharmocological
doxorubicin NN Pharmocological
PLD NNP Pharmocological
PLD NNP Pharmocological
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
PLD NNP Pharmocological
. . None
PLD NNP Pharmocological
doxorubicin NN Pharmocological
. . None
PLD NNP Pharmocological
doxorubicin VB Pharmocological
-DOCSTART- -X- N

degarelix NN Pharmocological
: : None
degarelix NN Pharmocological
gonadotropin-releasing JJ None
hormone NN None
antagonist NN None
. . None
leuprolide JJ Pharmocological
acetate NN Pharmocological
vs NN None
degarelix NN Pharmocological
. . None
degarelix NN Pharmocological
leuprolide NN Pharmocological
degarelix NN Pharmocological
leuprolide NN Pharmocological
degarelix NN Pharmocological
leuprolide NN Pharmocological
. . None
degarelix NN Pharmocological
leuprolide NN Pharmocological
-DOCSTART- -X- N

were VBD Educational
performed VBN Educational
on IN Educational
baseline NN Educational
and CC Educational
nine-month JJ Educational
follow-up JJ Educational
data NNS Educational
. . None
-DOCSTART- -X- N

rTMS JJ Surgical
( ( None
rTMS NN Surgical
) ) None
rTMS NN Surgical
randomly RB None
assigned VBN None
to TO None
either DT None
active JJ Physical
rTMS NN Physical
treatment NN Physical
or CC None
wait-list NN Educational
( ( Educational
WTL NNP Educational
) ) Educational
groups NNS Educational
. . None
was VBD Physical
collected VBN Physical
using VBG Physical
128 CD Physical
channel NNS Physical
EEG NNP Physical
system NN Physical
. . Physical
-DOCSTART- -X- N

liberal JJ None
versus NN None
restrictive JJ None
guidelines NNS None
for IN None
red JJ None
blood NN None
cell NN None
transfusion NN None
restrictive JJ None
guidelines NNS None
for IN None
red JJ None
blood NN None
cell NN None
( ( None
RBC NNP None
) ) None
transfusions NNS None
liberal- NN Physical
or CC Physical
the DT Physical
restrictive-transfusion NN Physical
restrictive-transfusion NN None
restrictive-transfusion NN None
transfusion NN None
restrictive JJ None
RBC-transfusion NNP None
restrictive JJ None
transfusions NNS None
-DOCSTART- -X- N

antibiotics NNS Pharmocological
randomly RB None
assigned VBN None
to TO None
either DT None
receive JJ None
systemic JJ Pharmocological
metronidazole NN Pharmocological
plus CC Pharmocological
amoxicillin NN Pharmocological
( ( Pharmocological
AP+AB NNP Pharmocological
) ) Pharmocological
or CC None
were VBD None
treated VBN Pharmocological
mechanically RB Pharmocological
alone RB Pharmocological
( ( Pharmocological
AP NNP Pharmocological
) ) Pharmocological
. . None
identified VBN None
with IN None
before IN None
and CC None
at IN None
days NNS None
2 CD None
, , None
3 CD None
, , None
4 CD None
, , None
7 CD None
, , None
10 CD None
, , None
and CC None
21 CD None
of IN None
healing VBG None
. . None
placebo JJ Control
tablets NNS Control
. . Control
-DOCSTART- -X- N

sodium NN Pharmocological
controls NNS Control
versus NN Pharmocological
strict JJ Pharmocological
sodium NN Pharmocological
diet NN Pharmocological
sodium JJ Pharmocological
-DOCSTART- -X- N

anesthesia NN Physical
periprostatic JJ Physical
nerve NN Physical
block NN Physical
or CC None
no DT Physical
anesthesia NN Physical
. . None
Patients NNS None
were VBD None
evaluated VBN None
for IN None
the DT None
, , None
and CC None
symptoms NNS Physical
and CC Physical
signs NNS Physical
of IN Physical
anesthesia NN Physical
-DOCSTART- -X- N

Torasemide NNP Pharmocological
furosemide NN Pharmocological
torasemide NN Pharmocological
furosemide NN Pharmocological
spironolactone NN Pharmocological
torasemide NN Pharmocological
furosemide NN Pharmocological
. . None
Torasemide VB Pharmocological
furosemide NN Pharmocological
torasemide NN Pharmocological
torasemide NN Pharmocological
-DOCSTART- -X- N

received VBD None
etanercept IN None
with IN None
etanercept-treated JJ None
( ( None
with IN None
and CC None
without IN None
methotrexate NN None
) ) None
patients NNS None
-DOCSTART- -X- N

estradiol NN Pharmocological
and CC None
trimegestone NN Pharmocological
or CC None
dydrogesterone NN Pharmocological
6 CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
either DT Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
2mg CD Pharmocological
) ) Pharmocological
+trimegestone NN Pharmocological
( ( Pharmocological
0.5mg CD Pharmocological
) ) Pharmocological
( ( Pharmocological
T-group NNP Pharmocological
) ) Pharmocological
or CC None
estradiol NN Pharmocological
( ( Pharmocological
2mg CD Pharmocological
) ) Pharmocological
+dydrogesterone NN Pharmocological
( ( Pharmocological
10mg CD Pharmocological
) ) Pharmocological
( ( Pharmocological
DYDR NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
. . None
were VBD None
measured VBN None
before IN None
, , None
after IN None
cycle NN None
1 CD None
, , None
3 CD None
and CC None
6 CD None
and CC None
at IN None
4 CD None
weeks NNS None
post-treatment JJ None
. . None
-DOCSTART- -X- N

cerivastatin NN Pharmocological
cerivastatin NN Pharmocological
cerivastatin NN Pharmocological
placebo NN Control
cerivastatin NN Pharmocological
. . Pharmocological
placebo NN Control
-DOCSTART- -X- N

anticholinergic NN Pharmocological
and CC Pharmocological
beta VB Pharmocological
2-agonist JJ Pharmocological
and CC None
combination NN Pharmocological
therapy NN Pharmocological
inhaled JJ Pharmocological
bronchodilators NNS Pharmocological
ipratropium JJ Pharmocological
bromide NN Pharmocological
fenoterol JJ Pharmocological
hydrobromide NN Pharmocological
a DT None
combination NN Pharmocological
of IN Pharmocological
40 CD Pharmocological
micrograms NNS Pharmocological
ipratropium NN Pharmocological
and CC Pharmocological
100 CD Pharmocological
micrograms NNS Pharmocological
fenoterol VBP Pharmocological
-DOCSTART- -X- N

SI NNP Pharmocological
vaccines NNS Pharmocological
commercial JJ Pharmocological
inactivated JJ Pharmocological
bivalent NN Pharmocological
( ( Pharmocological
H1N1/H3N2 NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
field NN Pharmocological
SI NNP Pharmocological
variant NN Pharmocological
. . None
Vaccination NN Pharmocological
-DOCSTART- -X- N

imiquimod JJ Pharmocological
cream NN Pharmocological
imiquimod JJ None
5 CD None
% NN None
imiquimod JJ Pharmocological
cream NN Pharmocological
or CC None
vehicle NN None
to TO None
3 CD None
times NNS None
per IN None
week NN None
for IN None
a DT None
maximum NN None
of IN None
12 CD None
weeks NNS None
or CC None
until IN None
lesions NNS None
had VBD None
resolved VBN None
. . None
imiquimod NN Pharmocological
imiquimod JJ Pharmocological
cream NN Pharmocological
imiquimod NN Pharmocological
imiquimod NN None
imiquimod NN Pharmocological
imiquimod JJ Pharmocological
cream NN Pharmocological
-DOCSTART- -X- N

esomeprazole NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

home NN Physical
strength NN Physical
training NN Physical
and CC Physical
stretching VBG Physical
versus NN None
stretching VBG Physical
alone RB Physical
combined JJ Physical
strength NN Physical
and CC Physical
stretching NN Physical
home NN Physical
exercise NN Physical
regimen NNS Physical
versus IN None
stretching VBG Physical
alone RB Physical
combined JJ Physical
strength NN Physical
training NN Physical
and CC Physical
stretching VBG Physical
group NN Physical
control NN Control
group NN Control
strength NN Physical
training NN Physical
stretching NN Physical
and CC Physical
stabilization NN Physical
exercises NNS Physical
-DOCSTART- -X- N

intraoral JJ Physical
fluoride NN Physical
releasing VBG Physical
system NN Physical
intraoral JJ None
fluoride-releasing NN None
system NN None
( ( None
IFRS NNP None
) ) None
containing VBG None
a DT None
sodium NN None
fluoride NN None
core NN None
fluoride-gel-containing JJ Physical
tray NN Physical
IFRS NNP None
IFRS NNP None
retainers NNS None
1100-ppm JJ Physical
fluoride JJ Physical
conventional JJ Physical
sodium NN Physical
fluoride NN Physical
dentifrice NN Physical
twice RB Physical
daily RB Physical
. . None
sodium NN Pharmocological
fluoride NN Pharmocological
-DOCSTART- -X- N

rocuronium NN Pharmocological
N2O/O2-fentanyl NNP Pharmocological
or CC Pharmocological
N2O/O2-sevoflurane NNP Pharmocological
( ( None
one CD None
MAC NNP None
) ) None
anesthesia NN None
. . None
electromyographically RB Physical
. . None
rocuronium NN Pharmocological
-DOCSTART- -X- N

lifestyle NN Educational
intervention NN Educational
lifestyle JJ Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

Interferential JJ Physical
therapy NN Physical
electrode NN Physical
placement NN Physical
technique NN Physical
interferential JJ Physical
therapy NN Physical
( ( Physical
IFT NNP Physical
) ) Physical
electrode VBP Physical
placement NN Physical
technique NN Physical
control NN Control
treatment NN Control
IFT NNP Pharmocological
painful JJ Pharmocological
area NN Pharmocological
and CC Pharmocological
The DT Pharmocological
Back NNP Pharmocological
Book NNP Pharmocological
IFT NNP Physical
spinal JJ Physical
nerve NN Physical
and CC Pharmocological
The DT Physical
Back NNP Physical
Book NNP Physical
Control NN Control
, , Control
The DT Control
Back NNP Control
Book NNP Control
IFT NNP Pharmocological
IFT NNP Physical
electrode FW Physical
placement NN Physical
technique NN Physical
-DOCSTART- -X- N

alfuzosin NN Pharmocological
alfuzosin NN Pharmocological
placebo-controlled JJ Control
alfuzosin NN Pharmocological
or CC Control
matching VBG Control
placebo NN Control
alfuzosin NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Rioprostil NNP Pharmocological
Rioprostil NNP Pharmocological
ranitidine NN Pharmocological
, , Pharmocological
150 CD Pharmocological
mg JJ Pharmocological
once-daily RB Pharmocological
orally RB Pharmocological
. . None
rioprostil NN Pharmocological
ranitidine NN Pharmocological
. . None
rioprostil NN Pharmocological
ranitidine NN Pharmocological
. . None
Rioprostil NNP Pharmocological
ranitidine NN Pharmocological
-DOCSTART- -X- N

virulent JJ Physical
NIA-3 NNP Pharmocological
strain NN Pharmocological
or CC None
the DT None
avirulent JJ Pharmocological
Bartha NNP Pharmocological
strain NN Pharmocological
, , None
or CC None
they PRP None
were VBD None
inoculated VBN None
IM NNP Pharmocological
with IN Pharmocological
an DT Pharmocological
inactivated JJ Pharmocological
vaccine NN Pharmocological
containing VBG Pharmocological
the DT Pharmocological
Phylaxia NNP Pharmocological
strain NN Pharmocological
. . None
challenge-exposed JJ Physical
intranasally RB Pharmocological
with IN Pharmocological
strain JJ Pharmocological
NIA-3 NNP Pharmocological
. . None
-DOCSTART- -X- N

lamivudine NN Pharmocological
, , Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
zidovudine NN Pharmocological
and CC Pharmocological
efavirenz NN Pharmocological
3TC CD Pharmocological
3TC CD Pharmocological
-DOCSTART- -X- N

Intravesical JJ Physical
seeding NN Physical
of IN Physical
upper JJ Physical
urinary JJ Physical
tract NN Physical
urothelial JJ Physical
carcinoma NN Physical
cells NNS Physical
pirarubicin NN Pharmocological
intravesical JJ Physical
seeding NN Physical
of IN Physical
cancer NN Physical
cells NNS Physical
. . None
pirarubicin JJ None
instillation NN None
Intravesical NNP Pharmocological
instillation NN Pharmocological
of IN Pharmocological
pirarubicin NN Pharmocological
nephroureterectomy NN Pharmocological
-DOCSTART- -X- N

Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Physical
absorbable JJ Physical
adhesion NN Physical
barrier NN Physical
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Physical
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Pharmocological
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) None
other JJ Educational
was VBD Educational
left VBN Educational
uncovered JJ Educational
. . None
laparotomy NN Physical
. . None
Interceed NNP Pharmocological
( ( Pharmocological
TC7 NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

hormonal JJ Pharmocological
contraceptives NNS Pharmocological
contraceptive JJ Pharmocological
pills NNS Pharmocological
ethynylestradiol NN Pharmocological
( ( Pharmocological
EE NNP Pharmocological
) ) Pharmocological
30 CD Pharmocological
mcg NN Pharmocological
and CC Pharmocological
levonorgestrel NN Pharmocological
( ( Pharmocological
LNG NNP Pharmocological
) ) Pharmocological
150 CD Pharmocological
mcg NN Pharmocological
or CC Pharmocological
EE NNP Pharmocological
20 CD Pharmocological
mcg NN Pharmocological
and CC Pharmocological
LNG NNP Pharmocological
100 CD Pharmocological
mcg NN Pharmocological
EE30/LNG150 NNP Pharmocological
EE20/LNG100 NNP Pharmocological
EE20/LNG100 NNP Pharmocological
EE30/LNG150 NNP Pharmocological
EE20/LNG100 NNP Pharmocological
-DOCSTART- -X- N

gonadotropin-releasing JJ Pharmocological
hormone NN Pharmocological
agonists NNS Pharmocological
antagonists NNS Pharmocological
versus NN None
GnRH NNP Pharmocological
antagonist NN Pharmocological
protocols NNS None
GnRH NNP Pharmocological
antagonist NN Pharmocological
( ( Pharmocological
cetrorelix NN Pharmocological
) ) Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
( ( Pharmocological
buserelin NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
carbasalate NN Pharmocological
plus CC None
metoclopramide JJ Pharmocological
versus NN None
ergotamine NN Pharmocological
tartrate NN Pharmocological
plus CC None
caffeine NN Pharmocological
calcium NN Pharmocological
carbasalate NN Pharmocological
( ( Pharmocological
equivalent JJ Pharmocological
to TO Pharmocological
900 CD Pharmocological
mg NNS Pharmocological
aspirin RB Pharmocological
) ) Pharmocological
plus CC None
metoclopramide $ Pharmocological
10 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
CM NNP Pharmocological
) ) Pharmocological
with IN None
ergotamine JJ Pharmocological
tartrate NN Pharmocological
1 CD Pharmocological
mg NN Pharmocological
plus CC Pharmocological
caffeine JJ Pharmocological
100 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
EC NNP Pharmocological
) ) Pharmocological
CM NNP Pharmocological
EC NNP Pharmocological
-DOCSTART- -X- N

Family RB Educational
education NN Educational
family NN Educational
treatments NNS Educational
patient NN Educational
and CC Educational
family NN Educational
education NN Educational
family NN Educational
education NN Educational
control NN Control
group NN None
. . None
Family NNP Educational
education NN Educational
-DOCSTART- -X- N

sumatriptan VB Pharmocological
5-HT JJ Pharmocological
1d CD Pharmocological
agonist NN Pharmocological
, , Pharmocological
sumatriptan NN Pharmocological
sumatriptan NN Pharmocological
placebo NN Control
sumatriptan VB Pharmocological
. . Pharmocological
5-HT JJ Pharmocological
1d CD Pharmocological
receptor NN Pharmocological
-DOCSTART- -X- N

Conservative JJ Control
treatment NN Control
conservative JJ Physical
therapy NN Physical
mechanical JJ Control
treatment NN Control
with IN Control
taping VBG Control
and CC Control
orthoses NNS Control
anti-inflammatory JJ Other
accommodative JJ Other
modalities NNS Other
. . Other
-DOCSTART- -X- N

Combination NN Pharmocological
peel NN Pharmocological
with IN Pharmocological
incorporated JJ Pharmocological
fractional JJ Pharmocological
prickle NN Pharmocological
coral JJ Pharmocological
calcium NN Pharmocological
fractional JJ None
prickle JJ None
coral JJ None
calcium NN None
( ( None
FCR? NNP None
) ) None
in IN None
-DOCSTART- -X- N

topical JJ Pharmocological
boswellic JJ Pharmocological
acid NN Pharmocological
Boswellic NNP Pharmocological
acids NNS Pharmocological
( ( Pharmocological
BAs NNP Pharmocological
) ) Pharmocological
base NN Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
BAs NNP Pharmocological
the DT Pharmocological
same JJ Pharmocological
cream NN Pharmocological
without IN Pharmocological
these DT Pharmocological
active JJ Pharmocological
ingredients NNS Pharmocological
BAs NNP Pharmocological
; : Pharmocological
BAs NNP Pharmocological
-DOCSTART- -X- N

methylprednisolone NN Pharmocological
Medrol NNP Pharmocological
methylprednisolone NN Pharmocological
methylprednisolone NN Pharmocological
Solu-Medrol NNP Pharmocological
. . None
methylprednisolone NN Pharmocological
. . None
methylprednisolone NN Pharmocological
-DOCSTART- -X- N

Vigorous JJ Physical
, , Physical
aerobic JJ Physical
exercise NN Physical
versus NN None
general JJ Physical
motor NN Physical
training NN Physical
activities NNS Physical
: : None
antecedent JJ Physical
exercise NN Physical
conditions NNS Physical
exercise NN Physical
non-exercise JJ Physical
conditions NNS None
. . None
aerobic JJ Physical
exercise NN Physical
antecedent JJ Physical
aerobic JJ Physical
exercise NN Physical
aerobic JJ Physical
exercise NN Physical
antecedent JJ Physical
exercise NN Physical
. . None
antecedent NN Physical
aerobic JJ Physical
exercise NN Physical
-DOCSTART- -X- N

sodium NN Pharmocological
ferric JJ Pharmocological
gluconate NN Pharmocological
complex NN Pharmocological
( ( Pharmocological
SFGC NNP Pharmocological
) ) Pharmocological
IV NNP Pharmocological
SFGC NNP Pharmocological
in IN Pharmocological
sucrose JJ Pharmocological
Ferrlecit NNP None
? . None
Injection NNP None
-DOCSTART- -X- N

intramedullary JJ Surgical
nailing NN Surgical
of IN Surgical
the DT Surgical
femur NN Surgical
: : Surgical
intramedullary JJ None
nailing NN None
of IN None
the DT None
femur NN None
( ( Surgical
piriformis JJ Surgical
fossa NN Surgical
portal NN Surgical
) ) Surgical
( ( Surgical
trochanteric JJ Surgical
portal NN Surgical
) ) Surgical
intramedullary JJ None
nailing VBG None
intramedullary JJ Educational
nailing NN Educational
-DOCSTART- -X- N

cognitive-behavioral JJ Educational
therapy NN Educational
Cognitive-Behavioral JJ Psychological
Therapy NNP Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
program NN Educational
and CC None
a DT None
Social NNP Psychological
Recreational NNP Psychological
( ( Psychological
SR NNP Psychological
) ) Psychological
program NN Psychological
( ( None
CBT NNP Educational
) ) None
regular JJ None
sessions NNS None
in IN None
a DT None
structured JJ None
setting NN None
, , None
consistent JJ None
therapists NNS None
, , None
social JJ None
exposure NN None
autism-friendly JJ Educational
strategies NNS Educational
-DOCSTART- -X- N

photodynamic JJ Pharmocological
therapy NN Pharmocological
, , None
imiquimod JJ Pharmocological
immunotherapy NN Pharmocological
and CC None
combination NN Pharmocological
of IN Pharmocological
both DT Pharmocological
therapies NNS Pharmocological
5-aminolevulinic JJ Pharmocological
acid JJ Pharmocological
photodynamic JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
PDT NNP Pharmocological
) ) Pharmocological
, , None
5 CD Pharmocological
% NN Pharmocological
imiquimod JJ Pharmocological
cream NN Pharmocological
and CC None
combination NN Pharmocological
of IN Pharmocological
both DT Pharmocological
therapies NNS Pharmocological
Combination NNP None
therapy NN None
while IN None
PDT NNP None
and CC None
imiquimod JJ None
therapy NN None
of IN None
PDT NNP None
or CC None
imiquimod JJ None
therapy NN None
. . None
either DT None
PDT NNP None
or CC None
imiquimod JJ None
monotherapy NN None
. . None
However RB None
with IN None
combination NN None
therapy NN None
, , None
which WDT None
-DOCSTART- -X- N

pentoxifylline NN Pharmocological
. . Pharmocological
pentoxifylline NN Pharmocological
placebo NN Control
or CC None
400 CD Pharmocological
mg JJ Pharmocological
tid NN Pharmocological
of IN Pharmocological
pentoxifylline NN Pharmocological
. . None
Pentoxifylline NNP Pharmocological
therapy VBZ Pharmocological
-DOCSTART- -X- N

antidepressant JJ Pharmocological
treatment NN Pharmocological
. . None
antidepressant VB Pharmocological
treatment NN Pharmocological
. . None
baseline JJ Physical
MRIs NNP Physical
sertraline NN Pharmocological
and CC None
nortriptyline NN Pharmocological
in IN None
the DT None
antidepressant JJ None
treatment NN None
compared VBN None
-DOCSTART- -X- N

lavender NN Pharmocological
aromatherapy NN Pharmocological
aromatherapy NN Pharmocological
, , Pharmocological
lavender JJR Pharmocological
aroma NN Pharmocological
placebos NNS Control
lavender NN Pharmocological
aroma NN Pharmocological
mixed-factorial JJ Control
placebo-controlled JJ Control
exposed VBN Pharmocological
to TO Pharmocological
lavender VB Pharmocological
, , None
placebo NN Control
, , None
or CC None
no DT Other
aroma NN Other
cognitive JJ None
task NN None
. . None
lavender NN Control
aroma NN Control
-DOCSTART- -X- N

cognitive-behavioral JJ Educational
treatment NN Educational
. . None
with IN None
cognitive-behavioral JJ None
therapy NN None
( ( None
CBT NNP None
) ) None
. . None
from IN None
family NN None
CBT NNP None
( ( None
FCBT NNP None
) ) None
than IN None
individual JJ None
CBT NNP None
( ( None
ICBT NNP None
; : None
OR NNP None
Study CC None
2 CD None
: : None
CBT JJ None
greater JJR None
in IN None
FCBT NNP None
and CC None
outperformed VBD None
ICBT NNP None
for IN None
involvement NN None
in IN None
FCBT NNP None
. . None
-DOCSTART- -X- N

( ( None
conventional JJ Surgical
liver NN Surgical
resection NN Surgical
versus IN None
anterior JJ Physical
approach NN Physical
) ) None
Surgical NNP Surgical
hepatic JJ Surgical
resection NN Surgical
liver JJ Surgical
resection NN Surgical
techniques NNS Surgical
of IN Surgical
liver NN Surgical
metastases NNS Surgical
anterior JJ Physical
approach NN Physical
technique NN Physical
conventional JJ Physical
resection NN Physical
-DOCSTART- -X- N

dual-switch JJ Physical
valve NN Physical
conventional JJ Physical
differential-pressure NN Physical
( ( Physical
DP- NNP Physical
) ) Physical
valve NN Physical
. . None
DSV NNP Physical
DSV NNP Physical
DP NNP Physical
valves NNS Physical
DP NNP Physical
valve NN Physical
DSV NNP Physical
DSV NNP Physical
DP NNP Physical
valve FW Physical
DSV NNP Physical
DSV NNP Physical
-DOCSTART- -X- N

Pazopanib NNP Pharmocological
Pazopanib NNP Pharmocological
oral JJ Pharmocological
angiogenesis NN Pharmocological
inhibitor NN Pharmocological
placebo-controlled JJ Control
pazopanib JJ Pharmocological
monotherapy NN Pharmocological
receive VB None
oral JJ Pharmocological
pazopanib NN Pharmocological
or CC None
placebo NN Control
. . None
pazopanib NNS Pharmocological
placebo NN Control
treatment-naive JJ None
pazopanib NN Pharmocological
placebo NN Control
pazopanib JJ Pharmocological
versus NN None
placebo NN Control
. . None
Pazopanib NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

Removal NN Surgical
of IN Surgical
hypertrophied JJ Surgical
anal JJ Surgical
papillae NN Surgical
and CC Surgical
fibrous JJ Surgical
anal JJ Surgical
polyps NN Surgical
removal NN Surgical
of IN Surgical
hypertrophied JJ Surgical
anal JJ Surgical
papillae NN Surgical
and CC Surgical
fibrous JJ Surgical
anal JJ Surgical
polyps NNS Surgical
randomized VBN None
into IN None
two CD None
groups NNS None
to TO None
have VB None
their PRP$ None
fibrous JJ None
polyps NNS None
and CC None
hypertrophied VBD None
anal JJ None
papillae NN None
either DT None
removed VBN None
by IN None
radiofrequency NN Surgical
surgery NN Surgical
or CC None
left VBN Control
intact JJ Control
. . None
Removal NNP Surgical
of IN Surgical
hypertrophied JJ Surgical
anal JJ Surgical
papillae NN Surgical
and CC Surgical
fibrous JJ Surgical
anal JJ Surgical
polyps NNS Surgical
Radiofrequency NNP Surgical
procedure NN Surgical
-DOCSTART- -X- N

amphotericin NN Pharmocological
B NNP Pharmocological
deoxycholate NN Pharmocological
amphotericin JJ Pharmocological
B NNP Pharmocological
( ( Pharmocological
AMB NNP Pharmocological
) ) Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
-DOCSTART- -X- N

Virtual JJ Educational
reality NN Educational
intervention NN Educational
virtual JJ Educational
reality NN Educational
distraction NN Educational
intervention NN Educational
virtual JJ Educational
reality NN Educational
a DT None
head-mounted JJ None
display NN None
( ( None
Sony NNP None
PC NNP None
Glasstron NNP None
PLM NNP None
- : None
S700 NN None
) ) None
was VBD None
used VBN None
to TO None
display VB None
encompassing VBG None
images NNS None
and CC None
block NN None
competing VBG None
stimuli NNS None
during IN None
chemotherapy JJ None
infusions NNS None
. . None
were VBD None
used VBN None
to TO None
measure VB None
symptom JJ None
distress NN None
. . None
VR NNP Educational
distraction NN Educational
intervention NN Educational
during IN Educational
one CD Educational
chemotherapy NN Psychological
treatment NN Educational
and CC None
received VBD None
no DT Control
distraction NN Control
intervention NN Control
( ( Control
control VB Control
condition NN Control
) ) Control
during IN None
an DT None
alternate JJ None
chemotherapy NN None
treatment NN None
. . None
-DOCSTART- -X- N

m-chlorophenylpiperazine NN Pharmocological
m-chlorophenylpiperazine NN Pharmocological
( ( Pharmocological
m-CPP JJ Pharmocological
) ) Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

special-effect JJ Physical
contact NN Physical
lenses NNS Physical
( ( Physical
Crazy NNP Physical
Lenses NNP Physical
) ) Physical
Special-effect JJ Physical
contact NN Physical
lenses NNS Physical
A DT Physical
clear JJ Physical
soft JJ Physical
contact NN Physical
lens NNS Physical
and CC None
a DT Physical
special-effect JJ Physical
soft JJ Physical
contact NN Physical
lens NNS Physical
( ( Physical
Crazy NNP Physical
lens VBZ Physical
, , Physical
) ) Physical
clear JJ Physical
lens NNS Physical
special-effect JJ Physical
lenses NNS Physical
Special-effect JJ Physical
contact NN Physical
lenses NNS Physical
-DOCSTART- -X- N

inguinal JJ Surgical
herniorrhaphy NN Surgical
. . Surgical
-DOCSTART- -X- N

halothane NN Pharmocological
isoflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
. . None
halothane NN Pharmocological
isoflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
-DOCSTART- -X- N

lipid JJ Pharmocological
therapy NN Pharmocological
lipid JJ Pharmocological
emulsions NNS Pharmocological
medium-chain JJ Pharmocological
triglycerides/short-chain JJ Pharmocological
triglycerides NNS Pharmocological
( ( Pharmocological
MCT/LCT NNP Pharmocological
) ) Pharmocological
physical JJ Pharmocological
mixture NN Pharmocological
with IN Pharmocological
a DT Pharmocological
four-component JJ Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
i.v JJ Pharmocological
. . Pharmocological
) ) Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
( ( Pharmocological
LCT NNP Pharmocological
, , Pharmocological
MCT NNP Pharmocological
, , Pharmocological
Olive-oil NNP Pharmocological
and CC Pharmocological
Fish-oil NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
with IN Pharmocological
the DT Pharmocological
lipid JJ Pharmocological
emulsions NNS Pharmocological
lipid JJ Pharmocological
emulsions NNS Pharmocological
TPN NNP Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
TENS NN Physical
placebo NN Control
TENS NNP Control
, , None
or CC None
( ( None
3 CD None
) ) None
control NN Control
treatments NNS Control
TENS NNP Physical
-DOCSTART- -X- N

shearing VBG Physical
shearing VBG Physical
. . None
a DT Control
control NN Control
group NN Control
already RB Physical
shorn VBN Physical
, , None
and CC None
a DT None
treatment NN None
group NN None
left VBN Control
unshorn JJ Control
-DOCSTART- -X- N

Combined VBN Physical
modality NN Physical
therapy NN Physical
ABVD/MOPP NNP Pharmocological
compared VBN Pharmocological
to TO Pharmocological
ABVD/OPP NNP Pharmocological
ABVD/OPP NNP Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

sodium NN Pharmocological
( ( None
Na NNP None
) ) None
400 CD None
mmol/d NN None
Na NNP Pharmocological
as IN Pharmocological
the DT Pharmocological
chloride NN Pharmocological
salt NN Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
-DOCSTART- -X- N

low-dose JJ Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
: : None
multiphasic JJ Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
( ( Pharmocological
OCs NNP Pharmocological
) ) Pharmocological
multiphasic JJ Pharmocological
pill NN Pharmocological
, , None
a DT Pharmocological
lower-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
a DT None
higher-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
or CC None
nonsteroidal JJ Pharmocological
contraception NN Pharmocological
. . None
monophasic NN Pharmocological
pill NN Pharmocological
multiphasic NN Pharmocological
pill NN Pharmocological
multiphasic NN Pharmocological
pill NN Pharmocological
multiphasic JJ Pharmocological
pill NN Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
-DOCSTART- -X- N

gonadotropin-releasing JJ Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
gonadotropin-releasing JJ Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
( ( Pharmocological
GnRH-a NNP Pharmocological
) ) None
GnRH-a NNP Pharmocological
-DOCSTART- -X- N

Botulinum NNP Pharmocological
toxin NN Pharmocological
botulinum NN Pharmocological
toxin NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
BTX-A NNP Pharmocological
) ) Pharmocological
BTX-A NNP Pharmocological
injection NN Pharmocological
BTX-A NNP Pharmocological
BTX-A NNP Pharmocological
-DOCSTART- -X- N

Prolonged NNP Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
and CC None
add-back JJ Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
; : None
norethindrone NN Pharmocological
acetate NN Pharmocological
C-daily NNP Pharmocological
norethindrone NN Pharmocological
acetate NN Pharmocological
conjugated VBD Pharmocological
equine NN Pharmocological
estrogens VBZ Pharmocological
norethindrone NN Pharmocological
acetate NN Pharmocological
conjugated VBD Pharmocological
equine NN Pharmocological
estrogens VBZ Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
norethindrone JJ Pharmocological
acetate NN Pharmocological
alone RB Pharmocological
low-dose JJ Pharmocological
conjugated JJ Pharmocological
equine NN Pharmocological
estrogens NNS Pharmocological
-DOCSTART- -X- N

practice NN Psychological
on IN Psychological
the DT Psychological
lateralization NN Psychological
of IN Psychological
mental JJ Psychological
rotation NN Psychological
skills NNS Psychological
. . None
trials NNS None
in IN None
a DT None
lateralized JJ Psychological
mental JJ Psychological
rotation NN Psychological
task NN Psychological
. . None
-DOCSTART- -X- N

transporters NNS Other
DVD NNP Other
learning NN Educational
tool NN Educational
home NN Educational
based VBN Educational
DVD NNP Educational
intervention NN Educational
The DT Other
Transporters NNPS Other
DVD NNP Other
. . None
DVD NNP Other
alternate NN Other
DVD NNP Other
Transporters NNP Other
DVD NNP Other
-DOCSTART- -X- N

disease JJ Other
management NN Other
program NN Other
with IN Other
repetitive JJ Other
education NN Other
and CC None
telephone NN Other
monitoring NN Other
Education NNP Other
and CC Other
Monitoring NNP Other
control NN Control
. . Control
-DOCSTART- -X- N

ketamine NN Pharmocological
opioids NNS Pharmocological
ketamine NN Pharmocological
opioids NNS Pharmocological
placebo NN Pharmocological
opioids NNS Pharmocological
plus CC Pharmocological
ketamine NN Pharmocological
regular JJ Pharmocological
opioids NNS Pharmocological
plus CC Pharmocological
placebo NN Pharmocological
. . Pharmocological
opioid JJ Pharmocological
analgesia NN Pharmocological
-DOCSTART- -X- N

buspirone NN Pharmocological
serotonin-1A JJ Pharmocological
( ( Pharmocological
5-HT1A JJ Pharmocological
) ) Pharmocological
receptor NN Pharmocological
agonist VBP Pharmocological
buspirone NN Pharmocological
buspirone NN Pharmocological
placebo-controlled JJ Control
buspirone NN Pharmocological
30 CD None
mg JJ None
daily JJ None
or CC None
placebo NN Control
. . None
placebo NN Control
. . None
buspirone NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

filgrastim NN Pharmocological
( ( None
r-metHuG-CSF JJ Pharmocological
) ) None
filgrastim NN Pharmocological
( ( None
recombinant JJ Pharmocological
methionyl NN Pharmocological
human JJ Pharmocological
granulocyte NN Pharmocological
colony-stimulating NN Pharmocological
factor NN Pharmocological
, , None
r-metHuG-CSF NN Pharmocological
) ) None
CAE NNP Pharmocological
chemotherapy NN Pharmocological
( ( None
cyclophosphamide NN Pharmocological
, , None
doxorubicin NN Pharmocological
, , None
and CC None
etoposide RB Pharmocological
) ) None
and CC None
placebo NN Control
or CC None
filgrastim NN None
. . None
-DOCSTART- -X- N

angiotensin-converting JJ Physical
enzyme NN Physical
inhibitors NNS Physical
captopril NN Pharmocological
placebo-controlled JJ Control
Captopril NNP Pharmocological
captopril NN Pharmocological
ACE NNP Physical
inhibitors NNS Physical
-DOCSTART- -X- N

amorphous JJ Pharmocological
cream NN Pharmocological
phosphate NN Pharmocological
complexes NNS Pharmocological
casein JJ Pharmocological
phosphoprotein-amorphous JJ Pharmocological
calcium NN Pharmocological
phosphate NN Pharmocological
fluoride JJ Pharmocological
bracket NN Surgical
removal NN Surgical
, , None
professional JJ Physical
tooth NN Physical
cleaning NN Physical
and CC Physical
drying NN Physical
, , None
a DT Physical
visual JJ Physical
scoring NN Physical
( ( Physical
0-4 JJ Physical
) ) Physical
and CC Physical
laser JJR Physical
fluorescence NN Physical
( ( Physical
LF NNP Physical
) ) Physical
readings NNS Physical
daily RB Pharmocological
topical JJ Pharmocological
applications NNS Pharmocological
of IN Pharmocological
a DT Pharmocological
dental JJ Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
CPP-ACP NNP Pharmocological
( ( Pharmocological
Topacal NNP Pharmocological
) ) Pharmocological
for IN Pharmocological
3 CD Pharmocological
months NNS Pharmocological
followed VBN Physical
by IN Physical
a DT Physical
3-month JJ Physical
period NN Physical
of IN Physical
daily JJ Physical
toothbrushing VBG Physical
with IN Physical
fluoridated JJ Physical
dentifrice NN Physical
, , Physical
or CC Physical
B NNP Physical
) ) Physical
daily RB Control
0.05 CD Control
% NN Control
sodium NN Control
fluoride NN Control
mouthwash NN Control
combined VBN Control
with IN Control
fluoridated JJ Control
dentifrice NN Control
for IN Control
6 CD Control
months NNS Control
. . None
amorphous JJ Pharmocological
calcium NN Pharmocological
phosphate NN Pharmocological
treatments NNS Pharmocological
-DOCSTART- -X- N

extracorporeal JJ Surgical
circulation NN Surgical
cardiopulmonary JJ Surgical
bypass NN Surgical
Minimal NNP Physical
extracorporeal NN Physical
circulation NN Physical
( ( Physical
MECC NNP Physical
) ) Physical
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
graft NN Surgical
( ( Surgical
CABG NNP Surgical
) ) Surgical
surgery NN Surgical
MECC NNP Surgical
conventional JJ Physical
extracorporeal JJ Physical
circulation NN Physical
( ( Physical
CECC NNP Physical
) ) Physical
MECC NNP Surgical
or CC None
CECC NNP Surgical
. . None
-DOCSTART- -X- N

orthotic JJ Physical
heel NN Physical
lifts NNS Physical
orthotic JJ Physical
heel NN Physical
lifts NNS Physical
Therefore RB None
, , None
heel NN None
lifts NNS None
-DOCSTART- -X- N

flumazenil NN Pharmocological
midazolam NN Pharmocological
craniotomy NN Pharmocological
. . None
midazolam NN Pharmocological
, , None
fentanyl NN Pharmocological
and CC None
nitrous JJ Pharmocological
oxide NN Pharmocological
. . None
Pancuronium NN Pharmocological
flumazenil JJ Pharmocological
flumazenil NN Pharmocological
. . None
Flumazenil NNP Pharmocological
-DOCSTART- -X- N

high-dose JJ Pharmocological
chemotherapy NN Pharmocological
: : None
Chemotherapy NNP Pharmocological
and CC Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
parenteral JJ Pharmocological
nutrition NN Pharmocological
( ( Pharmocological
PN NNP Pharmocological
) ) Pharmocological
bone NN Surgical
marrow NN Surgical
transplantation NN Surgical
( ( Surgical
BMT NNP Surgical
) ) Surgical
high-dose JJ Pharmocological
chemotherapy NN Pharmocological
PN NNP Pharmocological
PN NNP Pharmocological
standard JJ Pharmocological
PN NNP Pharmocological
containing VBG Pharmocological
conventional JJ Pharmocological
amounts NNS Pharmocological
of IN Pharmocological
dextrose NN Pharmocological
, , Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
, , Pharmocological
micronutrients NNS Pharmocological
, , Pharmocological
and CC Pharmocological
lipid JJ Pharmocological
solution NN Physical
containing VBG Physical
only JJ Physical
micronutrients NNS Physical
chemotherapy NN Pharmocological
and CC None
BMT NNP Surgical
. . None
BMT NNP Surgical
-DOCSTART- -X- N

glibenclamide NN Pharmocological
6 CD Pharmocological
minutes NNS Pharmocological
after IN Pharmocological
glucagon NN Pharmocological
( ( None
1 CD None
mg NN None
given VBN None
intravenously RB None
) ) None
after IN None
4 CD None
and CC None
6 CD None
months NNS None
of IN None
successive JJ None
periods NNS None
of IN None
treatment NN None
with IN None
insulin NN Pharmocological
and CC Pharmocological
oral JJ Pharmocological
hypoglycaemics NNS Pharmocological
( ( Pharmocological
glibenclamide NN Pharmocological
and CC Pharmocological
metformin NN Pharmocological
) ) Pharmocological
glibenclamide NN Pharmocological
-DOCSTART- -X- N

Diode NNP Physical
laser NN Physical
photocoagulation NN Physical
peripheral JJ Physical
cryotherapy NN Physical
Argon NNP Physical
laser NN Physical
indirect JJ Physical
ophthalmoscope NN Physical
photocoagulation NN Physical
cryotherapy VB Physical
diode NN Physical
lasers NNS Physical
argon NN Physical
laser NN Physical
ablative JJ Physical
therapy NN Physical
. . None
diode NN Physical
laser NN Physical
cryotherapy NN Physical
. . None
diode NN Physical
laser NN Physical
cryotherapy NN Physical
cryotherapy NN Physical
diode NN Physical
laser NN Physical
cryotherapy-treated JJ Physical
cryotherapy-treated JJ Physical
laser-treated JJ Physical
cryotherapy NN Physical
diode NN Physical
laser NN Physical
diode VB Physical
laser RBR Physical
peripheral JJ Physical
retinal JJ Physical
ablation NN Physical
cryotherapy NN Physical
-DOCSTART- -X- N

Pars NNS Surgical
plana VBP Surgical
vitrectomy NN Surgical
Internal NNP Surgical
limiting VBG Surgical
membrane NN Surgical
delamination NN Surgical
posterior JJ Surgical
hyaloid NN Surgical
removal NN Surgical
. . None
internal JJ Surgical
limiting VBG Surgical
membrane NN Surgical
( ( Surgical
ILM NNP Surgical
) ) Surgical
removal NN Surgical
25 CD None
) ) None
laser JJR None
coagulation NN None
was VBD None
permitted VBN None
underwent JJ None
surgical JJ None
induction NN None
of IN None
posterior JJ None
vitreous JJ None
detachment NN None
( ( None
PVD NNP None
) ) None
, , None
group NN None
patients NNS None
) ) None
PVD NNP None
and CC None
removal NN None
of IN None
the DT None
ILM NNP None
. . None
Eleven NNP None
ILM NNP None
removal NN None
. . None
CONCLUSION NNP None
Vitrectomy NNP None
, , None
PVD NNP None
with IN None
or CC None
without IN None
ILM NNP None
removal NN None
does VBZ None
-DOCSTART- -X- N

Intravenous JJ Pharmocological
magnesium NN Pharmocological
sulfate NN Pharmocological
intravenous JJ Pharmocological
Magnesium NNP Pharmocological
sulfate NN Pharmocological
( ( Pharmocological
i.v JJ Pharmocological
. . Pharmocological
MgSO4 NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
MgSO4 NNP Pharmocological
received VBD Pharmocological
0.2 CD Pharmocological
ml/kg NN Pharmocological
of IN Pharmocological
50 CD Pharmocological
% NN Pharmocological
MgSO4 NNP Pharmocological
as IN Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
i.v JJ Pharmocological
. . Pharmocological
) ) Pharmocological
infusion NN Pharmocological
placebo NN Control
normal JJ Pharmocological
saline JJ Pharmocological
infusion NN Pharmocological
MgSO4 NNP Pharmocological
solution NN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
oxygen NN Pharmocological
, , Pharmocological
nebulized JJ Pharmocological
salbutamol NN Pharmocological
, , Pharmocological
i.v NN Pharmocological
. . Pharmocological
aminophylline NN Pharmocological
corticosteroids NNS Pharmocological
. . Pharmocological
MgSO4 NNP Pharmocological
placebo VB Control
MgSO4 NNP Pharmocological
MgSO4 NNP Pharmocological
conventional JJ Physical
therapy NN Physical
-DOCSTART- -X- N

alpha-7 JJ Pharmocological
nicotinic JJ Pharmocological
neurotransmission NN Pharmocological
Alpha7 NNP None
nicotinic JJ None
acetylcholine NN None
receptor NN None
( ( None
?7 NNP None
nAChR RB None
) ) None
agonists NNS None
combined VBD None
CDP-choline NNP None
, , None
with IN None
galantamine NN None
, , None
a DT None
positive JJ None
allosteric JJ None
modulator NN None
( ( None
PAM NNP None
) ) None
of IN None
nicotinic JJ None
acetylcholine NN None
receptors NNS None
, , None
comparing VBG None
galantamine/CDP-choline NN None
to TO None
placebos VB None
received VBN None
galantamine JJ None
and CC None
CDP-choline JJ None
matching JJ None
placebos NNS None
for IN None
galantamine/CDP-choline NN None
for IN None
placebo NN None
of IN None
?7 NNP None
nAChR JJ None
agonist/PAMs NN None
is VBZ None
-DOCSTART- -X- N

docetaxel JJ Pharmocological
plus CC Pharmocological
fluorouracil JJ Pharmocological
and CC None
cisplatin NNS Pharmocological
cisplatin NN Pharmocological
and CC None
fluorouracil NN Pharmocological
docetaxel JJ Pharmocological
plus CC Pharmocological
cisplatin JJ Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
DCF NNP Pharmocological
) ) Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
CF NNP Pharmocological
) ) Pharmocological
. . Pharmocological
CF NNP Pharmocological
DCF NNP Pharmocological
protocol-specific JJ Physical
chemotherapy NN Physical
. . None
D NNP Pharmocological
CF NNP Pharmocological
CF NNP Pharmocological
. . None
-DOCSTART- -X- N

Hypoxic NNP Educational
exercise NN Educational
training NN Educational
normoxic NN None
( ( None
21 CD None
% NN None
O? NNP None
) ) None
resting NN None
( ( None
N-C NNP None
) ) None
, , None
hypoxic NN None
( ( None
15 CD None
% NN None
O? NNP None
) ) None
resting NN None
( ( None
H-C NNP None
) ) None
, , None
normoxic JJ None
exercise NN None
( ( None
50 CD None
% NN None
W NNP None
( ( None
max NN None
) ) None
under IN None
21 CD None
% NN None
O? NNP None
, , None
N-T NNP None
) ) None
, , None
hypoxic-relative JJ None
exercise NN None
( ( None
50 CD None
% NN None
maximal JJ None
heart NN None
rate NN None
reserve NN None
under IN None
15 CD None
% NN None
O? NNP None
, , None
H-RT NNP None
) ) None
, , None
or CC None
hypoxic-absolute JJ None
exercise NN None
( ( None
50 CD None
% NN None
W NNP None
( ( None
max NN None
) ) None
under IN None
15 CD None
% NN None
O? NNP None
, , None
H-AT NNP None
) ) None
for IN None
Simultaneously RB None
, , None
this DT None
intervention NN None
increased VBD None
the DT None
N-C NNP None
, , None
H-C NNP None
, , None
N-T NNP None
, , None
and CC None
H-RT NNP None
interventions NNS None
. . None
Therefore RB None
, , None
H-AT NNP None
intervention NN None
hypoxic NN None
exercise NN None
regimen NNS None
-DOCSTART- -X- N

nebivolol NN Pharmocological
and CC None
valsartan NN Pharmocological
valsartan NN Pharmocological
nebivolol RB Pharmocological
-DOCSTART- -X- N

medroxyprogesterone NN Pharmocological
megestrol NN Pharmocological
Estrogen NNP Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
i.m NN None
. . None
injection NN None
of IN None
depot NN Pharmocological
MPA NNP Pharmocological
500 CD None
mg NN None
on IN None
days NNS None
1 CD None
, , None
14 CD None
and CC None
28 CD None
, , None
or CC None
oral JJ Pharmocological
megestrol NN Pharmocological
acetate VBP Pharmocological
40 CD None
mg JJ None
daily RB None
for IN None
6 CD None
weeks NNS None
. . None
MPA NN Pharmocological
: : None
megestrol NN Pharmocological
MPA NNP Pharmocological
megestrol NN Pharmocological
. . None
-DOCSTART- -X- N

Assisted VBN Physical
exercise NN Physical
exercise NN Physical
assisted JJ Physical
exercise NN Physical
control NN Control
daily JJ Physical
passive JJ Physical
extension NN Physical
and CC Physical
flexion NN Physical
range-of-motion NN Physical
exercise NN Physical
exercise NN Physical
-DOCSTART- -X- N

immunotherapy NN Pharmocological
tablet NN Pharmocological
grass NN Pharmocological
allergy NN Pharmocological
immunotherapy NN Pharmocological
tablet NN Pharmocological
( ( Pharmocological
AIT NNP Pharmocological
) ) Pharmocological
grass NN Pharmocological
AIT NNP Pharmocological
placebo NN Control
placebo VB None
: : None
AIT NNP Pharmocological
placebo VB None
. . None
-DOCSTART- -X- N

bupivacaine NN Pharmocological
sufentanil NN Pharmocological
: : None
combined VBN None
spinal-epidural JJ Pharmocological
vs. FW Pharmocological
epidural JJ Pharmocological
initiated VBN None
with IN None
intrathecal JJ None
bupivacaine NN Pharmocological
0.25 CD Pharmocological
% NN Pharmocological
1 CD Pharmocological
mL NN Pharmocological
+ NNP None
sufentanil VBD Pharmocological
5 CD Pharmocological
microg NN Pharmocological
in IN None
the DT None
combined JJ None
spinal-epidural JJ None
group NN None
( ( None
n JJ None
= NNP None
54 CD None
) ) None
, , None
and CC None
with IN None
bupivacaine JJ Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
+ JJ None
epinephrine NN Pharmocological
2.5 CD Pharmocological
microg NN Pharmocological
mL NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
+ VBD None
sufentanil $ Pharmocological
7.5 CD Pharmocological
microg NN Pharmocological
in IN None
the DT None
epidural JJ None
group NN None
( ( None
n JJ None
= NNP None
59 CD None
) ) None
. . None
In IN Pharmocological
both DT Pharmocological
cases NNS Pharmocological
this DT Pharmocological
was VBD Pharmocological
followed VBN Pharmocological
by IN Pharmocological
patient-controlled JJ Pharmocological
epidural JJ Pharmocological
analgesia NN Pharmocological
with IN Pharmocological
bupivacaine JJ Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
( ( None
+ JJ None
sufentanil NN Pharmocological
0.25 CD Pharmocological
microg NN Pharmocological
mL NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

17 CD Pharmocological
alpha-hydroxyprogesterone JJ Pharmocological
caproate NN Pharmocological
. . None
17 CD Pharmocological
alpha-hydroxyprogesterone NN Pharmocological
caproate NN Pharmocological
, , None
250 CD None
mg NN None
by IN None
intramuscular JJ None
injection NN None
once RB None
a DT None
week NN None
, , None
or CC None
a DT None
placebo NN Control
control NN Control
progesterone NN Pharmocological
caproate NN Pharmocological
-DOCSTART- -X- N

hyaluronic JJ Pharmocological
acid NN Pharmocological
exercise VB Physical
therapy NN Physical
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
exercise NN Physical
therapy NN Physical
three CD Pharmocological
intra-articular JJ Pharmocological
HA NNP Pharmocological
injections NNS Pharmocological
exercise NN Physical
therapy NN Physical
HA NNP Pharmocological
exercise NN Physical
therapy NN Physical
HA NNP Pharmocological
exercise NN Physical
therapy NN Physical
-DOCSTART- -X- N

vacuum-assisted JJ Physical
closure NN Physical
therapy NN Physical
the DT Physical
Vacuum-Assisted JJ Physical
Closure NNP Physical
( ( Physical
V.A.C NNP Physical
. . Physical
) ) Physical
system NN Physical
standard VB Physical
moist NN Physical
wound IN Physical
therapy NN Physical
( ( Physical
MWT NNP Physical
) ) Physical
. . None
MWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
NPWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
. . None
-DOCSTART- -X- N

docetaxel NN Pharmocological
docetaxel NN Pharmocological
. . Physical
randomized VBN None
to TO None
receive VB None
nab-paclitaxel JJ Pharmocological
300 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
q3w NN None
, , None
nab-paclitaxel JJ Pharmocological
100 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
or CC None
150 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
the DT None
first JJ None
3 CD None
of IN None
4 CD None
weeks NNS None
( ( None
qw VB None
3/4 CD None
) ) None
, , None
or CC None
docetaxel VB Pharmocological
100 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
q3w NN None
. . None
docetaxel NN Pharmocological
docetaxel NN None
docetaxel NN Pharmocological
. . None
-DOCSTART- -X- N

Trimetazidine NN Pharmocological
: : None
propranolol NN Pharmocological
Trimetazidine NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

relaxation NN Psychological
training NN Psychological
relaxation-training JJ Educational
sessions NNS Educational
relaxation-training JJ None
relaxation NN None
training NN None
-DOCSTART- -X- N

paromomycin NN Pharmocological
placebo-controlled JJ Control
paromomycin NN Pharmocological
sulfate NN Pharmocological
placebo NN Pharmocological
paromomycin NN Pharmocological
placebo NN Control
paromomycin NN Pharmocological
placebo NN Control
paromomycin NN Pharmocological
placebo NN Control
paromomycin JJ Pharmocological
paromomycin NN Pharmocological
-DOCSTART- -X- N

intravenous JJ Pharmocological
and CC Pharmocological
intramuscular JJ Pharmocological
morphine NN Pharmocological
opioids NNS Pharmocological
morphine NN Pharmocological
given VBN Pharmocological
IM NNP Pharmocological
or CC Pharmocological
IV NNP Pharmocological
IM NNP Pharmocological
or CC Pharmocological
IV NNP Pharmocological
morphine VBP Pharmocological
morphine JJ Pharmocological
surgery NN Surgical
morphine VBD Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

clarithromycin NN Pharmocological
, , None
roxithromycin NN Pharmocological
and CC None
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
, , None
roxithromycin NN Pharmocological
and CC None
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
500 CD Pharmocological
mg NN Pharmocological
12-hourly RB Pharmocological
, , None
30 CD None
with IN None
roxithromycin NN Pharmocological
150 CD None
mg NN None
12-hourly JJ None
, , None
and CC None
27 CD None
with IN None
erythromycin JJ Pharmocological
stearate NN None
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
. . None
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
-DOCSTART- -X- N

Cholesterol-lowering JJ Physical
therapy NN Physical
cholesterol-lowering JJ None
therapy NN None
lovastatin NN Pharmocological
, , Pharmocological
an DT Pharmocological
HMG NNP Pharmocological
CoA NNP Pharmocological
reductase NN Pharmocological
inhibitor NN Pharmocological
placebo NN Control
Lovastatin NNP Pharmocological
placebo NN None
lovastatin-treated JJ Pharmocological
placebo-treated JJ None
lovastatin NN Pharmocological
Lovastatin NNP Pharmocological
-DOCSTART- -X- N

exercise NN Other
training NN Other
and CC Physical
dietary JJ Educational
macronutrient NN Educational
composition NN Educational
exercise NN Other
intervention NN Other
very RB Other
low JJ Other
energy NN Other
diet NN Other
( ( Other
VLED NNP Other
) ) Pharmocological
high-fat NN Other
( ( Other
Hi.F NNP Other
) ) Other
diet NN Other
( ( Pharmocological
60 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
( ( Pharmocological
En NNP Pharmocological
% NN Pharmocological
) ) Pharmocological
fat NN Pharmocological
) ) Pharmocological
or CC Pharmocological
a DT Pharmocological
reduced-fat JJ Other
( ( Other
Red.F NNP Other
) ) Other
diet NN Other
( ( Pharmocological
30 CD Pharmocological
En NNP Pharmocological
% NN Pharmocological
fat NN Pharmocological
) ) None
. . None
-DOCSTART- -X- N

melatonin NN Pharmocological
melatonin NN Pharmocological
placebo NN Control
melatonin NN Pharmocological
placebo NN Control
melatonin NN Pharmocological
-DOCSTART- -X- N

citalopram NN Pharmocological
citalopram NN Pharmocological
citalopram JJ Pharmocological
-DOCSTART- -X- N

Ipratropium NNP Pharmocological
bromide NN Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
( ( Pharmocological
IB NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
saline NN Control
nasal NN Control
spray NN Control
IB NNP Pharmocological
or CC None
saline NN Control
IB NNP Pharmocological
saline NN Control
IB NNP Pharmocological
or CC None
saline NN Control
) ) None
-DOCSTART- -X- N

dezocine NN Pharmocological
dezocine NN Pharmocological
intravenous JJ Pharmocological
dezocine NN Pharmocological
or CC None
a DT None
matching JJ Control
placebo NN Control
midazolam JJ None
0.1 CD None
mg/kg NN None
, , None
fentanyl VBP None
5 CD None
?g/kg NN None
, , None
propofol JJ None
1-1.5 JJ None
mg/kg NN None
, , None
and CC None
suxamethonium NN None
intravenous JJ None
dezocine NN None
-DOCSTART- -X- N

nicorandil NNS Pharmocological
: : Pharmocological
nifedipine NN Pharmocological
. . Pharmocological
nicorandil NN Pharmocological
nifedipine NN Pharmocological
placebo-controlled JJ Physical
active JJ Pharmocological
drugs NNS Pharmocological
placebo NN Pharmocological
nicorandil NN Pharmocological
nifedipine NN Pharmocological
placebo NN Pharmocological
. . None
Methergin NNP Pharmocological
( ( Pharmocological
ergometrine NN Pharmocological
) ) Pharmocological
placebo NN Pharmocological
ergometrine NN Pharmocological
nicorandil NN Pharmocological
ergometrine NN Pharmocological
placebo NN Pharmocological
) ) Pharmocological
nifedipine NN Pharmocological
ergometrine NN Pharmocological
placebo NN Pharmocological
) ) None
Nifedipine NNP Pharmocological
nicorandil NNS Pharmocological
Nicorandil NNP Pharmocological
-DOCSTART- -X- N

donepezil NN Pharmocological
cognitive JJ Pharmocological
enhancing VBG Pharmocological
drugs NNS Pharmocological
cholinesterase NN Physical
inhibitors NNS Physical
placebo-controlled JJ Control
donepezil NN Pharmocological
( ( None
doses NNS None
of IN None
5 CD None
and CC None
10 CD None
mg NN None
) ) None
, , None
followed VBN None
by IN None
a DT None
10-week JJ None
open JJ None
label NN None
trial NN None
for IN None
placebo NN None
nonresponders NNS None
. . None
donepezil NN None
treatment NN None
-DOCSTART- -X- N

CBT NNP Educational
approach NN Educational
with IN Educational
conjoint JJ Educational
family NN Educational
therapy NN Educational
and CC Educational
an DT Educational
eclectic JJ Educational
approach NN Educational
. . Educational
CBT NNP Educational
naturalistic JJ Educational
follow-up JJ Educational
design NN None
. . None
-DOCSTART- -X- N

antifibrinolytic JJ Pharmocological
tranexamic JJ Pharmocological
acid NN Pharmocological
tranexamic JJ Pharmocological
acid NN Pharmocological
tranexamic JJ None
acid NN None
) ) None
intravenous JJ Physical
intraoperative NN Surgical
dose NN Surgical
( ( Surgical
IO NNP Surgical
) ) Surgical
given VBN None
before IN None
tourniquet JJ None
deflation NN None
, , None
( ( None
2 CD None
) ) None
additional JJ Pharmocological
preoperative NN Pharmocological
dose NN Pharmocological
( ( Pharmocological
POIO NNP Pharmocological
) ) Pharmocological
, , None
( ( None
3 CD None
) ) None
additional JJ Pharmocological
postoperative NN Pharmocological
dose NN Pharmocological
( ( Pharmocological
IOPO NNP Pharmocological
) ) Pharmocological
, , None
and CC None
( ( None
4 CD None
) ) None
all DT None
three CD None
doses NNS None
( ( None
POIOPO NNP None
) ) None
local JJ Pharmocological
application NN Pharmocological
tranexamic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
. . None
WST-1 JJ Physical
assay NN Physical
tamoxifen NN Pharmocological
tamoxifen NN None
, , None
tamoxifen NN None
randomised VBN None
weaker JJR None
tamoxifen NN None
in IN None
decreased VBN None
tamoxifen NN None
sensitivity NN None
-DOCSTART- -X- N

nifedipine NN Pharmocological
nifedipine NN Pharmocological
Nifedipine CC Pharmocological
pentagastrin NN Pharmocological
-- : None
that WDT None
pentagastrin JJ Pharmocological
Nifedipine NNP Pharmocological
-DOCSTART- -X- N

Blood NNP Physical
transfusions NNS Physical
standard JJ Physical
care NN Physical
or CC Physical
transfusions NNS Physical
Transfusion NNP Physical
-DOCSTART- -X- N

cognitive JJ Educational
behavioural JJ Educational
intervention NN Educational
intervention NN None
wait-list JJ Control
control NN Control
conditions NNS Control
. . None
six CD Educational
2-h JJ Educational
weekly JJ Educational
sessions NNS Educational
-DOCSTART- -X- N

Interactive NNP Educational
voice NN Educational
response NN Educational
( ( Educational
IVR NNP Educational
) ) Educational
technology NN Educational
Quitline NNP Educational
treatment NN Educational
-- : Educational
a DT Educational
interactive JJ Educational
voice NN Educational
response NN Educational
( ( Educational
IVR NNP Educational
) ) Educational
IVR NNP Control
screening NN Control
for IN Control
current JJ Control
smoking NN Control
( ( Control
control VB Control
group NN Control
) ) Control
IVR NNP Educational
screening VBG Educational
plus CC Educational
an DT Educational
IVR NNP Educational
intervention NN Educational
. . Educational
IVR NNP Educational
intervention NN Educational
IVR NNP Educational
system NN Educational
IVR NNP Educational
system NN Educational
IVR NNP Educational
messages NNS Educational
Proactive NNP Educational
IVR NNP Educational
outreach NN Educational
IVR NNP Educational
-DOCSTART- -X- N

sterile JJ Pharmocological
water NN Pharmocological
injection NN Pharmocological
technique NN Pharmocological
sterile JJ Pharmocological
water NN Pharmocological
injections NNS Pharmocological
( ( Pharmocological
SWI NNP Pharmocological
) ) Pharmocological
SWI NNP Pharmocological
SWI NNP Pharmocological
intradermal JJ Pharmocological
needle JJ Pharmocological
SWI NNP Pharmocological
technique NN Pharmocological
. . None
intradermal JJ None
SWI NNP None
technique NN None
requesting VBG None
SWI NNP None
during IN None
-DOCSTART- -X- N

gastric JJ Physical
electrical JJ Physical
stimulation NN Physical
gastric JJ Surgical
electrical JJ Surgical
stimulation NN Surgical
( ( Surgical
GES NNP Surgical
) ) Surgical
GES NNP Surgical
gastric JJ Surgical
electrical JJ Surgical
stimulator NN Surgical
butylscopolamine NN Pharmocological
. . None
GES-induced NNP Surgical
GES NNP Surgical
GES NNP Surgical
. . None
-DOCSTART- -X- N

bedtime JJ None
aspirin JJ Pharmocological
administration NN Pharmocological
Aspirin NNP Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
nonpharmacological JJ None
hygienic-dietary JJ None
recommendations NNS None
; : None
the DT None
same JJ None
recommendations NNS None
and CC None
aspirin NN Pharmocological
( ( None
100 CD None
mg/day NN None
) ) None
on IN None
awakening VBG None
; : None
the DT None
same JJ None
recommendations NNS None
and CC None
aspirin NN Pharmocological
at IN None
bedtime NN None
. . None
nonpharmacological JJ Physical
intervention NN Physical
aspirin NN Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

Gum NNP Physical
elastic JJ Physical
bougie-guided JJ Physical
insertion NN Physical
gum VBZ Physical
elastic-bougie-guided JJ Physical
insertion NN Physical
second JJ Surgical
insertion NN Surgical
attempt NN Surgical
using VBG Surgical
either CC Surgical
the DT Surgical
gum JJ Surgical
elastic JJ Surgical
bougie-guided JJ Surgical
or CC Surgical
introducer JJ Surgical
tool NN Surgical
techniques NNS Surgical
. . Surgical
bougie-guided JJ Physical
technique NN Physical
introducer JJ Physical
tool NN Physical
technique NN Physical
gum JJ Physical
elastic JJ Physical
bougie-guided JJ Physical
insertion NN Physical
tool NN None
insertion NN None
technique NN None
-DOCSTART- -X- N

Vaginal JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
the DT Physical
pelvic JJ Physical
floor NN Physical
: : Physical
intravaginal JJ Physical
electrical JJ Physical
stimulation NN Physical
( ( Physical
ES NNP Physical
) ) Physical
ES NNP Physical
of IN Physical
the DT Physical
pelvic JJ Physical
floor NN Physical
ES NNP Physical
of IN Physical
the DT Physical
pelvic JJ Physical
floor NN Physical
, , None
or CC None
a DT None
daily JJ Physical
Kegel NNP Physical
exercise NN Physical
( ( Physical
KE NNP Physical
) ) Physical
program NN None
. . None
ES NNP None
KE NNP None
ES NNP None
ES NNP None
. . None
-DOCSTART- -X- N

Aztreonam NNP Pharmocological
versus NN None
gentamicin NN Pharmocological
aztreonam NN Pharmocological
gentamicin NN Pharmocological
aztreonam NN Pharmocological
gentamicin NN Pharmocological
. . Pharmocological
aztreonam JJ Pharmocological
aztreonam NN Pharmocological
-DOCSTART- -X- N

cooperation NN Other
radioiodine JJ Pharmocological
treatment NN None
radioiodine NN Pharmocological
substitution NN None
therapy NN None
radioiodine NN Pharmocological
radioiodine NN Pharmocological
radiation NN Physical
therapy NN Physical
cooperation NN Other
-DOCSTART- -X- N

( ( None
diflunisal NN Pharmocological
) ) None
( ( Pharmocological
bupivacaine NN Pharmocological
) ) Pharmocological
( ( Pharmocological
paracetamol NN Pharmocological
with IN Pharmocological
codeine NN Pharmocological
) ) Pharmocological
lignocaine NN Pharmocological
diflunisal/bupivacaine NN Pharmocological
treatment NN Pharmocological
diflunisal NN Pharmocological
-DOCSTART- -X- N

Escort NNP Pharmocological
spirometer NN Pharmocological
Micromed NNP Pharmocological
turbine NN Pharmocological
spirometer NN Pharmocological
mini-Wright JJ Pharmocological
peak NN Pharmocological
flow NN Pharmocological
meter NN Pharmocological
. . Pharmocological
spirometer NN Pharmocological
new JJ Physical
portable JJ Physical
Fleisch NNP Physical
pneumotachograph NN Pharmocological
spirometer NN Pharmocological
( ( None
known VBN None
as IN None
the DT None
Escort NNP None
) ) None
mini-Wright JJ Pharmocological
peak NN Pharmocological
flow NN Pharmocological
meter NN Pharmocological
Micromed NNP Pharmocological
Pocket NNP Pharmocological
turbine NN Pharmocological
spirometer NN Pharmocological
. . Pharmocological
new JJ Pharmocological
spirometer NN Pharmocological
mini-Wright JJ Physical
peak NN Physical
flow NN Physical
meter NN Physical
new JJ Pharmocological
spirometer NN Pharmocological
turbine NN Pharmocological
spirometer NN Pharmocological
. . Pharmocological
mini-Wright JJ None
turbine JJ None
mini-Wright JJ Physical
meter NN Physical
new JJ None
meter NN None
-DOCSTART- -X- N

tunnelling VBG Physical
tunnelling NN Physical
Tunnelling NN Physical
tunnelled JJ Physical
catheters NNS Physical
non-tunnelled JJ Physical
catheters NNS Physical
tunnelling NN Physical
-DOCSTART- -X- N

histamine-induced JJ Physical
mizolastine NN Pharmocological
. . None
Mizolastine NNP Pharmocological
once-daily JJ Pharmocological
mizolastine NN Pharmocological
placebo NN Control
Histamine NN Physical
tests NNS Physical
mizolastine NN Pharmocological
placebo NN Control
mizolastine NN Pharmocological
mizolastine NN Pharmocological
-DOCSTART- -X- N

radiolabelled JJ Pharmocological
anti-carcinoembryonic JJ Pharmocological
antigen NN Pharmocological
I PRP Pharmocological
( ( Pharmocological
131 CD Pharmocological
) ) Pharmocological
KAb201 NNP Pharmocological
( ( None
gemcitabine NN Physical
based VBN Physical
chemotherapy NN Physical
) ) None
KAb201 NNP Pharmocological
KAb201 NNP Pharmocological
-DOCSTART- -X- N

adjuvant JJ Physical
portal JJ Physical
chemotherapy NN Physical
adjuvant JJ Surgical
portal JJ Surgical
infusion NN Surgical
( ( Surgical
5-Fluorouracil JJ Surgical
, , Surgical
Mitomycin NNP Surgical
C NNP Surgical
) ) Surgical
compared VBN Surgical
to TO Surgical
radical JJ Surgical
surgery NN Surgical
alone RB Surgical
. . None
-DOCSTART- -X- N

chemical NN Surgical
or CC Surgical
surgical JJ Surgical
castration NN Surgical
alone RB Surgical
. . None
Anandron NNP Pharmocological
surgical JJ Surgical
castration NN Surgical
MAB NNP Pharmocological
using VBG Pharmocological
Anandron NNP Pharmocological
-DOCSTART- -X- N

creatine JJ Pharmocological
supplementation NN Pharmocological
. . None
Cr NNP Pharmocological
supplementation NN Pharmocological
( ( Pharmocological
CrS NNP Pharmocological
) ) Pharmocological
Cr NNP Pharmocological
or CC None
placebo NN Control
supplements NNS Control
alternative JJ None
treatment NN None
. . None
Muscle NNP Physical
sampling VBG Physical
Cr NNP Pharmocological
Cr NNP Pharmocological
CrS NNP Pharmocological
. . None
-DOCSTART- -X- N

conventional JJ Pharmocological
GIC NNP Pharmocological
( ( Pharmocological
group NN Pharmocological
1 CD Pharmocological
) ) Pharmocological
or CC Pharmocological
GIC NNP Pharmocological
with IN Pharmocological
0.01 CD Pharmocological
% NN Pharmocological
, , Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
1 CD Pharmocological
% NN Pharmocological
collagen NN Pharmocological
( ( Pharmocological
groups NNS Pharmocological
2 CD Pharmocological
, , Pharmocological
3 CD Pharmocological
, , Pharmocological
4 CD Pharmocological
respectively RB Pharmocological
) ) Pharmocological
or CC Pharmocological
, , Pharmocological
10 CD Pharmocological
% NN Pharmocological
, , Pharmocological
30 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
50 CD Pharmocological
% NN Pharmocological
bioactive JJ Pharmocological
glass NN Pharmocological
( ( Pharmocological
groups NNS Pharmocological
5 CD Pharmocological
, , Pharmocological
6 CD Pharmocological
, , Pharmocological
7 CD Pharmocological
respectively RB Pharmocological
) ) Pharmocological
, , Pharmocological
or CC Pharmocological
Mineral NNP Pharmocological
Trioxide NNP Pharmocological
Aggregate NNP Pharmocological
( ( Pharmocological
group NN Pharmocological
8 CD Pharmocological
) ) Pharmocological
. . Pharmocological
-DOCSTART- -X- N

caregiver-based JJ Educational
intervention NN Educational
program NN Educational
caregiver-based JJ Educational
intervention NN Educational
program NN Educational
parents NNS Educational
and CC Educational
child NN Educational
care NN Educational
workers NNS Educational
received VBD Educational
a DT Educational
12-week JJ Educational
intervention NN Educational
consisting NN Educational
of IN Educational
lectures NNS Educational
and CC Educational
on-site JJ Educational
consultations NNS Educational
to TO Educational
day-care JJ Educational
centers NNS Educational
. . Educational
day NN Control
care VB Control
alone RB Control
. . Educational
-DOCSTART- -X- N

electro-acupuncture NN Physical
electro-acupuncture NN Physical
Electro-acupuncture NN Physical
chemotherapy NN Pharmocological
electro-acupuncture NN Physical
chemotherapy NN Pharmocological
electro-acupuncture NN Physical
Electro-acupuncture NN Physical
chemotherapy NN Pharmocological
-DOCSTART- -X- N

n3 JJ Pharmocological
fatty JJ Pharmocological
acid NN Pharmocological
ethyl NN Pharmocological
esters NNS Pharmocological
n3 JJ Pharmocological
fatty RB Pharmocological
acid JJ Pharmocological
ethyl NN Pharmocological
ester NN Pharmocological
( ( Pharmocological
FAEE NNP Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
deficit NN Physical
WL NNP Physical
WL+FAEE NNP Pharmocological
intervention NN Pharmocological
WL+FAEE NNP Pharmocological
WL NNP Physical
n3 JJ Pharmocological
FAEEs NNP Pharmocological
-DOCSTART- -X- N

Expectant JJ Physical
management NN Physical
hormonal JJ Pharmocological
therapy NN Pharmocological
. . None
oral JJ Pharmocological
contraceptives NNS Pharmocological
low-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
a DT None
high-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
a DT None
multiphasic JJ Pharmocological
pill NN Pharmocological
or CC None
no DT Control
therapy NN Control
. . None
oral JJ Pharmocological
contraceptive JJ Pharmocological
oral JJ Pharmocological
contraceptive JJ Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

lisinopril NN Pharmocological
captopril NN Pharmocological
captopril NN Pharmocological
lisinopril NN Pharmocological
captopril NN Pharmocological
lisinopril NN Pharmocological
antihypertensive JJ Pharmocological
regimen NNS Pharmocological
-DOCSTART- -X- N

azimilide NN Pharmocological
Azimilide NNP Pharmocological
dihydrochloride NN Pharmocological
electrocardiogram NN None
. . None
Azimilide NNP Pharmocological
-DOCSTART- -X- N

chlorhexidine NN Pharmocological
gluconate NN Pharmocological
chlorhexidine JJ Pharmocological
gluconate NN Pharmocological
( ( Pharmocological
CHG NNP Pharmocological
) ) Pharmocological
chlorhexidine NN Pharmocological
nonmedicated JJ Physical
skin NN Physical
cleanser NN Physical
. . None
-DOCSTART- -X- N

rapacuronium NN Pharmocological
and CC None
rocuronium NN Pharmocological
anaesthesia NN None
with IN None
propofol JJ None
2.5 CD None
mg JJ None
kg-1 NN None
, , None
either CC None
rapacuronium NN Pharmocological
1.5 CD None
mg NN None
kg-1 NN None
( ( None
n JJ None
= NNP None
30 CD None
) ) None
or CC None
rocuronium $ Pharmocological
0.6 CD None
mg JJ None
kg-1 NN None
( ( None
n JJ None
= NNP None
30 CD None
) ) None
was VBD None
administered VBN None
to TO None
facilitate VB None
tracheal JJ None
intubation NN None
. . None
Anaesthesia NNP None
was VBD None
maintained VBN None
with IN None
either CC None
a DT None
propofol JJ Physical
infusion NN Physical
( ( Physical
100 CD Physical
micrograms NNS Pharmocological
kg-1 JJ Physical
min-1 JJ Physical
) ) Physical
or CC None
sevoflurane NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
% NN Pharmocological
end-tidal JJ Pharmocological
) ) Pharmocological
with IN Pharmocological
66 CD Pharmocological
% NN Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
N2O NNP Pharmocological
) ) Pharmocological
, , None
n JJ None
= VBP None
15 CD None
in IN None
each DT None
subgroup NN None
. . None
was VBD None
performed VBN None
using VBG None
an DT None
electromyographic JJ Physical
( ( None
EMG NNP None
) ) None
device NN None
( ( None
Datex NNP None
Relaxograph NNP None
) ) None
. . None
-DOCSTART- -X- N

vitamin NN Pharmocological
K2 NNP Pharmocological
Vitamin NNP Pharmocological
K2 NNP Pharmocological
( ( Pharmocological
VK2 NNP Pharmocological
) ) Pharmocological
VK2 NNP Pharmocological
control VB Control
Glakay NNP Pharmocological
dynamic JJ Physical
CT NNP Physical
abdominal JJ Physical
angiography NN Physical
. . None
-DOCSTART- -X- N

warfarin NN Pharmocological
aspirin NN Pharmocological
receive VB None
warfarin NN Pharmocological
( ( None
target VB None
international JJ None
normalized JJ None
ratio NN None
, , None
2.0 CD None
to TO None
3.0 CD None
) ) None
or CC None
aspirin NN Pharmocological
( ( None
1300 CD None
mg NN None
per IN None
day NN None
) ) None
in IN None
a DT None
double-blind NN None
, , None
multicenter RB None
clinical JJ None
trial NN None
. . None
aspirin NN Pharmocological
aspirin JJ Pharmocological
warfarin VB Pharmocological
Warfarin NNP Pharmocological
Aspirin NNP Pharmocological
-DOCSTART- -X- N

Creon NNP Pharmocological
10,000 CD Pharmocological
Minimicrospheres NNP Pharmocological
vs. FW None
Creon NNP Pharmocological
8,000 CD Pharmocological
microspheres NNS Pharmocological
-- : None
an DT None
Creon NNP Pharmocological
10,000 CD Pharmocological
Minimicrospherestrade NNP Pharmocological
mark NN Pharmocological
( ( Pharmocological
Creon NNP Pharmocological
) ) Pharmocological
10,000 CD Pharmocological
MMS NNP Pharmocological
) ) Pharmocological
microspheres NNS Pharmocological
( ( Pharmocological
Creon NNP Pharmocological
) ) Pharmocological
8,000 CD Pharmocological
) ) Pharmocological
. . Pharmocological
28 CD None
days NNS None
of IN None
Creon NNP Pharmocological
8,000 CD Pharmocological
ms NN Pharmocological
followed VBN None
by IN None
28 CD None
days NNS None
of IN None
Creon NNP Pharmocological
10,000 CD Pharmocological
MMS NNP Pharmocological
, , None
or CC None
vice NN None
versa NN None
. . None
( ( None
Creon JJ Pharmocological
Creon NNP Pharmocological
-DOCSTART- -X- N

rofecoxib NN None
indomethacin NN None
indomethacin NN Pharmocological
COX-2 NNP Pharmocological
selective JJ Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
-- : None
has VBZ None
COX-2 NNP Pharmocological
selective NN Pharmocological
indomethacin NN Pharmocological
rofecoxib NN Pharmocological
rofecoxib NN Pharmocological
indomethacin NN Pharmocological
-DOCSTART- -X- N

liquid-polish JJ Pharmocological
coating NN Pharmocological
crown NN Other
confocal JJ Pharmocological
laser NN Pharmocological
scanning VBG Pharmocological
microscope NN Pharmocological
scanning VBG Pharmocological
electron NN Pharmocological
microscope NN Pharmocological
-DOCSTART- -X- N

peginterferon NN Pharmocological
alfa-2a NN Pharmocological
peginterferon NN Pharmocological
alfa-2a NN Pharmocological
peginterferon JJ Pharmocological
alfa-2a NN Pharmocological
peginterferon JJ Pharmocological
alfa-2a JJ Pharmocological
peginterferon VB Pharmocological
alfa-2a JJ Pharmocological
peginterferon NN Pharmocological
alfa-2a JJ Pharmocological
plus CC Pharmocological
lamivudine JJ Pharmocological
. . Pharmocological
peginterferon NN Pharmocological
alfa-2a NN Pharmocological
pegylated JJ Pharmocological
interferon NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

lanreotide NN Pharmocological
lanreotide NN Pharmocological
transsphenoidal VB Surgical
surgery NN Surgical
lanreotide NN Pharmocological
-DOCSTART- -X- N

donepezil NN Pharmocological
placebo-controlled JJ Control
cholinesterase NN Pharmocological
inhibitors NNS Pharmocological
. . None
donepezil NN Pharmocological
donepezil JJ Pharmocological
donepezil $ Pharmocological
placebo NN Control
donepezil NN Pharmocological
placebo NN None
donepezil NN Pharmocological
donepezil VBZ Pharmocological
placebo NN None
donepezil JJ Pharmocological
Donepezil-treated JJ None
placebo NN None
donepezil NN None
donepezil VBZ None
Donepezil NNP None
( ( None
placebo NN None
donepezil CC None
donepezil CC None
placebo NN None
) ) None
-DOCSTART- -X- N

preventive JJ Psychological
intervention NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
based VBN Psychological
intervention NN Psychological
program NN Psychological
, , Psychological
FRIENDS NNP Psychological
the DT None
story-reading NN None
or CC None
FRIENDS JJ None
-DOCSTART- -X- N

standardized JJ Educational
pamphlet NN Educational
pamphlet NN Educational
actigraphy NN Other
device NN Other
pamphlet NN Educational
( ( None
pamphlet VB Educational
versus NN Educational
no DT Control
pamphlet NN Control
) ) None
. . None
pamphlet NN Educational
sleep JJ Educational
education NN Educational
pamphlet NN Educational
-DOCSTART- -X- N

metronidazole NN Pharmocological
erythromycin-neomycin JJ Pharmocological
and CC None
metronidazole-neomycin JJ Pharmocological
-DOCSTART- -X- N

Risperidone NNP Pharmocological
Risperidone NNP Pharmocological
risperidone NN Pharmocological
placebo-substitution JJ Control
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
; : Pharmocological
Risperidone NNP Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

standard JJ Pharmocological
danazol NN Pharmocological
and CC None
modified VBD Pharmocological
triptorelin NN Pharmocological
regimens NNS Pharmocological
danazol NN Pharmocological
and CC None
triptorelin NN Pharmocological
danazol NN Pharmocological
or CC None
triptorelin NN Pharmocological
danazol NN Pharmocological
triptorelin NN Pharmocological
triptorelin NN Pharmocological
. . Pharmocological
danazol NN Pharmocological
triptorelin NN Pharmocological
triptorelin JJ Pharmocological
triptorelin NN Pharmocological
danazol NN Pharmocological
. . Pharmocological
triptorelin JJ Pharmocological
-DOCSTART- -X- N

Arthroscopic NNP Surgical
rotator NN Surgical
cuff NN Surgical
repair NN Surgical
with IN Surgical
and CC None
without IN Physical
acromioplasty NN Physical
arthroscopic VBN Surgical
cuff JJ Surgical
repair NN Surgical
with IN Surgical
or CC None
without IN Physical
acromioplasty JJ Physical
-DOCSTART- -X- N

Auditory NNP Educational
integration NN Educational
training NN Educational
Auditory NNP Educational
integration NN Educational
training NN Educational
and CC None
a DT None
control NN Control
treatment NN Control
auditory JJ Educational
integration NN Educational
training NN Educational
. . Educational
-DOCSTART- -X- N

Both DT None
children NNS None
's POS None
eyes NNS None
were VBD None
examined VBN None
an DT Physical
was VBD Physical
taken VBN Physical
from IN Physical
each DT Physical
child NN Physical
's POS Physical
right JJ Physical
eye NN Physical
and CC Physical
processed VBN Physical
by IN Physical
to TO Physical
test VB Physical
for IN Physical
the DT Physical
presence NN Physical
of IN Physical
C. NNP Physical
trachomatis NN None
DNA NNP None
. . None
-DOCSTART- -X- N

evening VBG None
primrose JJ None
oil NN None
( ( None
gamma NN Pharmocological
linolenic RB Pharmocological
acid NN Pharmocological
) ) None
and CC None
fish JJ None
oil NN None
( ( None
eicosapentaenoic JJ Pharmocological
+ NNP Pharmocological
docahexaenoic NN Pharmocological
acid NN Pharmocological
) ) None
versus NN None
magnesium NN Pharmocological
, , None
and CC None
versus NN None
placebo NN Control
placebo NN Control
combination NN None
of IN None
evening VBG None
primrose JJ None
oil NN None
and CC None
fish JJ None
oil NN None
was VBD None
compared VBN None
to TO None
Magnesium NNP Pharmocological
Oxide NNP Pharmocological
, , None
and CC None
to TO None
a DT None
Placebo NNP Control
Placebo NNP Control
evening VBG Pharmocological
primrose JJ Pharmocological
oil NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
Gamma-linolenic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
GLA NNP Pharmocological
) ) Pharmocological
, , None
Eicosapentaenoic NNP Pharmocological
acid NN Pharmocological
( ( Pharmocological
EPA NNP Pharmocological
) ) Pharmocological
Docosahexaenoic NNP Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
Magnesium NNP Pharmocological
Oxide NNP Pharmocological
Placebo NNP Control
-DOCSTART- -X- N

Primary JJ Surgical
deep JJ Surgical
sclerectomy NN Surgical
primary JJ Surgical
deep JJ Surgical
sclerectomy NN Surgical
with IN Surgical
the DT Surgical
use NN Surgical
of IN Surgical
mitomycin NN Surgical
C NNP Surgical
deep JJ Surgical
sclerectomy NN Surgical
without IN Surgical
the DT Surgical
use NN Surgical
of IN Surgical
mitomycin NN Surgical
C NNP Surgical
( ( Surgical
DS NNP Surgical
group NN Surgical
) ) Surgical
and CC None
deep JJ Surgical
sclerectomy NN Surgical
with IN Surgical
the DT Surgical
application NN Surgical
of IN Surgical
mitomycin NN Surgical
C NNP Surgical
( ( Surgical
DSMMC NNP Surgical
group NN Surgical
) ) Surgical
-DOCSTART- -X- N

radial JJ Educational
artery NN Educational
internal JJ Educational
thoracic NN Educational
artery NN Educational
saphenous JJ Educational
vein NNS Educational
Protocol-directed JJ Physical
angiography NN Physical
-DOCSTART- -X- N

new JJ Pharmocological
and CC Pharmocological
commercially RB Pharmocological
available JJ Pharmocological
drugs NNS Pharmocological
surgery NN Surgical
and/or NN None
radiation NN Physical
therapy NN Physical
18 CD Other
agents NNS Other
chemotherapy VB Physical
radiation NN Physical
therapy NN Physical
-DOCSTART- -X- N

light-cured JJ Physical
sealant NN Physical
( ( Physical
HFLCS NNP Physical
) ) Physical
37 CD Physical
% NN Physical
phosphoric JJ Physical
acid NN Physical
for IN Physical
20 CD Physical
seconds NNS Physical
, , None
and CC None
RMGIC NNP Physical
( ( Physical
Fuji NNP Physical
Ortho NNP Physical
LC NNP Physical
, , Physical
GC NNP Physical
Europe NNP Physical
, , Physical
Leuven NNP Physical
, , Physical
Belgium NNP Physical
) ) Physical
HFLCS NNP Physical
( ( Physical
Pro NNP Physical
Seal NNP Physical
, , Physical
Reliance NNP Physical
Orthodontic NNP Physical
Products NNP Physical
, , Physical
Itasca NNP Physical
, , Physical
Ill NNP Physical
) ) Physical
. . None
metal JJ Physical
brackets NNS Physical
ceramic JJ Physical
brackets NNS Physical
. . None
-DOCSTART- -X- N

Antibiotic JJ Pharmocological
prophylaxis NN Pharmocological
one-day JJ Pharmocological
five-day JJ Pharmocological
therapy NN Pharmocological
. . None
antibiotic JJ Pharmocological
prophylaxis NN Pharmocological
. . None
cefoperazone NN Pharmocological
sodium NN Pharmocological
24 CD None
hours NNS None
or CC None
120 CD None
hours NNS None
. . None
perioperative JJ Pharmocological
antibiotic JJ Pharmocological
prophylaxis NN Pharmocological
. . None
antibiotics NNS Pharmocological
-DOCSTART- -X- N

haloperidol NN Pharmocological
, , None
risperidone NN Pharmocological
and CC None
olanzapine NN Pharmocological
. . None
haloperidol NN Pharmocological
, , None
risperidone NN Pharmocological
and CC None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
, , None
risperidone NN Pharmocological
, , None
and CC None
olanzapine NN Pharmocological
-DOCSTART- -X- N

Villalta-Prandoni NNP Other
scale NN Other
venous JJ Other
clinical JJ Other
severity NN Other
score NN Other
graduated JJ Physical
compressive JJ Physical
stockings NNS Physical
30-40 JJ Physical
mm NN Physical
Hg NNP Physical
graduated VBD Physical
compressive JJ Physical
stockings NNS Physical
( ( Physical
GCS NNP Physical
) ) Physical
or CC None
no DT Control
stockings NNS Control
. . None
CONCLUSION NNP None
Both NNP None
VPS NNP None
and CC None
VCSS NNP None
scoring VBG None
-DOCSTART- -X- N

availability NN Educational
of IN Educational
information NN Educational
( ( Educational
not RB Educational
available JJ Educational
, , Educational
available JJ Educational
upon IN Educational
request NN Educational
, , Educational
available JJ Educational
automatically RB Educational
) ) None
-DOCSTART- -X- N

lorazepam JJ Pharmocological
0.5 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
1 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
2 CD Pharmocological
mg NN Pharmocological
, , None
sertraline VBP Pharmocological
50 CD Pharmocological
mg NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

Low-intensity NNP Physical
exercise NN Physical
low-intensity JJ Physical
exercise NN Physical
program NN Physical
exercise NN Physical
intervention NN Physical
no-intervention JJ Control
control NN Control
. . Control
Exercise NN Physical
exercise NN Physical
sessions NNS Physical
exercise NN Physical
low-intensity JJ Physical
exercise NN Physical
program NN Physical
-DOCSTART- -X- N

etching VBG Pharmocological
with IN Pharmocological
hydrofluoric JJ Pharmocological
acid NN Pharmocological
+ NNP Pharmocological
silane NN Pharmocological
application NN Pharmocological
or CC None
2 CD None
) ) None
tribochemical NN Pharmocological
silica NN Pharmocological
coating NN Pharmocological
. . None
-DOCSTART- -X- N

right JJ Physical
ventricular JJ Physical
myocardial JJ Physical
isovolumic JJ Physical
relaxation NN Physical
time NN Physical
. . None
RV NNP Physical
IVRT NNP Physical
( ( Physical
IVRT NNP Physical
' POS Physical
) ) Physical
invasively RB Surgical
measured VBN Surgical
PAP NNP Surgical
. . Surgical
Transthoracic NNP Physical
echocardiography NN Physical
with IN Physical
myocardial JJ Physical
velocity NN Physical
imaging NN Physical
and CC Physical
right JJ Surgical
heart NN Surgical
catheterization NN Surgical
-DOCSTART- -X- N

Zinc NNP Pharmocological
supplementation NN Pharmocological
zinc NN Pharmocological
sulfate NN Pharmocological
and CC None
a DT None
placebo NN Control
zinc NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

stage-of-change NN Educational
oriented VBN Educational
smoking VBG Educational
cessation NN Educational
intervention NN Educational
stage-of-change NN Educational
oriented VBN Educational
smoking VBG Educational
cessation NN Educational
intervention NN Educational
three CD Educational
to TO Educational
five CD Educational
minute NN Educational
scripted VBN Educational
intervention NN Educational
and CC Educational
booklet NN Educational
specific NN Educational
to TO Educational
the DT Educational
woman NN Educational
's POS Educational
stage-of-change NN Educational
in IN Educational
the DT Educational
smoking NN Educational
continuum NN Educational
, , Educational
versus JJ Educational
standard NN Other
of IN Other
care NN Other
. . None
Exhaled VBN Physical
carbon-monoxide NN Physical
( ( Physical
CO NNP Physical
) ) Physical
monitoring NN None
-DOCSTART- -X- N

phenytoin NN Pharmocological
phenytoin NN Pharmocological
